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1. 1 Introduction to DExD/H box heilcases. 
DExD/H-box proteins are a class of enzymes that are thought to unwind RNA-RNA 
duplexes in an NTP-dependent manner, and therefore are required for all aspects of 
RNA metabolism (Bork and Koonin, 1993: Koonin, 1993). All DExD/H-box 
proteins employed in splicing and pre-rRNA processing belong to the SF2 family of 
helicases, and can be easily identified by the presence of 7-9 conserved motifs (de la 
Cruz et al., 1999). An amino acid sequence in motif II gives the name for the whole 
family (Linder et al., 1989). Mutational analysis implicated these motifs in RNA 
binding and translocation (motifs La, Lb. IV and V), NTP binding and hydrolysis (I, 
II, VI and Q) and motif III is believed to couple NTP hydrolysis to remodelling 
events reviewed in Tanner and Linder, 2001 (figure 1.1). 
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Figure 1.1. Schematic representation of DExD/H helicases structure. The 
conserved motifs of DExD/H box helicases are folded into two distinct domains 
(highlighted). Role of the motifs in substrate recognition and ATP binding is shown 
(adapted from Jankowsky et at., 2001). 
Among RNA helicases of the SF2 superfamily, three subfamilies can be 
distinguished: DEAD, DEAH and Ski2-like (DExH) proteins, which are often 
referred by the common name DExD/H-box helicases (Cordin et al., 2006; de la 
Cruz et al., 1999; Tanner and Linder, 2001). Despite sharing a highly similar 
structure, several distinctive characteristics allowed identification of these sub- 
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families. Thus, DEAD-box proteins are non-processive RNA binding ATPases, 
whose main function is believed to be displacing proteins from RNA (Cordin et al., 
2006; Linder et al., 2001). DEAH-box proteins are NTPases, which show significant 
levels of NTP hydrolysis even without RNA bound. The third sub-family, DExH-box 
helicases, are ATP-dependent and processive enzymes that are capable of active 
translocation along the substrate (Fairman et al., 2004; Kawaoka et al., 2004). The 
mechanism of their translocation is believed to be similar to that of processive DNA 
helicases (Pyle, 2008). 
Structurally, all DExD/H-box helicases are very similar and possess two RecA-like 
domains connected by a linker (Caruthers and McKay, 2002). It is believed that this 
linker enables relative movements of domains during different stages of the 
biochemical cycle of the helicases. However there is a noticeable difference in the 
domain organisation between the subfamilies, which is believed to influence their 
biochemical properties (figure 1 .2)(Pyle, 2008). Structural studies of DEAD-box 
proteins revealed that their two RecA-like domains are connected with a very 
flexible linker that allows significant movement of helicase domains relative to each 
other dependent on their RNA and ATP-nucleotide bound state (Pyle, 2008). At the 
same time, helicase domains of DExH-box proteins are positioned close to each 
other at all times even without bound nucleotide, which determines the ability of the 

















Pyle AM. 2008. 
Annu. Rev. Biophys. 37:317-36. 
Figure 1.2 The architectural changes in DEXH and DEAD proteins upon 
binding of RNA and ATP. The actual three-dimensional structures of the bound 
states are shown as ribbon diagrams (adapted from Pyle, 2008). 
Despite high similarity in sequence and structure, DExD/H-box helicases possess 
high specificity in vivo. The mechanisms, which govern their specificity, activity and 
recruitment to the specific substrates, remain largely unknown. It is believed that 
specificity and activity of DExD/H-box proteins is mostly determined by the protein-
protein interactions within large protein complexes (Silverman et al., 2003). As the 
C- and N-termini of DExD/H-box helicases are variable in sequence and 
composition, it is suggested that they are largely responsible for the specificity of 
interactions of DExD/H box proteins with either co-factors, or substrates (Edwalds-
Gilbert et al., 2004; Silverman et al., 2003). Several examples of the role of flanking 
regions in the regulation of activity and specificity of DExD/H-box proteins have 
been obtained. The C-terminal domain of E. coli DEAD-box helicase DbpA enables 
it to recognize a specific part of 23S rRNA, which also provides a unique example of 
sequence specificity among DExD/H-box helicases (Fuller-Pace et al., 1993; Pugh et 
al., 1999). Over-expression of the flanking regions of yeast DEAH-box helicase 
Prpl6p impairs viability, suggesting that flanking regions have a dominant negative 
phenotype, and possibly play a role in binding of the Prpl6p to the spliceosome 
(Burgess et al., 1990; Wang and Guthrie, 1998). Also the N-terminus of Prp2p was 
shown to be necessary for the interaction with Spp2p, which is required for Prp2p 
recruitment to the spliceosome (Edwalds-Gilbert et al., 2004; Silverman et al., 2004). 
However, eIF4AIIIp and Dbp8p, which do not possess extensive flanking sequences, 
were shown to be able to bind their co-factors with the conserved helicase core; this 
suggests that flanking regions, while important for the specificity, are not the only 
regions capable of interaction with co-factors (Granneman et al., 2006b; Tanner and 
Linder, 2001) 
Several biochemical characteristics of DExD/H-box helicases are important for their 
function. 
1.2 Nucleic acid binding. 
DExD/H-box helicases are thought to unwind RNA-RNA duplexes, therefore they 
should have the capacity to bind RNA. For several DExD/H-box proteins no RNA 
binding activity has been shown; it is largely believed that their RNA binding 
activity depends on co-factors, which are absent in vitro assay (Silverman et al., 
2003). However, there is a principal difference between RNA binding between 
DEAD and DExH helicases. DEAD-box proteins require RNA binding for their 
ATPase activity, while DExH-box proteins are able to hydrolyze ATP even without 
RNA present (lost et al., 1999; Tanaka and Schwer, 2005, 2006). Most DExD/H box 
helicases show no sequence specificity in vitro (apart from bacterial DEAD-box 
helicase DbpA mentioned above), and therefore the high specificity of DExD/H box 
helicases is believed to depend on multiple protein-protein interactions (Silverman et 
al., 2003). 
7 
1.3 Activity of DExD/H helicases. 
RNA helicases are thought to unwind RNA duplexes in an NTP-dependent manner. 
Two principally different mechanisms of activity for DEAD and DExH proteins 
were proposed based on crystal structures and their biochemical properties 
(figure 1.2). 
Without ATP and RNA bound, DEAD-box helicases adopt various "open" 
conformations with no contacts between two domains as was revealed after solving 
their crystal structures (reviewed in Cordin et al., 2005). Cooperative binding of ATP 
and RNA brings the two domains together, forming a "closed" conformation with 
extensive interactions between the domains as was revealed by crystal structures of 
DEAD-box helicase Vasa and eIF4A with a non-hydrolysable analog of ATP and 
ssRNA (Bono et al., 2006; Sengoku et al., 2006). It has also been suggested that the 
change from "open" to "closed" conformations activates DEAD-box proteins 
enabling them to perform ATP hydrolysis and unwinding. Recently, a FRET assay 
with Bacillus subtilis DEAD-box helicase YxiN carrying donor and acceptor on 
different domains showed that indeed cooperative binding of ATP and ssRNA causes 
changes in conformation of YxiN; ATP hydrolysis leads to "open" conformation, 
supporting the existence of a biochemical cycle of "open"-"closed" conformations 
(Theissen et al., 2008). In vitro studies established that the unwinding step of DEAD-
box proteins is only 5-6 bp, which is approximately the binding site of a single 
molecule of the enzyme, and it is believed that DEAD-box helicases couple binding 
of RNA to unwinding of RNA-RNA duplex. It was suggested that DEAD-box 
enzymes upon their binding of RNA duplex, change their conformation in ATP -
dependent manner thus they destabilize the duplex, releasing ssRNA. Subsequent 
change of conformation probably leads to spontaneous dissociation of the helicase 
from RNA (Pyle, 2008).. 
Processive DExH helicases load on the ss overhang, and are able to translocate 
alongside the loading strand displacing RNA or proteins, therefore the best way to 
describe their activity mode as "wire strippers" (Pyle, 2008). 
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1.4 Translocation. 
Several models originally developed for DNA and processive RNA helicases, based 
on observation in vitro, are likely to be applicable to explain the mode of action of 
DExH helicases. The models can be divided into two large groups: deterministic 
stepping models and stochastic brownian models, which in a certain sense are 
complementary to each other. Both of these models rely on the fact that a helicase 
has at least two nucleic acid binding sites, which independently bind and release the 
substrate with one binding site at a time staying bound to the substrate. Stepping 
models include the active rolling model and the inchworm model (reviwed in 
(Soultanas and Wigley, 2000, 2001; Tanner and Linder, 2001). The active rolling 
model is applicable to dimeric helicases, and suggests that the two nucleic acid 
binding sites have high affinity to either dsRNA or ssRNA, respectively. ATP 
hydrolysis causes changes in the affinity state, and results in duplex unwinding. The 
inchworm mechanism can be used to describe ATP-hydrolysis dependent relative 
movements of domain 1 and domain 2 within a helicase monomer. According to this 
model, the substrate is bound simultaneously by two domains, but only one of them 
is tightly bound to the substrate at any time. To date the inchworm model is the best 
to explain DExD/H-box helicase activity. 
ILI 




Figure 1.2 Models of helicase activity. The active rolling model requires a dimer 
for the activity in which each monomer has a different affinity to the substrate. These 
conformations require binding ATP and ATP hydrolysis. The inchworm model 
works for monomeric or oligomeric helicases. In this case distances between 
domains vary with ATP binding and hydrolysis. (Adapted from Tanner and Linder, 
2001) 
The Brownian model is also a two-state model, but instead of deterministic 
movement it invokes Brownian motion and two different states of helicase: with high 
and low affinities to the substrate based on NTP bound states (Levin et al., 2005). 
When the helicase changes its nucleotide bound state, its affinity to the nucleic acid 
changes (as in case of the inchworm model). It can move alongside the substrate in 
either direction in Brownian motion or dissociate. After resuming the high affinity 
state, the helicase makes a move forward, performing the unwinding (Levin et al., 
2005). This model agrees well with low processivity of RNA helicases, however the 
stochastic nature of the model does not agree with the observed polarity, and does 
not really agree with a proposed role of "motors" for DExD/H-box helicases. 
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1.5 Functions of DExD/H box helicases. 
Despite that DExD/H proteins are called RNA helicases, and a priori are able to 
unwind RNA duplexes, increased evidence is accumulating regarding functions of 
these enzymes in activities unrelated to duplex unwinding. Additionally, many 
proteins of this class show very weak unwinding activity in vitro, which initially was 
attributed to lack of co-factors in in vitro assays. However, at present DEAD-box 
proteins viewed as RNA binding proteins, which are unable to translocation, and the 
primary function for DEAD-box proteins is thought to be protein displacement 
(Cordin et al., 2006; Fairman et al., 2004). This function for DEAD proteins was 
supported not only in in vitro studies, but also in analyses of in vivo genetic 
interactions. If developed further, this idea suggests the function of DEAD-box 
proteins could assist in snRNP maturation and biogenesis through prevention of 
premature interactions, or facilitating processing events by displacing proteins from 
the processing sites. Recently, the functions of Dedip and Mss116p in strand 
annealing were uncovered (Halls et al., 2007; Yang and Jankowsky, 2005). Indeed, 
these proteins were shown to stabilize RNA duplexes in the absence of ATP, 
suggesting that DExD/H box proteins might play opposite roles in RNA processing. 
For some processive helicases duplex unwinding is a confirmed function 
(Raghunathan and Guthrie, 1998), however they are also shown to be able to remove 
proteins from the single stranded RNA (Linder et al., 2001). 
1.6 Co-factors of DExD/H box helicases. 
It has been suggested that the activity and specificity of DExD/H box proteins is 
largely modulated by protein-protein interaction, and that they are required to be part 
of a complex to be active. Numerous co-factors for the DExD/H box proteins were 
identified. Some of them are required for the association with complexes, and others 
were shown to be required for the activity. Both of these functions might be 
performed by the same protein, however most of the studies assayed only one or the 
other. Several examples of helicases and their co-factors are given below. 
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Several co-factors, enhancing activity of DExD/H-box helicases were identified. 
Interestingly, some of the co-factors have RNA binding motifs, or putative RNA 
binding motifs. As many DExDIH box helicases were shown to have weak RNA 
binding, it is possible that using an RNA-binding protein as a cofactor is a way of 
stimulating the helicase activity (Silverman et al., 2003). It is conceivable that 
interacting proteins help to "correct" conformation of DExD/H box helicases, and 
switch helicase domains into a functional mode. AlteRNAtively, the RNA binding 
domains of the accessory proteins might provide a bridge between DExD/H box 
helicase and RNA substrate (Silverman et al., 2003). 
Studies of DEAD - box helicase Rh1B of E. coil provided support for the first 
hypothesis. RhlBp is a component of the degradosome, which contains RNAseE (Py 
et al., 1996). Rh1B was shown to interact directly with RNAseE, and this interaction 
is required for the stimulation of activity of RhIB. Additionally, it was established 
that small recombinant peptides of RNAseE, which mimicked RNAseE interaction 
with RhlB, were able to stimulate ATPase activity of RhlB, and this implied that the 
RNA-binding domain of RNAseE was not required for the activity of RhlB (Vanzo 
et al., 1998). It was therefore proposed that interaction between these two proteins 
triggers small structural changes in conformation of RhlB, which lead to its 
activation and eliminated the possibility that RNAseE acts like a bridging factor 
(Chandran et al., 2007). 
Another well-known example is the translation initiation eIF4F complex from higher 
eukaryotes (reviwed in (Gingras et al., 1999). One of the components of this 
complex, DExiD/H box helicase eIF4AIII was stimulated by protein eIF4G (Rogers 
et al., 2001). A co-crystal structure of eIF4AIII and eIF4G showed that eIF4G 
interacts with both RecA-like domains of eIF4AIII; eIF4G was proposed to act as a 
"stopper", preventing eIF4AIII from going into a non-productive conformation 
(Marcotrigiano et al., 1997). 
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The only known example of helicase activator in pre-rRNA processing in yeast is 
Esf2p, which is required for activation of helicase Dbp8p (Granneman et al., 2006b). 
In vitro experiments showed that the presence of Esf2p and RNA stimulated the 
ATPase activity of Dpb8p, by increasing its affinity for ATP (Granneman et al., 
2006b), providing an example of modulation of biochemical parameters of helicase 
by co-factor. 
DEAD-box helicase Dbp5p involved in mRNA export provides an interesting 
example of helicase regulation (Snay-Hodge et al., 1998; Weirich et al., 2006). 
Dbp5p, a cytoplasmic helicase, interacts directly with the nuclear pore protein Gle 1 p. 
Interestingly, it was shown that Dbp5p does not show helicase activity or RNA 
binding activity in vitro when assayed alone. However, addition of Gleip increases 
the biochemical activity of Dbp5p, suggesting that Gleip is an activator of Dbp5p. 
As these proteins have different sites of localization, it was proposed that Gle 1 p 
locally activates Dbp5p thus providing an example of means of regulation of 
DExD/H-box helicases by separation of helicase in space from its activators to 
prevent premature action (Weirich et al., 2006). 
Prp43 protein and its co-factors are the object of the research in this study, and will 
be discussed in detail below. 
Several other studies showed genetic interactions of helicases with RNA binding 
proteins, however no biochemical studies were performed. Thus, DEAD-box 
helicase Prp5p involved in spliceosome assembly has a genetic interaction withRNA-
binding protein Cus2p (Perriman et al., 2003), and DEAH-box protein Prp2p requires 
G-patch protein Spp2p for association with the spliceosome (Silverman et al., 2004). 
In pre-rRNA processing, proteins Rrp5p and Garip were shown to have genetic 
interaction with helicase Rok 1 p  with pre-rRNA processing machinery (dosage rescue 
and synthetic lethality, respectively) (Torchet et al., 1998; Venema and Tollervey, 
1996). Remarkably, several helicases were found to possess genetic interactions with 
each other. Thus, in a yeast two-hybrid assay, splicing DEIH-box helicase Brr2p 
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interacted with DEAH-box proteins Prp2p and Prp l6p, and Prp I 6 interacted with 
Prp22p (van Nues and Beggs, 2001). Moreover, Prp22p seems to require Prp I 6 for 
its association with the spliceosome (McPheeters et al., 2000). In pre-rRNA 
processing, weak yeast two-hybrid interaction between Dbp6p and Dbp9p, and 
synthetic growth defect between Dbp7p and Dbp3p were reported (Bernstein et al., 
2006; Daugeron et al., 2001; Granneman et al., 2006a). Also, it has been shown that 
increased dosage of Dbp9p suppresses mutations in DBP6 (dbp6-4, dbp6-13), 
suggesting the existence of a functional relationship between the two proteins 
(Daugeron et al., 2001). Additionally, synthetic enhancement of the defect caused by 
mutations in DBP6, DBP7 and DBP9 were reported, which indicates that these 
helicases are likely to affect the same pathway (Daugeron et al., 2001). The 
possibility of close association between helicases was also proposed by Bernstein 
and colleagues as their investigation of DExD/H-box helicases revealed that some of 
them co-precipitate other helicases which were shown to be functionally close in pre-
rRNA processing (Bernstein et al., 2006). Strikingly, a gene dosage effect was 
observed for pre-rRNA processing helicases in E. coli as over-expression of the 
DExD/H-box helicase RhlE, participating in pre-rRNA processing, suppresses or 
exacerbates the slow growth phenotypes of mutations in helicases CsdA and SrmB, 
respectively (Jam, 2008). This allows speculation that interactions between helicases 
are conserved through evolution and different RNA processing machineries, and 
likely has some functional significance. Also it is possible that there might be an as 
yet unappreciated level of regulation between helicases. As many processive viral 
RNA helicases were shown to act as oligomers, it is conceivable that association 
between DExD/H-box helicases serves as some kind of activation and regulation 
mechanism. Moreover, the existence of such a network of interactions supports the 
idea that DExDIFI-box proteins might act as driving motors for biological processes, 
possibly by chain activation of helicases. 
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1,7 Possible targets for DExD/H-box helicases in pre-mRNA splicing 
and pre-rRNA processing 
At present, the targets of most DExD/H box helicases remain unknown; although, 
several genetic and crosslinking studies have identified potential targets for helicases 
or RNPase activity of DExDIH box helicases. 
Potential targets of DExDIH-box helicases in splicing. 
In splicing in many cases potential targets of DExD/H-box helicases were 
characterised (figure 1.4) Through the use of yeast genetics it was established that 
altering certain RNA-protein interactions could make DEAD box proteins 
dispensable for growth. Thus, during spliceosome assembly the need for the essential 
Prp28p can be alleviated when either U1-Cp or the Ui snRNA structure are altered 
(Chen et al., 2001; Strauss and Guthrie, 1994). Analysis of several mutants suggested 
that destabilization of interaction of Ui with 5'SS and altering the structure of Ui-
Cp probably makes the switch from Ul/5'SS to U6/5'SS easier to occur as U1-Cp is 
believed to stabilize the U 1 association with the 5'S S. Therefore it was proposed that 
Prp28p might play a role in displacing Ui-Cp from the 5'SS (Chen et al., 2001). 
At another step of spliceosome assembly BBP and Mud2 proteins should be 
displaced from the branch-point region by U2 binding to the 3'SS. Two DEAD-box 
helicases were implicated in this step of spliceosome assembly - Sub2p and Prp5p. It 
was established that deletion of the non-essential MUD2 gene makes otherwise 
essential Sub2p helicase dispensable for this stage of spliceosome assembly (Kistler 
and Guthrie, 2001). Additionally, deleting the non-essential RNA binding protein 
Cus2p alleviates requirement for the activity of Prp5p (Perriman and Ares, 2000), 
suggesting that Prp5p might displace Cus2p from U2. However, ATPase activity of 
Prp5p has been shown to be required for U2 association with the branch-point region 
(Xu and Query, 2007), however these two functions might be overlapping. 
While DEAD-box helicases were implicated in protein displacement, the precise 
roles of DEAR-box helicases remains largely unidentified. Recently developed 
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knowledge about catalytic reactions identified a putative role for Prp l6p in 
remodeling of the U2 snRNA stem lic to ha, therefore playing a role in toggling of 
U2 snRNA structure between two conformations (Perriman and Ares, 2007). 
Additionally, cross-linking data revealed interaction of Prpl6p with the 3'SS, 
suggesting a possible role for Prpl6p in remodeling of the 3'SS during catalytic steps 
(McPheeters and Muhlenkamp, 2003). Mutational analysis implicated another 
DEAH-box helicase Prp22p in mRNA release from the spliceosome, and recently 
direct evidence for this was obtained (Wagner et al., 1998). Cross-linking studies and 
an RNAse H protection assay found Prp22p to be associated with the 3'SS, which 
supported a function for Prp22 in unwinding of rnRNA/U5 loop contacts and thus 
promoting mRNA release (Schwer, 2008). 
The only DEIH helicase of the spliceosome, Brr2p, is also the only integral helicase 
of the spliceosome. As was stated above, the main distinction of the proteins 
belonging to this class is their processivity. Indeed, Brr2p was implicated in 
unwinding U4//U6 duplex during the formation of the catalytic spliceosome 
(Raghunathan and Guthrie, 1998). Furthermore, the helicase activity of Brr2p was 
implicated in spliceosome disassembly (Small et al., 2006), and it was shown that 
Brr2p unwinds U211J6 duplex in vitro (Xu et al., 1996), suggesting that Brr2p might 
play an opposite roles during spliceosomal cycle. 
Prp2p and Prp43p are helicases with unknown RNA/protein targets, despite it is 
known that Prp2p is involved in activation of the spliceosome, and Prp43p plays a 
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Figure 1.3 RNA helicases in pre-mRNA splicing and schematic representation 
of pre-mRNA splicing cycle. DExD/H-box helicases involved at each step of 
splicing reaction are indicated. (Adapted from (Bleichert and Baserga, 2007). 
Potential targets of DExDIH-box helicases in pre-rRNA processing. 
Pre-rRNA processing, like splicing, requires RNA-RNA remodelling, and 18 
DExD/H-box helicases were found to play a role in ribosomal RNA maturation 
(figure 1.4). The helicases of pre-rRNA processing mostly belong to the DEAD-box 
subfamily, which are non-procesive enzymes. There are only three exceptions - 
Dhrlp and Dhr2p are classified as DEAH-box class proteins, and Mtr4p is a DExH-
helicase. 
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Fugure 1.4 Schematic representation of DExDIH-box helicases involved in pre-
rRNA processing pathway. Simplified schematic of pre-rRNA processing for small 
(18S; left side) and large subunit (5.8S, 25S; right side) maturation with indicated 
cleavage sites. The 18S, 5.8S and 25S are transcribed as a polycystronic precursor. 
Several endo- and exonucleolytic cleavage steps occur in order to mature the rRNAs. 
RNA helicases involved in 18S maturation are indicated in red, those involved in 
5.8S and 25S maturation are indicated in green, and RNA helicases that have been 
implicated in biogenesis of both large and small ribosornal subunits are represented 
in yellow. Esf2p, the only known and characterised co-factor of a helicase involved 
in ribosome biogenesis, is indicated in blue. (Adapted from (Bleichert and Baserga, 
2007). 
The functions of the helicases in pre-rRNA processing remain largely unknown, 
apart from several examples given below. It was proposed that the role of DExD/H-
box helicases might be remodeling multiple snoRNA-rRNA interactions. However, 
the only snoRNAs directly implicated in cleavages (U3, U14 and snR30) are 
essential. The rest of the snoRNAs are dispensable for growth, and even double 
deletion mutants do not show a phenotype. Therefore it is unlikely that the sole 
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function of DExD/H box helicases in pre-rRNA processing is snoRNA remodelling. 
At the same time, experiments have shown that depletion of Dbp4p results in 
retention of U14 and Snr41 snoRNAs with pre-rRNA processing particles, and led to 
the proposition that Dbp4p unwinds U14 snoRNA from pre-rRNA processing 
machinery (Kos and Tollervey, 2005). Direct evidence of the unwinding has not been 
obtained, however, the existence of a genetic interaction between U14 and Dbp4p 
suggests that U14 retention is likely to be a direct consequence of depletion of 
Dbp4p (Kos and Tollervey, 2005; Liang et al., 1997). Additionally, a mutation in 
Rokip helicase is synthetic lethal with snRlO, suggesting that Rokip might be 
involved in remodelling of snoRNA interaction with pre-rRNA (Venema et al., 
1997). Strikingly, depletion of Hasip resulted in retention of U14, U3, snR3, snRlO, 
snR30, snR63 and snR77 with pre-rRNA processing particles, suggesting that either 
Hasi and Dbp4p have overlapping functions, or retention of snoRNAs might be an 
indirect result of faulty pre-rRNA processing (Liang and Fournier, 2006). 
Additionally, depletion of several other helicases (Dbp8p, Rokip, Dhrlp, Dhr2p) has 
no effect on snoRNA association with the pre-rRNA processing machinery (Kos and 
Tollervey, 2005), indicating that remodeling of snoRNA - pre-rRNA interactions is 
not the only function of the helicases. Therefore, despite that a direct effect of 
DExD/H-box helicases on snoRNA remodeling is possible, it is likely that helicases 
in pre-rRNA processing perform other unidentified functions. 
Attempts were made to address possible functions by over-expressing dominant 
negative mutants of DExD/H-box helicases and assaying pre-rRNA processing 
defects, however, no specific phenotype was attributed to particular helicases and 
little information about their function was revealed (Bernstein et al., 2006; 
Granneman et al., 2006a). Overall, only really mild pre-rRNA processing defects, or 
no defects at all, were observed for large subunit pre-rRNA processing helicases, 
however all mutants studied had a growth defects. Comprehensive studies of the 
helicases of the small subunit revealed that over-expression of the dominant negative 
mutants resulted in accumulation of 23S, which suggests the inhibition of A 2 
cleavage, but no specific phenotype was observed (Granneman et al., 2006a). 
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DExH-box helicase Mtr4p was shown to play a role in 5.8S maturation and exosome 
activation (de la Cruz et al., 1998). Analysis of Mtr4p mutants revealed accumulation 
of extended 5.8S species (Alimang et al., 1999), which indicates that Mtr4p might 
play a role in remodelling of some secondary structures in ITS2. 
As the question about the potential targets of DExD/H-box helicases in pre-rRNA 
processing remains open, current studies are concentrated on investigation of the 
interaction of helicases with pre-rRNA, which might help to identify their potential 
targets. 
1.2.1 Introduction to splicing 
Coding (exonic) sequences of most eukaryotic genes are interrupted by non-coding 
sequences (introns). At the time this discovery was made, the advantage in 
possessing interrupted genes was not really obvious. While analysing genomes it was 
noticed that many proteins are composed of a patchwork of active modules with 
borders of the domains corresponding to exon-introns boundaries. Therefore the 
presence of interrupted genes might be evolutionally advantageous as it allows 
increased genome capacity without increased size and combines existing active units 
to generate proteins with new functions. 
Seven types of introns were identified so far, but only two of them were identified in 
eukaryotic protein coding genes (U2-dependent and U12-dependent). 
Analysis of intron distribution shows that generally, lower eukaryotes have fewer 
introns. Thus around 250 introns were identified in the genome of the yeast 
Saccharomyces cerevisiae, while individual human genes might contain more than 
100 introns (collagen Type VI contains 117 introns). Although only approximately 
4% of Saccharomyces cerevisiae genes contain introns, many intron-containing 
genes in yeast are highly expressed. For example, most of the ribosomal proteins 
genes contain intron, therefore intron-containing transcripts comprise approximately 
25% of all transcripts in yeast (Ares et al., 1999; Lopez and Seraphin, 1999). S. 
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cerevisiae introns are mainly distributed towards the 5'of genes. The extremely 5'- 
biased intron distribution of genes in the yeast genome is likely driven by secondary 
intron loss via intronless cDNAs produced by reverse transcription of a processed 
mRNA (Fink, 1987). 
The process of removing intronic regions from precursor mRNA (pre-mRNA) 
transcripts is called pre-mRNA splicing. Pre-mRNA splicing is catalysed by a large 
ribonucleoprotein complex called the spliceosome and research shows that all known 
spliceosomes rely on the same mechanism of splicing reaction (Brody and Abelson, 
1985; Grabowski et al., 1985). Two distinctive classes of spliceosomes were 
described, which perform splicing on U2 or U12 introns. The canonical (U2-
dependent) or major spliceosomes are universal, while minor spliceosomes (U12-
dependent) are present only in metazoans and plants and are able to catalyse splicing 
of an atypical class of introns (Hall and Padgett, 1994, 1996). 
1. 2.2 Sequences important for splicing 
Precise definition and excision of introns is a necessity in living cells. Incorrectly 
spliced RNA can potentially lead to reduced viability or death of the cell as in most 
cases incorrectly spliced pre-mRNA can cause premature stop codon inclusion and 
therefore promote RNA degradation through NMD. Recent advances in large-scale 
studies with human material revealed that incorrect splicing determines multiple 
diseases, or accounts for disease severity, therefore correct excision of the introns is 
extremely important. Correct choice of splice sites is defined, on one hand, by cis-
elements in sequences in the RNA, and on the other hand, by a wide range of trans-
acting factors of the spliceosomal machinery. 
Three short conserved sequences were shown to be important for splicing in yeast: 
the 5' splice site, the 3' splice site and branch-point sequence. 
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Mutagenesis analysis identified the consensus sequence of the 5'splice site in yeast 
as AG/GUAUGU, with the first two nucleotides of intron being extremely 
conserved, and changes in these nucleotides were shown to abolish splicing 
completely (Vii ayraghavan et al., 1986). Another important intronic sequence is 
usually located 20-60 nucleotides upstream of the 3'SS, and has a sequence 
UACUAAC. The last A of this sequence is a highly conserved adenosine residue, 
which provides the nucleophile for the first attack in first splicing reaction, and is the 
site where intron-lariat forms a branch (branch-point). 
Introns in yeast and higher eukaryotes have the dinucleotide AG at their 3' end. In 
addition, 3'S S in mammals is preceded by a stretch of pyrimidine bases located just 
upstream. This stretch is called the polypyrimidine tract and it affects efficiency of 
3' SS choice in alteRNAtive splicing. The polypyrimidine tract is rarely seen in yeast 
introns, and the 3'SS choice is determined mainly by the branch-point sequence. 
Mutagenesis of the consensus sequences in pre-mRNA in yeast either abolishes 
splicing completely, or results in accumulation of aberrant intermediates. On the 
contrary, in mammals nucleotide changes in splice sites usually result in using 
cryptic splice sites, which probably reflects the difference in spliceosomal 
machineries between yeast and higher eukaryotes. In higher eukaryotes, multiple 
trans-acting factors affect splice site selection, in addition to cis-elements encoded in 
the RNA. 
1.2.3 Pre-mRNA splicing reaction 
Introns are removed from pre-mRNA by two sequential trans-esterification reactions. 
In the first step of the splicing reaction, the phosphodiester bond at the 5'S S is 
cleaved as a result of nucleophilic attack by the conserved adenosine (branch point 
nucleotide) located upsteam of the 3'SS. This step generates a S'exon. intermediate 
exonl with a free 3'-hydroxyl group and a branched intron-exon II (branched intron 
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is often referred to as lariat) with a 2'-5' bond at the branch site. In the second step, 
attack by the 3'hydroxyl of exoni at the 3'SS results in joining of the two exons 
together via a 3'-5' phosphodiester bond. This produces two products of the splicing 
reaction: mRINA and excised intron-lariat (Ruby and Abelson, 1991). 
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Figure 1.6 Schematic representation of pre-mRNA splicing reaction. Splicing 
occurs via two trans-esterification reactions. Products and intermediates of the 
splicing reaction are shown. 
1.2.4 The spliceosome 
The spliceosome is a large and dynamic ribonucleoprotein complex, consisting of 5 
small nuclear ribonucleoprotein particles (snRNPs) and non-snRNP proteins. Each 
snRNP contains an snRNA associated with the defined set of proteins (Guthrie and 
Patterson, 1988). 
Spliceosomal snRNAs form a highly conserved and dynamic network of RNA-RNA 
interactions, which plays a primary role in recognition of splice sites (SS) and is 
likely to be the key elements in catalysis. Consistent with this, Ui, U2, U4, U5 
snRNAs have extremely conserved primary structure in functionally important 
regions, but vary in length and sequence among different species. At the same time 
U6 snRNA is highly conserved in sequence and structure, which might represent the 
preservation of the important function of U6 sRNA in pre-mRNA splicing. 
Some of the snRNP proteins are the common components of several snRNPs, like 
Sm-proteins, while others are specific to individual snRNPs. Seven Sm-proteins 
designated B, Dl, D2, D3, E, F, G are components of Ui, U2, U4, U5 snRNPs, and 
recognize a highly conserved Sm-motif on snRNAs. U6 snRNP does not contain Sm-
proteins, instead it is associated with Sm-like proteins called Lsm proteins for their 
similarity and possession of Sm-like domains. 
Additionally, several spliceosomal proteins are not associated with snRNPs. These 
proteins are involved in stabilization of snRNP association with the spliceosome, 
play roles in rearrangements of RNA-RNA and RNA-protein interactions and 
spliceosome recycling. 
1.2.5 Spliceosome assembly 
Spliceosome assembly is a dynamic and ordered process. It involves recognition of 
splice sites on the pre-mRNA by snRNAs, and results in assembly of catalytically 
competent spliceosome able to perform the first step of splicing (Brow, 2002). 
Spliceosome assembly is initiated by basepairing of the 5' end region of Ui sliRNA 
with a conserved complementary sequence at the 5' end of the intron in the pre-
mRNA in an ATP-independent manner (Ruby and Abelson, 1988). As a result 
commitment complex (CC) in yeast, or E' complex in mammals is formed (Seraphin 
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and Rosbash, 1989). It was shown that recruitment of Ui snRNA to the nascent 
transcript might occur co-transcriptionally, however the role and significance of co-
transcriptional splicing in yeast is debated. While it is accepted that spliceosome 
assembly might occur co-transcriptionally, the large proportion of splicing in yeast is 
believed to be transcription-independent. 
On the next step base pairing between U2 snRNA and the branch point sequence 
occurs, forming Complex A in yeast. First, BBP (Branch point Binding Protein) - 
Mud2 heterodimer recognizes the branch-point sequence, and the KH domain of 
BBP specifically binds the branch-point sequence and flanking nucleotides (Abovich 
et al., 1994; Abovich and Rosbash, 1997). BBP-Mud2p dimer is believed to serve as 
a bridge between 5'SS and branch-point as interactions between Ui snRNP proteins 
Prp39p and Prp40p and BBP were reported (Abovich and Rosbash, 1997; Kao and 
Siliciano, 1996). Additionally, Mud2p interacts with Clflp (Prpl9 complex protein) 
and Sub2p suggesting that BBP-Mud2p dimer also serves as an anchor for the 
proteins involved in later stages in splicing (Abovich and Rosbash, 1997; Wang et 
al., 2005). Further U2 snRNP recruitment to CC2 complex occurs, and it is believed 
to be initially based on protein-protein interactions (Gozani et al., 1998). Before 
stable association of U2 snRNA with the branch-point occurs, U2 snRNA undergoes 
ATP-dependent structure rearrangements and BBP is removed from the branch-point 
allowing U2 snRINA to take its place (Zavanelli and Ares, 1991; Zavanelli et al., 
1994). DexD/H box helicases Sub2p and Prp5p are implicated at this stage of 
spliceosome assembly (Dalbadie-McFarland and Abelson, 1990; Perriman and Ares, 
2000). It was suggested that Prp5p alters the conformation of U2 in an ATP-
dependent manner, and enables it to associate with the branch-point (Perriman et al., 
2003). Study of Prp5p mutants with altered ATPase activity supported a role for 
Prp5p in stable association of U2 snRNA with the branch-point sequence (Xu et al., 
2004; Xu and Query, 2007). While Prp5p function was characterised very well, the 
function of Sub2p in spliceosome assembly remains elusive. While depletion or 
inactivation of Sub2p affects spliceosome assembly, this protein was also shown to 
be involved in mRNA export in yeast (Jensen et al., 2001; Libri et al., 2001; Zhang 
and Green, 2001). On the contrary, the human homologue of Sub2p, protein. 
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hUAP56, is the only protein involved in stable U2 snRNA association with the 
spliceosome (Fleckner et al., 1997; Zhang and Green, 2001). 
The mechanism of U4/U6.U5 tri-snRNP complex binding to Complex A is not well 
understood. However, certain evidence suggests that the U5 snRNP might target tn-
snRNP to the spliceosome. Thus, the U5 snRNP component Prp8p was shown to 
interact with Prp39p and Prp40p in yeast two-hybrid screen (Abovich and Rosbash, 
1997). Additionally, psoralen crosslinking of Ui and U5 saRNAs was observed, 
indicating that US snRNA might be the first component of the tri-snRNP to establish 
interaction with the Complex A (Newman et al., 1995; Wassarman and Steitz, 1992; 
Wyatt et al., 1992). This idea is supported by the fact that Aar2-associated U5 
snRNP was consistently co-isolated with U  snRNA (Gottschalk et al., 2001). 
According to the currently accepted model, snRNPs assemble on pre-mRNA in a 
stepwise manner. Isolation of a penta-snRNP and tetra-snRNP challenged the step-
wise assembly hypothesis (Stevens et al., 2002). It was argued that while penta-
snRNP was isolated under very mild conditions similar to those in cells, other 
spliceosomal complexes were isolated under stringent conditions and likely to be 
artefacts of the isolation procedures (Stevens et al., 2002). This led to the proposition 
that the spliceosome does not assemble in an ordered manner, but rather interacts 
with pre-mRNA pre-assembled. However, lately several groups demonstrated co-
transcriptional recruitment of U1 snRNA to pre-mRNA, which supports the step-
wise assembly theory (Kotovic et al., 2003; Lacadie and Rosbash, 2005), and 
studying of arrested complexes in vivo favours step-wise spliceosome assembly 
(Tardiff and Rosbash, 2006). 
1.2.6 Towards a catalytic spliceosome 
After spliceosome assembly, a series of activation steps take place, which result in 
formation of a catalytically competent spliceosome. Rearrangements include 
dissociation of Ui and U4 snRNAs and assembly of U2/U6 duplex, which 
presumably comprises the catalytic centre of the spliceosome (Madhani and Guthrie, 
1994; Staley and Guthrie, 1998; Valadkhan, 2005). Additionally, new interactions 
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between 5'exon and U5 snRNA, and 5' intron and U6 snRNA are formed 
(Sontheimer and Steitz, 1993). 
To activate spliceosomes, first Ui snRNA must be displaced from the 5'SS, and U6 
interaction with the 5'SS takes place. Before that, extensive base-pairing of U4/U6 
duplex must be disrupted. It was noticed that Ui snRNA release requires unwinding 
of U4/U6 duplex, suggesting that these two events are likely coupled (Kuhn et al., 
1999; Staley and Guthrie, 1999). Recent data indicated that a highly conserved 
InteRNAl Stem-Loop of U6 snRNA plays a role in regulation of the coupling of the 
release of Ui and U4 snRNAs from the spliceosome, possibly by stabilising the 
U6/5'SS interaction (McManus et al., 2007). 
DEAD-box helicase Prp28p was shown to promote Ui snRNA release from the 
spliceosome, and Brr2p was implicated in U4/U6 unwinding (Raghunathan and 
Guthrie, 1998; Staley and Guthrie, 1999) as Brr2-1 mutant fails to release U4 snRNA 
from complex B. It was shown that Snul 14p derepresses Brr2p during spliceosome 
activation. Also a mutation in the tri-snIRNP protein, Prp38p, affects U4 release, 
suggesting that Prp38p affects Brr2 function (Xie et al., 1998). Strikingly, several 
alleles of Prp8p suppress brr2-1 and prp28-1 alleles suggesting that Prp8p might act 
as a switch, promoting unwinding of U4/1J6 and release of Ui snRNA directly or 
indirectly (Kuhn et al., 1999; Kuhn et al., 2002). 
Immediately after or concomitantly with U4 snRNA release, a protein complex 
consisting at least eight components (Prpl9 complex; NTC) joins the spliceosome 
(Chen et al., 2002). It is believed that Prpl9 complex stabilizes U6 and U5 snRNAs 
interactions with pre-mRNA after Ui and U4 release (Chan and Cheng, 2005; Chan 
et al., 2003). It was proposed that the presence of Prpl9-mediates stabilization of U6 
interaction with pre-mRNA through remodelling of U6 snRNP (Chan and Cheng, 
2005). During the remodelling, Lsm proteins are removed from the 3'end of U6 
allowing it to establish novel RNA-RNA interaction within the intron (Chan et al., 
2003). Also it was proposed that U6/5'SS and U5/exon5' interactions are dynamic 
during tri-snRNP association with the spliceosome, and addition of the NTC 
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stabilizes or "locks" the interactions (Chan and Cheng, 2005). Thus initial U6 
interaction with the intron involves two sets of conserved ACA triads. After the NTC 
joins the spliceosome switch of ACA 42-44 box to ACA 47-49 box occurs, 
generating active spliceosomes. Additionally, while immediately after tri-snRNP 
association U5 snRNA establishes dynamic interactions between U5 and pre-mRNA, 
in the presence of the NTC the U5 interaction with 5' exonic sequence becomes 
strictly defined (Chan and Cheng, 2005). 
DEAH-box helicase Prp2p is required for the final step of spliceo some activation, 
however the nature of the activation events is not known (Kim and Lin, 1996). It was 
hypothesised that the spliceosome might change its conformation to gain catalytic 
competence, however nothing is known about the Prp2p-dependent rearrangements. 
Interestingly, dominant negative forms of Prp2p can be cross-linked to pre-mRNA, 
suggesting that pre-mRNA might be the target of Prp2p activity (Edwalds-Gilbert et 
al., 2004; Teigelkamp et al., 1994). 
Recently obtained data exposed a potential role of U2 snRNA in regulation of 
spliceosome conformations. It was noticed that U2 snRNAs fluctuates between two 
competing conformations, which are compatible with different stages of splicing 
(Hilliker et al., 2007; Perriman and Ares, 2007). These conformations, stem-loop ha 
and stem-loop hic, are mutually exclusive forms of U2 snRNA (Hilliker et al., 2007; 
Perriman and Ares, 2007). Numerous studies showed that stem-loop ha is necessary 
for spliceosome assembly, while mutations hyperstabilizing stem-loop TIc inhibit 
pre-spliceosome formation. (Zavanelli et al., 1994). Rearrangement of U2 snRNA 
between steps will be discussed in detail in the next section. 
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1.2.7 The catalytic spliceosome. 
After U4 release, U6 snRNA forms a duplex with U2, however this event is not well 
understood. Several lines of evidence suggest that U6 structure undergoes 
rearrangements, suggesting the existence of some intermediates of U2/U6 duplex 
(Brow and Vidaver, 1995). On the contrary UV cross-linking suggests that U2/U6 
duplex starts forming even before U4/U6 duplex is unwound (Frilander and Steitz, 
2001). 
The U2f1J6 duplex composes the catalytic centre of the spliceosome (helix II). The 
U211J6 snRNA duplex shares structural similarity and demonstrates 
interchangeability of domains between U2/1J6 duplex and group II introns, 
suggesting that the spliceosome is likely a ribozyme (Hetzer et al., 1997; Shukla and 
Padgett, 2002). Supporting this notion, recently the ability of fragments of U2/1J6 to 
catalyze a first-step like reaction was demonstrated in a cell-free system (Valadkhan 
and Manley, 2001). Strikingly, the loop region of US snRNA can be dispensable for 
this reaction. As the invariant loop of U5 snRNA interacts with both exonic 
sequences it is proposed that U5 snRNA aligns the exons during the splicing reaction 
for ligation (Newman and Norman, 1992; O'Keefe et al., 1996; Sontheimer and 
Steitz, 1993; Wyatt et al., 1992), and this explains how the first-step like reaction 
might occur in the absence of U5. While interaction of U5 with the 5' exon is formed 
during spliceosome activation, interaction of U5 loop with the 3'exon occurs only 
after the first step is complete (Cortes et al., 1993; Newman and Norman, 1991; 
Newman and Norman, 1992; Newman et al., 1995). It is not entirely clear how the 
U5 loop interacts with exonic sequences, however the protein "in the heart of the 
spliceosome" Prp8p is proposed to serve as a scaffold for U5 snIRNA/substrate 
interaction, and substrate repositioning during catalytic steps (Grainger and Beggs, 
2005). It was noticed that certain mutant alleles of Prp8 inhibit one step of the 
splicing while promoting another one (Konarska et al., 2006; Liu et al., 2007). 
The catalytic centre is not rigid, and undergoes changes, as the second step of 
splicing is not simply the reverse reaction of step one (Burgess and Guthrie, 1993; 
Konarska et al., 2006). Thus, the branch-point should be removed from the catalytic 
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centre and substituted with the 3'SS. Supporting this reorganization, products of rare 
trans-splicing events were discovered (Smith et al., 2007). Further, it was discovered 
that sequences of U2 snRNA located downstream of branch-point interaction region 
fluctuate between 2 mutually exclusive structures (Stem ha and Stem JIc) during 
spliceosome assembly and trans-esterification reactions. While Stem ha promotes 
toward the catalytic spliceosome, Stem lic is necessary for the first catalytic reaction 
(and likely for the second one), and is restored back to Stem ha after the step 1 
reaction is completed (Hilliker et al., 2007; Perriman and Ares, 2007). Toggling of 
U2 structure supports the idea that binding of U2 to the branch point helix could be 
disrupted during splicing as Stem lic prevents U2 binding to the branch-point, and 
supports the idea of a flexible catalytic centre. 
In between catalytic steps not only RNA-RNA rearrangements occur, but several 
second step specific factors (Prpl7p, Slu7p) were shown to join the spliceosome 
(Jones et al., 1995). These factors include DEAH-box helicase Prp22p, which is 
required for the second trans-esterification reaction, and ATP-dependent release of 
mature mRNA from the spliceosome (McPheeters et al., 2000). 
1.2.8 The post-spliceosome. 
After splicing occurs, the products of the splicing reaction (mRNA and excised 
intron-lariat) must be released and U2/U6.U5 snRNPs dissociate. DEAH box protein 
Prp22p was proposed to unwind mRNA from the loop of U5 snRNA, thus promoting 
mRNA release (Schwer, 2008). However, much less is known about events, which 
take place after mRNA release. No post-splicing complex(es) were isolated so far, 
and no models of spliceosome disassembly were proposed. However, two 
possibilities of the mode of spliceosome disassembly exist. First, by analogy with the 
step - wise spliceosome assembly process, spliceosome disassembly might require 
several stages. AlteRNAtively, after mRNA release post-splicing complex might fall 
apart releasing individual snRNPs and excised intron. Before snRNPs get released, 
several RNA-RNA rearrangements take place. Thus in the post-splicing complex, U2 
still remains base-paired with U6, and this duplex must be disrupted in order for U2 
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and U6 to undergo recycling. Additionally, U2 snRNA is still associated with the 
excised intron lariat. At the same time, after mRNA leaves the post-splicing 
complex, no known RNA-RNA interactions between U5 snRNA and remaining 
snRNAs and excised intron-lariat exist, and it is not known when U5 leaves the 
spliceosome. 
Several factors were shown to play a role in intron-lariat release/spliceosome 
disassembly. Initially, the ATPase activity of DEAH-box helicase Prp43p was shown 
to be required for lariat release as ATPase deficient mutants of Prp43p accumulate 
excised intron in the post-splicing complex (Martin et al., 2002). Recently mutants of 
several other splicing factors were found to affect lariat release. Thus, mutant of 
DExH box helicase Brr2p was found to accumulate excised intron-lariat (Small et al., 
2006). Interestingly, U2/U6 duplex was found to stimulate helicase activity of Brr2p 
in vitro (Xu et al., 1996), suggesting that Brr2p unwinds U2/U6 in addition to its 
function in unwinding U4/U6 duplex, providing an example of a protein playing 
opposite functions during the splicing reaction. The activity of Brr2p in spliceosome 
disassembly, as in spliceosome assembly, is governed by Snull4p and Prp8p (Small 
et al., 2006). The fact that proteins involved in spliceosome disassembly have 
function elsewhere in the spliceosome (Brr2p, Snul 14p, Prp8p) or in different RNA 
processing machinery (Prp43p) explains the lack of information about spliceosome 
disassembly and difficulties of isolation of the post-splicing complex. 
1.2.9 DExD/H box proteins as fidelity factors. 
All biological systems rely on programmed intrinsic ability to proofread the transfer 
of the information, and discard aberrant molecules/intermediates, which are below a 
certain standard. Moreover, most of the reactions in multi-step biological processes 
are bi-directional, therefore in order to complete the cycle or reaction, some kind of 
driving force is often necessary. The driving force provides directionality to the 
biological reactions by introducing irreversible steps into the pathways; and one of 
the commonly used irreversible reactions is ATP hydrolysis. Combining two 
necessities for the cell, it was postulated that not only the fact of the hydrolysis, but 
also the rate of ATP hydrolysis is important, as it was suggested that rate of ATP 
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hydrolysis serves as a proofreading mechanism by providing a limited amount of 
time for the reaction to occur. 
It was noticed in biochemical analysis and by observation of the splicing of the group 
II of introns that the net change of energy during a splicing reaction is zero, which 
indicates that the splicing reaction per se does not require ATP hydrolysis and 
possibly can occur spontaneously (Konarska and Query, 2005). However, ATP was 
shown to be utilized by multiple DExD/H box helicases during the splicing process, 
and therefore a role for DExD/H box helicases as driving force and fidelity factors 
was proposed. 
In a pioneering screen for factors that reduce splicing fidelity, the DEAH box 
helicase Prpl6p was identified (Burgess et al., 1990). It was observed that 
compromising Prp l6p ATPase activity causes suppression of branch-point mutants, 
and therefore allows aberrant splicing to take place. This observation led to the 
introduction of a kinetic proofreading theory as a mechanism of fidelity in splicing 
(Staley and Guthrie, 1998). The main postulate of this hypothesis is that ATP 
hydrolysis determines rearrangement of the catalytic centre independently of the 
splicing reaction. It is accepted that "correct" or "right" substrate will have the best 
conformation/sequence to base-pair with snRNAs, while the absence of 
complementarity of aberrant substrate causes delay in base pairing. If the act of ATP 
hydrolysis by DExD/H box helicase occurs after the right conformation was 
achieved, the substrate goes to the next level of processing, if before - substrate is 
not processed, and gets discarded. 
After discovery of the role of Prp l6p as a fidelity factor, several other splicing 
helicases were found to employ similar mechanism for proofreading. Alterations of 
Prp22p and Prp5p activities were shown to affect 3'SS and branch-point/U2 
interactions respectively (Mayas et al., 2006; Xu and Query, 2007). In mRNA 
surveillance, Upflp, an RNA helicase of SF  superfamily, was suggested to use ATP 
hydrolysis to distinguish proper translation termination events, suggesting that 
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kinetic proofreading might be used in many aspects of RNA metabolism (Hilleren 
and Parker, 1999). It is possible that DExD/i-I box helicases in pre-rRNA processing 
play a role of fidelity factors in addition to their role in complex remodelling as 
suggested by kinetic proofreading. 
1.3.1 Ribosomal biosynthesis. 
The yeast ribosome consists of 4 different types of rRNAs and associated proteins. 
18S RNA and associated proteins together create the small subunit (40S), and 25S, 
5.8S and 5S with respective proteins compose the large (60S) subunit. The process of 
ribosome biogenesis is initiated with transcription of pre-rRNA precursors, and 
concominantly with the transcription, processing steps and assembly of ribosomal 
proteins on the pre-rRNA precursors starts. Following initial assembly steps, pre-
ribosomes are transported to the cytoplasm, where the final maturation steps occur 
(reviewed in (Henras et al., 2008; Venema and Tollervey, 1999). 
Most of the events of pre-rRNA processing take place in a specialised part of the 
nucleus called the nucleolus, although late steps of 60S maturation take place in the 
nucleus and late 40S maturation occurs in the cytoplasm. 
25S, 18S and 5.8S are transcribed as a single precursor (35S), which undergoes a 
series of nucleolytic cleavages and extensive covalent modifications in order to 
produce mature rRNA species. In the 35S RNA, the sequences of the 18S, 5.8S and 
25S species are separated by inteRNAl transcribed spacers (ITS 1 and ITS2), and 
flanked by exteRNAl spacers (ETS 1 and ETS2) as presented in figure 1.7 
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Figure 1.7 A. Organization of 35S operon of S. cerevisiae The organization of 
35S pre-rRNA precursor and location of processing sites. B. The pre-rRNA 
processing pathway in S. cerevisiae. The 35S precursor is generated by co-
transcriptional cleavage at site B0 within the 3ETS. This is followed by 
endonucleolytic cleavages at sites A 0, within 5'ETS, A 1 at the 5'end of the mature 
18S rRNA and A2 within ITS 1. Cleavage at A2 separates the precursors to the 40S 
and 60 S subunits and generates the 20S and 27SA 2 pre-rRNAs. 20S is subsequently 
exported from the nucleus to the cytoplasm where maturation to 18S is completed. 
The 27SA2 pre-rRNA follows one of two alternate pathways: approximately 85% is 
cleaved at A3 site within ITS2, followed by 5'-3' exonucleolytic processing 
generating the 27SB 15 pre-rRNA. The remained 15% is processed at site BIL, 
yielding the 27SBIL pre-rRNA. These two alternate forms of 27SB are cleaved 
within ITS2 at site C2, yielding 26S and 7S. The 7S is converted to 5.8S by a 
multistep 3'exonuclease pathway. Maturation of 26S to 25S rRNA similarly 




Ribosome biogenesis starts with the co-transcriptional cleavage of the nascent 
transcript at the B0 site in 3'ETS by Rntlp, which generates a 90S particle containing 
35S pre-rRNA (Kufel et al., 1999). Notably, mass-spectrometry studies of the 90S 
particle revealed that it is largely composed from U3 snoRNP, components required 
for small subunit processing, and also includes r-proteins of the small subunit 
(Grandi et al., 2002). It was shown that association of ribosomal proteins might play 
a role in pre-rRNA processing events, possibly by providing a scaffold for binding of 
pre-rRNA processing factors (Ferreira-Cerca et al., 2005). It was suggested that pre-
60S particles assemble on pre-rRNA after the small and large subunit processing 
pathways are separated (Lebaron et al., 2005), however recent findings were reported 
of some of the pre-60S proteins with 90S particles, indicating that at least several 
pre-60S might be a part of the 90S particle (Oeffinger et al., 2007). Analysis of the 
protein content of 90S suggested the directionality of the assembly of processing 
factors and pre-rRNA proteins as 35S transcript is synthesised, supporting the idea 
that 90S assembly occurs co-transcriptionally (Fatica and Tollervey, 2002). 
It is believed that the first set of proteins to become associated with 35S belongs to t-
UTP (U Three Protein) complex, which is required for optimal transcription of pre-
rRNA as well as early cleavages (Gallagher et al., 2004). Following association oft-
UTPs with 35S, U3 snoRNP and UTPB and UTPC complexes join 3 5 S (Gallagher et 
al., 2004). U3 snoRNP establishes direct interaction with pre-rRNA, and is required 
for early cleavages (Hughes and Ares, 1991). Additionally U3 snoRNA possibly acts 
as a chaperone preventing premature central pseudoknot formation in 18S sequence 
when it is still part of 35S (Beltrame and Tollervey, 1995; Sharma and Tollervey, 
1999). It was suggested that the U3 snoRNA associated DEAH-box helicase Dhrlp 
plays a role in remodelling/annealing of U3 to the 18S sequence during pseudoknot 
formation, however the precise function of Dbrlp is not known (Colley et al., 2000). 
After extensive modification, 35S is cleaved in ETS 1 at the A0 site, producing 33S 
species, which is subsequently cleaved at the A l site, generating 32S pre-rRNA. 32S 
species are rapidly cleaved at A 2 site, producing 20S and 27SA2, which are 
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precursors for the small and large subunit processing pathways. Enzymes responsible 
for these cleavages remain elusive, but there is evidence that these cleavages occur 
endo-nucleolytically. Mutations or defects that affect cleavages at A0, A1, or A2 sites 
do not inhibit cleavage at A3 site, which results in production of 23S/22S/21S and 
27SA3 pre-rRNA5. It is believed that 23S pre-rRNA is an unsuitable substrate for 
18S biosynthesis, as its accumulation usually correlates with the defect of 18S 
production (Ailmang et al., 2000). Surprisingly, 21S precursor is converted to 18S, 
suggesting that bypassing cleavage at A2 site does not always result in aberrant small 
subunit processing. 27SA3 precursor, on the other hand, is a normal substrate for the 
large subunit processing pathway (Vos et al., 2004). 
Cleavage at the A 2 site separates two processing pathways, which lead to production 
of mature rRNAs, and it promotes dissociation of 90S particle into pre-40S and pre- 
Small subunit biosysnthesis 
As a result of the cleavage at A 2 20S pre-rRNA is formed, which is rapidly exported 
from the nucleolus to cytoplasm, where the final step of 18S maturation takes place 
(Udem and Warner, 1973). 20S is converted to 18S via cleavage at site D located at 
the 3' end of mature 18S. It is believed that putative endonuclease Nobip is 
responsible for the cleavage at site D (Fatica et al., 2003). Nobip has a putative RNA 
binding domain, and a PIN-domain, a conserved motif found in several 
endonucleases that was proposed to determine RNAse activity (Fatica et al., 2004). 
In vivo, depletion of Nobip severely inhibits conversion of 20S to 18S in the 
cytoplasm. Interestingly, determinants of the cleavage at D site are thought to be 
sequence-specific, as nucleotide substitution was shown to abolish the cleavage 
completely. It is believed that premature cleavage might be prevented by secondary 
structure of site D, which is likely to be remodelled before the cleavage takes place 
(Fatica et al., 2003). 
Following cleavage at A2, pre-40 particle is released form 90S. This particle contains 
a few non-ribosomal proteins, and during 40S maturation only several protein factors 
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appear to join the pre-40S particles (Schafer et al., 2003). These mostly required for 
pre-405 export through the nuclear pore. 
Large subunit biosynthesis 
In comparison to small subunit biosynthesis, processing of 25S and 5.8S involves 
endonucleolytic cleavages and exonucleolytic digestion, and processing events can 
go two alteRNAtive ways (major and minor), which results in production of 25S and 
either short 5.8SS or long 5.8SL species. The functional difference between long and 
short forms of 5.8S RNAs is unknown. 
Correlating with the complexity of the processing events, several pre-60S complexes 
were identified. These complexes correspond to different stages of pre-60S RNA 
processing, and they defined by the association of certain non-ribosomal protein 
factors with characterised role in 60S assembly (Fatica et al., 2002; Saveanu et al., 
2001; Saveanu et al., 2003). Therefore analysis of protein content of pre-60S 
particles shows that early pre-60S particles are associated with numerous processing 
factors, however the number of the associated proteins appear to decline as 
maturation proceeds and particles are transported from the nucleolus to the 
nucleoplasm, and subsequently to the cytoplasm (Nissan et al., 2002). 
Processing events leading to production of large subunit rRNAs are initiated by the 
cleavage at of 27SA2 at A3 site, which is performed by RNAse MRP (Henry et al., 
1994; Schmitt and Clayton, 1993). RNAse MRP is a ribonucleoprotein complex, and 
consists of catalytic RNA and nine proteins; all the components were shown to be 
essential for the function of RNAse MRP (Chamberlain et al., 1998). Following 
cleavage at the A3 site, the end of 5.8S RNA is formed as a result of 5'-3' 
exonucleolytic activity of nucleases Ratip and Xrnlp (Henry et al., 1994). 
Exonucleolytic digestion stops at site B1,  and results in formation of 5.8SS species 
(Henry et al., 1994). In the minor pathway, 27SA3 is cleaved at B1L,  which produces 
the 5'end of 5.8SL (Faber et al., 2006). Following their formation, 27SB1 and 
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27SB 1 1 undergo the same processing events, which results in removal of ITS2, and 
formation of 5.8S and 25S species. Endonucleolytic cleavage at the C2 site of 27SB 
by an unidentified enzyme generates 7S and 26S precursors. In a final step mature 
25S is produced through trimming of 5' of 26S by Ratip and Xrnlp (Geerlings et al., 
2000). At the same time, maturation of 7S to 5.8S is likely to be a multi-step process, 
involving several exonucleases, including the exosome (Mitchell et al., 1997; 
Mitchell et al., 1996). DExH-box helicase Mtr4p is believed to couple 
rearrangements of highly structured ITS2 region with assisting exosome during 
digestion (Allmang et al., 1999; de la Cruz et al., 1998), followed by further 
nucleolytic digestion, resulting in formation of 5.8S species. 
1.4 Crosstalk 
Ribosome biogenesis is an extremely important process in living cells. It involves 
coordinated transcription by all three RNA polymerases, which produce pre-rRNA 
precursors and pre-mRNA of ribosomal proteins and pre-rRNA processing factors. 
Pre-rRNA transcripts undergo a series of processing events and assemble with 
ribosomal proteins and pre-rRNA processing factors. Obviously, this complicated 
process requires to be concerted and regulated. It was shown that under stress 
conditions transcription of pre-rRNA is likely to be affected as a result of action of 
the TOR network (Mayer and Grummt, 2006). In support of this, it was noticed that 
all ribosomal proteins create a regulon and therefore are likely to be co-regulated at 
the transcription level (Wade et al., 2006). Specific promoter elements of the 
ribosomal genes are likely to play a role in this process. 
Recently more and more pre-RNA processing factors were found to be shared 
subunits between different processes. Thus links between pre-rRNA processing and 
the cell cycle (Dez and Tollervey, 2004), and between pre-rRNA and splicing were 
identified (Lebaron et al., 2005). Links between pre-rRNA processing and splicing is 
an object of interest of this thesis, and will be discussed in detail. 
38 
So far, several splicing factors were implicated in pre-rRNA processing. One of 
them, Snul3p, was found to be a component of both U4/1J6.U5 tri-snRNP and CID 
box snoRNPs (Watkins et al., 2000). It was established that Snul3p binds directly to 
U4 snRNA, and is required for spliceosome assembly (Nottrott et al., 1999). 
Experiments with the human orthologue of Snul3p, protein 15.5K, revealed that 
15.5K binds to the C/D box motif (Vidovic et al., 2000). Interestingly, the C/D box 
motif has a striking structural resemblance to the binding site of Snul3p in U4 
snRNA, and mutagenesis analysis suggests that RNA secondary structure rather than 
sequence is required for 15.5K binding to RNA (Watkins et al., 2000). Despite U4 
snRNP and C/D box snoRNP having very distinctive functions, a number of 
similarities can be drawn. In addition to structural similarities of RNA-15.5 
interactions, there is an unusual analogy in the protein content of the RNPs. U3 
snoRNP proteins Nop56p and Nop58p which have a conserved NOP domain, and 
this was also identified in U4 snRNA component 'Prp3lp (Watkins et al., 2002). Also 
functional similarity between these RNPs can be identified as both classes of RNPs 
play roles as chaperons in RNA processing. Taken together these similarities are 
likely to indicate a common origin of U4 snRNP and C/D snoRNPs (Watkins et al., 
2000). 
DExD/H-box protein Prp43p is a helicase shared between splicing and pre-rRNA 
processing (Combs et al., 2006; Lebaron et al., 2005; Leeds et al., 2006). While in 
splicing it was shown to participate in spliceosome disassembly, its function in pre-
rRNA processing has not been identified yet. Prp43p was found to be associated with 
multiple pre-rRNA precursors of both small and large subunits, including 20S and 
mature 18S species. As conversion of 20S to 18S takes place in the cytoplasm, it 
suggests that Prp43p might be exported to the cytoplasm with pre-40S particles. In 
pre-rRNA processing, Prp43p was co-isolated with 0-patch containing protein 
Pfalp, which is a likely co-factor for Prp43p. Analysis of pre-RNA5 associated with 
Pfalp suggests that Pfalp is a novel component of pre-40S particles (Lebaron et al., 
2005). Additionally, Pfalp localises to the nucleus and cytoplasm (where the late 
stages of 40S maturation take place) (Huh et al., 2003), which confirms that Prp43p 
is a component of the late pre-40S particles and might be associated with pre-40S in 
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the cytoplasm. Remarkably, Pfalp was found to have genetic interaction with the 
splicing factor Spp382p, suggesting the existence of a cross-network link between 
splicing and pre-rRNA processing (Pandit et al., 2006). While such a link between 
processing machineries can be hypothesised as a connection or feedback mechanism, 
no direct evidence of this is known, and therefore it requires further investigation. 
Aims of the project 
The aims of the project were to characterise the newly identified splicing factors 
Spp382p and Ntr2p, and investigate their role as co-factors of DEAH-box helicase 
Prp43p in splicing and pre-rRNA processing. 
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Chapter 2 
Materials and methods 
2..1.1 Enzymes and chemicals 
Enzymes used in this study were purchased from NewEngland Biolabs, Promega, 
Roche and Startagene. 
Standard laboratory reagents were purchased from Sigma, Amersham, Formedium, 
Difco, Fluka and Gibco. 
2.1.2 Commonly used buffers 
Buffer Solution 
AGK buffer (0.51) 10mM Hepes (pH 7.9), 1.5mM MgC12, SOml 200mM 
KC1, 10% Glycerol, water 
Buffer B 0.1M Potassium Phosphate, pH 7.5, 1.2M Sorbitol 
Dialysis buffer (21) 20mM Hepes (pH7.9), 100mM KC1, 0.2mM EDTA, 
20% glycerol, 1mM DTT, 1 pellet of complete protease 
inhibitor/21 of dialysis buffer 
Lysis buffer 
______________________________ 
100mM NaCl, 50mM Tris-HCL (pH 7.5), 0.1% TritonX-
100 
BPTE 12mM Pipes, 30.6mM Bis-Tris, 1.2mM EDTA 
Church buffer (mod) 0.25M Sodium Phosphate (pH 7.2), 7% SDS, 1mM 
2xIPP 12mM Hepes (pH 7.9), 0.3M NaCl, 5mM MgC12, 0.1% 
(v/v) NonindetP40 
NTN 150mM NaCl, 50mM Tris-HC1 (pH 7.5), 0.1% (v/v) 
NonindetP40 
1xPBS 137mM NaCl, 2.7mMKC1, 3.3mM Na2HPO4 , pH 
adjusted to 7.4 
PBST 137mM NaCl, 2.7mMKC1, 3.3mM Na2HPO4 , pH 
adjusted to 7.4, 0.1 %(v/v) Tween-20 
20xSSC 3M NaCl, 0.3M sodium citrate, pH 7 
50xTAE I 2M Tris, 50mM EDTA, 5.7% (v/v) acetic asid 
2.2 Culture and media 
E.coli strains were grown in Luria-Bertani broth (LB medium). If required 
Ampicillin was added prior use (100tg/ml). 
LB medium 
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For 11 of medium 
1 Og Bacto-tryptone 
5g Yeast extract 
lOg NaCl 
pH was adjusted to 7.2 
For solid media 20g of agar was added to LB broth before autoclaving 
Standard growth and handling techniques were used for propagation of S. cerevisiae. 
Yeast were grown in either rich (YPDA, YPGR, YPGRS) or minimal SD or SG 
media. 
For 1 litre of the medium following components were mixed, dissolved in water and 
autoclaved. For solid media, agar in final concentration 2% (w/v) was added prior to 
autoclaving. 
YPDA: lOg Yeast extract, 20g Peptone, 20g Glucose, adenine sulphate 
YPGR: lOg Yeast extract, 20g Peptone, 20g Galactose, 20g Raffinose, adenine 
sulphate 
YPGRS lOg Yeast extract, 20g Peptone, 5g Galactose, 20g Raffinose, 20g 
Sacharose, adenine sulphate 
SD: 1.7g Yeast nitrogen base, 5g Ammonium sulphate, 20g Glucose, amino acids as 
required 
SG: 1.7g Yeast nitrogen base, 5g Ammonium sulphate, 20g Galactose, 20g 
Raffinose, amino acids as required 
2.3 Bacterial strains 
DH5a strain was used for propagation of al the plasmids. 
BL2 1 strain was used for protein expression. 
Table 2.3 Bacterial strains 
Strain Genotype Source 
DH5a F gyrA96 (Nair)  recAl relAl endAl thi-1 hsdR17 g1nV44 
deoRA(1acZYA-argF) Ul69[80dA(lacZ)Ml 5]  
Stratagene 
BL2 1 F, ompT, hsdSB , rB-,Mb-),  gal, dsm (DE3) Stratagene 
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2.4 Yeast strains 
Table 2.4 Yeast strains 
Strain Genotype Source 




BY4741 M4Ta, his3M, leu2itO, metl5tO, ura3AO Brachma 
et 	al., 
1998 
BK4H Kan-PGALI-3HA.. YLR424w, 	otherwise 	as 
BMA38a  
KL Boon 
BK2T YK022C:: TAP-URA3, otherwise as BMA38a KL Boon 
BK4T YLR424w::TAP-URA3, otherwise as BMA38a KL Boon 
BK43T PRP43: . TAP-URA3, otherwise as BMA38a KL Boon 
BK8T PRP8:.TAP-URA3, otherwise as BMA38a KL Boon 
BK4H2T Kan-PGALI-3H4.: YLR424w 	YK022C.. TAP- 
URA3,_  otherwise _as_BMA38a  
KL Boon 
KL3 TRPJ-PGALI-GST. :PRP8, otherwise as BMA38a KL Boon 
PRP43E7I6A 
______________ 




Table 2.5 Plasmids 
p283 Modified 	pGEM1, O'Keefe et al., 1996 
contains ACT] 	under 
regulation 	of T7 
promoter ___________________________ 
pBS1479 CEN, TAP_ URA 3 Rigautetal., 1999 
p113 CEN, 	TRPJ- Martin et al., 2002 
pRS3 13 CEN, URA3 Sikorski and Hieter, 1989 
pTAG1 G-patch 	of 	Spp382, This study 
otherwise as pRS3 13  
pPRP43wt CEN, LEU2-PRP43 G Edwalds-Gilbert 
pPRP43e716A CEN, 	LEU2- G Edwalds-Gilbert 
PRP43E71 6A  
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2.6 Oligonucleo tides 
Oligonucleotides used in this study were purchased from Invitrogen. 
Table 2.6 Oligonucleotides 
Name Sequence Comments 
Nothern blot probes 
003(27SA2) TGCTTACCTCTGGGCC Complementary 	to 	pre- 
rRNA sequence S'to A 3 
004(20S) CGGTTTTAATI'GTCCTA Complementary 	to 	pre- 
___________  rRNA sequence D- A2 
007(25S) CTCCGCTTATTGATATGC Complementary to 5' end 
of mature 25S rRNA 
008(18S) CATGGCTTAATCTTTGAGAC Complementary to S'end 
of mature 18S 
017(5.8S) GCGTTGTTCATCGATGC Complementary to 5.8S 
020(1TS25' TGAGAAGGAAATGACGCT Complementary to region 
across 5.8S/ITS2 
B) 
03 3(5 'ETS+ CGCTGCTCACCAATGG Complementary 	topre- 
rRNA 	278 	nucleotides 
278) downstream of A0 
200(U3) UUAUUGGGACUUGUU Anti-U3 
250(anti- ATCCCGGCCGCCTCCATCAC Complementary 	to 	the 
SCRP 
RNA component of the 
signal recognition particle 
G8102 CACGCCTTCCGCGCCGT Complementary 	to 	Ui 
snRNA 
G8103 CTACACTTGATCTAAGCCAAAAG Complementary 	to 	U2 
snRNA 
G6568 AGGTATTCCAAAAATTCCC Complementary 	to 	U4 
snRNA 
U5-7wsmnr AAGTTCCAAAAAATATGGCAAGC Complementary 	to 	U5 
snRNA 
U6knockout ATCTCTGTATTGTTTCAAATTGACCAA Complementary 	to 	U6 
snRNA 
RT-qPCR 
snR24EF GATGTAATAACATATFTGCTACTTCAGAT qPCR 
snR24ER CATCAGAGATCTTGGTGATAATTGGTATGT qPCR 
Ascl+600 GATTTGTGTATGCCATTCAAATGATGT qPCR 
YMRI 16C L F TGAATGGTTTAGCATTACTCTGCTCTTC qPCR 
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YMR1 1 6QL_R TGGAAAGAAAATATATCACATACATAGTAAGGGA 
AC  
qPCR 
Asci -1-692R TFGGTGATAATTGGTATGTCTCATTCG qPCR 
Asci +988R CATCTTGGGCAGACAAAGTG qPCR 
YMR1 16Cm1R TGATGTTGGAGTTGTGACCGATG qPCR 
YMR1 16C m2—F TCACCATCATTTCTGCCGGTAA qPCR 
YMR1 1631 F ACAAAAATGATATAATGACAGGCTTGGA qPCR 
YFL039C_1_p_F AGGGGCTTGAAATTTGGAAAAA qPCR 




YFL039C_1_L_R GCAAGCGCTAGAACATACATAGTACA qPCR 
YFL03 9C_1 _I _F TTGCTTCATCTTTTTGTTGCT qPCR 








Table 2.7 Antisera 
Antibody Description Source 
Anti-8.6 (batch:R1689) Anti-Prp8 aa2-35, Rabbot 
primary  
KL Boon 
Anti-HA Rabbit IgG, primary Santa-Cruz 
PAP 	(peroxidase-anti- 
peroxidase)  
Rabbit IgG Sigma 
Anti-Prp43 Rabbit IgG, primary Y.Henry 
Anti-Cefi Rabbit IgG, primary C. Gould 
Anti-Nopi Mouse IgG, Primary J.Aris 
Alexaflour 488 Goat 	anti-mouse 	IgG, 
secondary  
Molecular probes 









2.8 Bacterial techniques 
Growth, preparation of competent E. col4 and transformation of E. coli were 
followed as in Current Protocols in Molecular Biology (2001). 
2.9 Yeast transformation 
Transformation of yeast is based on high-efficiency lithium acetate method (Gleitz 
and Woods, 2002). 
For yeast transformation overnight culture was diluted in fresh medium thus cells 
will undergo 2-3 divisions and culture still will be in logarithmic phase. 
Culture (50ml) was harvested by centrifugation, washed 2 times with water, and 
pelleted. Cells were resuspended in transformation mix and placed on water bath for 
45min at 42°C. After the heat shock samples were spun, supeRNAtant was gently 
removed, resuspended in water and plated on selective media. 
Transformation mix 
240t1 of PEG3 
36tl of 1M LiAc 
5-25tl of DNA (depends on whether plasmid or PCR product was used) 
ssDNA -100Lg 
Water —to final volume 360tl 
2.10 Recombinant DNA techniques 
Standard DNA manipulations were carried out as described in Sumbrook and Russel, 
2001, or manufacturer's instructions. These include agarose gel electrophoresis, 
ethidium bromide staining, phenol-chloroform extraction of nucleic acids, isolation 
of DNA fragments from agarose gels, restriction enzymes digests, dephosphorylation 
of DNA and ligation of DNA fragments. 
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2. 11 Polymerase Chain Reaction 
PCR was used for amplification of regions of yeast genome, identification of 
recombinant clones and generation of short substrate for in vitro splicing. 
For yeast-colony PCR reaction using Taq polymerase (Roche) was used. 
For cloning and substrate generation either Pfu (Promega) or Phusion (Finnzymes) 
polymerases were used 
The choice of the enzyme dictated the protocol used, and the reactions were 
assembled according to the manufacture's instruction. 
2.12 RNA techniques 
2.12.1 RNA extraction 
Approximately 2-5 0D600 of exponentially growing cells were harvested by 
centrifugation, washed with sterile water and pelleted. Pellets were snap-frozen and 
stored at -80°C. 
100tl of Zirconia beads and lOOp! of GTC/Phenol mix were added to the each 
pellet. Samples were vortexed for 5 min at full speed at 4°C. After quick spin to 
remove liquid from the cap, 700p! of GTC/Phenol mix was added to the samples, 
which were subsequently incubated on a shaker at 65°C for 5 mm. 150p1 of 3M 
Sodium Acetate pH 5.2 and 350pJ of Chloroform were added to the mix, vortexed, 
and spun for 10 min at 14000 rpm. The aqueous phase was removed and combined 
with an equal volume of Phenol/Chloroform/IAA. Samples were vortexed and spun 
as described above. Finally, 1 ml of 100% Ethanol was added to aqueous phase, and 
samples were placed for 30 mm - 2 hours at-20°C. RNA was collected by 
centrfugation for 30 min at 14000rpm (4°C). The pellets were washed with 70% 
ethanol, dried and resuspended in sterile water. Samples were stored at -80°C. 
GTC mix 
4M Guanidine Thicyanate 
0.05M Tris pH 8 




2.12.2 In vitro transcription 
To prepare template for in vitro splicing reaction, plasmid p283 with shortened ACT] 
gene under T7 promoter was used. Plasmid preparation (using Qiagen miniprep kit is 
essential as preparations obtained with other brands were contaminated with 
RNAseA) was either digested with BamHI enzyme, or used as a template for PCR to 
generate an aberrant RNA substrate. Digestion products or PCR were purified with 
PCR purification kit (Amersham), and used for in vitro transcription. 
All the reaction components were added in the following order: 
Template DNA, corresponding 0.01 ug4.tl 
rNTP mix, containing 5mM of rGTP, rCTP , rUTP and 0.2mM rATP 	2.tl 
100mM DTT (dithiotbreitol) 	 2d 
1 O T7 transcription buffer 	 2l 
10mM cap analog structure 	 1 1 
Distilled water 	 to 20 l of the final 
mix 
1 OmCi/ml (a- 32P) rATP 
	
2tl 
10 units of rRNAsin (Promega) 	 1 tl 
T7 	 RNA 	 polymerase 
1 tl 
The components were mixed by pipetting and incubated for 30 minutes (or slightly 
longer) at 37°C. Transcription reaction was terminated by placing the reaction mix 
on ice, then P/C/I purified, and ethanol precipitated. The pellet was resuspended in 
water, and mixed with 2x RNA loading buffer. Sample was run on 6% denaturing 
polyacrylamide gel, the transcript was visualised with autoradiography, and cut out 
of the gel. The gel slice was stored at -20°C until required. To elute RNA, gel slice 
was defrosted, mashed in 1.5 ml eppendorf tube using a tip, and resuspended in 
Elution buffer. Elution was performed at 37°C for 6 hours on shaking platform 
(Eppendorf). After the elution, supeRNAtant containing RNA transcript was 
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carefully removed (special care should be taken to avoid small pieces of the gel), and 
precipitated with Ethanol. After precipitation, pellet was resuspended in de-ionized 
water and stored at -20°C. 
Elution buffer 5x 
50mM Tris, pH 7.6 
5% SDS 
50mM EDTA pH 8.0 
2.12.3 In vitro splicing 
For in vitro splicing reaction the following components were mixed: 
0.6M Potassium phosphate buffer 1l 
25mM MgCl2 1l 
3)20mM ATP 1fl 
30%(w/v) PEG8000 1 itl 
Splicing extract 4.tl 
Radiolabelled RNA 
Distilled water to 1 0tl 
The reaction mixture was incubated at RT for 25 min and terminated by putting the 
tube on ice. 31il of Proteinase K solution (lmg/ml ProteinaseK 50mM EDTA, 
1%(w/v) SDS) was added to the reaction, which was subsequently incubated for 45 
min at 37'C. 200ifl of splicing cocktail (50mM NaOAc, 1mM EDTA, 0.1% (w/v) 
SDS, 25tg of E. coil tRNA) was added to the samples, which were P/C/I extracted 
and ethanol precipitated. The samples were dried at RT from residual ethanol, 
resuspended in water, and mixed with an equal volume of the 2X RNA loading 
buffer (100% Formamide, a little bit of Bromphenol Blue and Cyanol Blue). 
Prepared samples were heated at 90°C for 3 minutes, placed on ice to cool down and 
loaded on 7% (w/v) denaturing polyacrylamide gel. 
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For immuno-precipitation of the products of in vitro splicing reaction 50-100tl 
splicing reactions were assembled, incubated for 30-40 min at RT, and mixed with 
an appropriate volume of 2xIPP buffer. 
2.12.4 Co-immunoprecipitation of snRNAslspliceosome. 
35 tl of pre-hydrated PAS (Protein A sepharose) beads were washed 3 times with 
1000tl of NTN buffer, and mixed with 300d of NTN buffer, an appropriate amount 
of antibody and 5tl of Blocking buffe. Beads were incubated on rotating wheel for 1 
hour at 4°C, washed twice in NTN buffer, and once with 1xIPP. After that beads 
were mixed with 501d of 2xIPP, 0.5tl of RNAsin and 50d of splicing extract or 
splicing reaction unless is stated otherwise. 
NTN buffer 
150mm NaCl 
50mM TrisCl pH7.5 
0.1 %(v/v) Nonindet P40 
1xIPP 
6mM Hepes p1-17.9 
150mM NaCl 
2.5mM MgC12 
0.05 %(vlv) Nonindet P40 
2xIPP 
12mM Hepes pH7.9 
300mM NaCl 
5mM MgCl2 
0.1% (v/v)  Nonindet P40 
Blocking buffer: 
Final concentrations are: 
100tg/mI of glycogen, 
100tgofBSA, 
100tg of tRNA 
All the ingredients were mixed in NTN buffer, and stored at -20°C. 
51 
Immunoprecipitation was performed for 1 hour at 4°C on rotating wheel. After the 
precipitation beads were washed 3 times with NTN, and mixed with 200tl of 
Extraction buffer. For total samples 180tl of Extraction buffer were mixed with 20% 
of unbound supeRNAtant; samples were processed as IPs described in 2.12.4. 
Obtained RNA samples were loaded on 6% polyacrylamide gel, and transferred to 
Hybond-N membrane. For nothern blot the membrane was directly put into 50ml of 
hybridisation buffer (modified Church Buffer) with added labelled oligo(s) for at 
least 3 hours at 37°C, or overnight. Membrane was washed 2-3 times with 1xSSC at 
37°C for 5-20 minutes, wrapped in Saran Wrap and exposed to MS film (Kodak). 
RNA extraction buffer 
50mM Tris-HCL,, 
pH 7.5, 5mM EDTA, 
1.4 (w/v) SDS, 
End-labeling of the oligonucleotides for northern blot was performed in 20d 
reaction for 1 hour at 37°C. Labelled oligonucleotides were purified through the 
0.2..tm filter to remove unincorporated radioactive label, and mixed with 
hybridisation buffer. 
Oligonucleotide labeling mixture: 
2.tl of T4 kinase buffer 
1 d of oligonucleotide 10pmoI/d 
2tl of y22  ATP (3000Ci/mmol) 
Water - up to 20d 
0.51..tl (10 Units) of T4 kinase 
Hybridisation buffer (modified version of Church buffer) 
7% SDS 
0.5M Sodium phosphate buffer 
1 mM EDTA 
2OxSSC 
175.3g NaCI 
88.2g Sodium Citrate 
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Adjust the volume to 1 litre 
2.12.5 Extract preparation for ribosomal RNA processing immuno-
precipitations. 
21 cell cultures were grown to OD6. 0.5-0.6, harvested, washed with ice-cold water 
and snap frozen dry in liquid nitrogen. To disrupt the cells pellets were ground using 
mortar and pestle in liquid nitrogen until pellet had a consistency of a very fine 
powder. Following grinding, cell powder was transferred into a tube with Lysis 
buffer and thawed on ice (1V of cell pellet - 3V of Lysis buffer). Lysate was cleared 
by centrifugation at 3500 rpm for 5 mm, and 14000rpm for 10 mm. Extract was 
collected, and mixed with pre-washed beads. Samples were placed on rotating wheel 
for 45 mm-i hour at 4°C, after that beads were extensively washed with Lysis buffer, 
and subjected to RNA extraction. For that 250tl of GTC mix, 150d of Sodium 
Acetate (100mM in TE), and 500tl P/C/IAA was added to the beads (or extracts), 
samples were vortexed, and incubated for 5min at 65°C with shaking. Samples were 
spun at 14000rpm for 10min at RT. 500tl of the aqueous supeRNAtant was removed 
and mixed with an equal volume of P/C/IAA, samples were vortexed and spun as 
described above. 450t1 of the supeRNAtant were taken, and precipiatated with imi 
of ice-cold Ethanol. RNA was spun down for 30 min at 14000 rpm, obtained RNA 
pellets were washed with 70% ethanol, dried and resupended in water. RNA sample 
was split into two equal parts, one of them was glyoxilated and run on denaturing 
agarose gel, another half was loaded on 6% polyacrylamide gel as described in detail 
below. For Total RNA samples RNA from the volume of the extract corresponding 
to 5% of that used for precipitation was extracted. 
Lysis buffer 
100mMKC1 
20mM Tris pH7.5 
5mM MgCl2 
0.2% TritonX 100 
1mM DTT - freshly added 
1 tablet of Complete Roche protease inhibitors 
7d of RNAsein (Promega) 
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For TAP purifications 100.tl of Rabbit IgG beads (Sigma) were washed trice with 
imi of lysis buffer. For immuno-precipitations, Protein A Sepharose beads 
(Amersham) were washed with lysis buffer, and mixed with antibodies and blocking 
buffer and processed further as described in protocol for spliceosomes. 
2.12.6 RNA gel electrophoresis and northern blot analysis. 
Low molecular weight RNA species were separated on polyacrylamide gels, and 
high molecular weight ribosomal RNA species were resolved on 1.2% agarose gel 
(Sambrook and Russel, 2001). 
For low molecular weight gels (0.5mm) Sequagel-6TM (National diagnostics) 
polyacrylamide was used. Samples were mixed with Formamide loading buffer, 
incubated for 3 min at 100°C, and chilled on ice. RNA was electrotransferred to 
Hybond-N or Hybond-N+ membranes for 1 hour at 60V in 0.5 TBE. After transfer 
was complete, RNA was UV cross-linked to the membrane once from each side 
using UV Stratalinker. 
For agarose gels corresponding amount of the agarose was dissolved in 1XBFTE 
(10mM Pipes, free acid, 30mM Bis-Tris, free base, 1mMEDTA, pH8) buffer, special 
care was taken to dissolve all the agarose granules. 
For sample preparation, 1-2iil of RNA was mixed with 10il of Glyoxal mix (60% 
DMSO, 20% deionised Glyoxal, 1.2xBPTE, 4.8% Glycerol, 0.2mg/mlof EtBr) and 
incubated at 55°C for 1 hour. After that samples were placed on ice for 10mm, and 
resolved on the gel at 60-65V for 12-16 hours. After gel run was finished, gel was 
soaked in 0.2M NaOH to hydrolyse RNA, followed by two consecutive washes in 
6xSSC buffer. RNA samples were transferred to charged HybondN+ membrane by 
passive capillary transfer; transfer time varied from 4 hours to 12 hours. Following 
transfer, membrane was UV cross-linked, and subjected to northern blot as 
described. 
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2.12.7 Pulse chase analysis. 
For pulse chase analysis strains to be labelled were transformed with pRS3 13 vector, 
which contains URA3 gene as a nutritional marker. Cell cultures were grown in —Ura 
medium at all times. For the analysis, appropriate amount of cultures OD E® 0.2-0.5 
was taken (usually 6ml), and place in 50m1 tube on rotating platform. For the pulse, 
200tl of tritium labelled Uracil was added to the culture for 1 mm. Following the 
pulse an excess of cold Uracil was added to the culture, at this point sample (imI) 
corresponding time-point zero was taken, quick spun, and snap frozen in liquid 
nitrogen. Samples of the culture were taken at desired time-points and processed as 
described above. 
RNA was extracted and ethanol precipitated as described in 2.12.1. High molecular 
weight species were resolved on denaturing agarose gel and transferred as described 
in 2.12.6. Following the transfer and cross-linking, membrane was dried and 
subjected to autoradiography with LE enhancer screen. 
2.13 Protein methods 
2.13.1 Purification of Prp43 from E. coli. 
PRP43 was cloned into pET16b (Martin et al. 2002). For expression, strain BL21-
Codon Plus(DE3)RIL was transformed with the expression vector. 
Single colony obtained after the transformation was inoculated into 3m! LB 
+ampicillin +chloramphenicol (stocks are 1,000x) and grown at 37 for a day. 
At the end of the day the culture was transferred to 500m1 of LB + ampicillin 
+chloramphenicol and grown at 23°C overnight. 
Following morning expression of the protein was induced by the addition of 
1 M IPTG to the culture to final concentration 0.1 mM. 
Following induction, culture was grown at 23°C for 3 hours and harvested at 
5000 rpm for 10 mm. 
Pellet was resuspended in 10 ml of Buffer A containing protease inhibitors. 
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To lyse the cells Lysozyme (to final concentration 0.2 mg/ml,) and Imidazole 
(to final concentration 20mM) were added to the suspension. Sample was 
kept on ice for 30 mm. 
Sample was sonicated to disrupt the cells. Sonicator was set at 38% 
amplitude and six cycles of 9 sec on, 9 sec off was performed. 
After sonication Triton X-100 was added to the sample to final concentration 
0.1%, subsequently tube was incubated with rotation at 4°C for 30 minutes. 
Sample was spun in JA25.5 rotor for 15 minutes at 12,000rpm at 4°C. 
Meanwhile, Ni-NTA agarose beads were prepared. For 10 ml of lysate, 1.5 
ml of a 50% slurry of NiNTA agarose (Qiagen) was equilibrated in Buffer A. 
Cleared lysate was mixed with washed beads and incubated with rotation at 
4°C for 45 mm-i hour. 
Beads were washed trice in Buffer E (5-10 ml per wash). 50 ml tube was used 
for the first two washes, and then third wash was performed in Bio-Rad 
econo-column. 
Protein was eluted using increasing concentrations of Imidazole. Peak 
fractions were combined and dialyzed versus Buffer D. 
Stock solutions for the purification: 1 M Tris, pH 7.4, 4M NaCl, 1 M Imidazole 
Buffer A: 50 mM Tris, pH 7.4, 250 mM NaCl, 10% Sucrose 
Buffer E: 50 mM Tris, pH 7.4, 250 mM NaCl, 15 mM Imidazole, 10% Glycerol 
Buffer D: 50 mM Tris, pH 7.4, 250 mM NaCl, 1 mM EDTA, 2 mM DU, 0.1% 
Triton X- 100, 10-20% Glycerol 
2.13.2 Yeast splicing extract. 
The overnight culture was used to inoculate 4-6 litres of an appropriate media. Cells 
were harvested by centrifugation when the OD 6. of the culture was 0.7-0.9. Cell 
pellet was resuspended in 50ml of cold AGK buffer, and spun at 3500rpm for 5 
minutes. The pellet was washed one more time with 20m1 of AGK buffer. After that, 
the pellet was resuspended in approximately 0.4 of the volume of AGK buffer, with 
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DTT added to the suspension to final concentration 2mM. After that the suspension 
was frozen in liquid nitrogen, and stored at -70°C. 
For further processing of the extract frozen suspension was ground with a mortar in 
liquid nitrogen to a fine powder. Then powder was transferred into polycarbonate 
centrifuge tubes, thawed on ice and spun at 17000rpm at 4°C for 30 minutes in a 
Beckman JA 25.50. 
The supeRNAtant without lipid layer was transferred to a fresh tube and spun down 
at 40000 rpm for 1 hour at 4°C. After the spin the supeRNAtant was transferred to 
dialysis tubing (with MW cut off 1OkDA), and placed in 2 litres of cold dialysis 
buffer for 3 hours at 4°C. Aliqouts of the extract was frozen and stored at —70°C. 
AGK buffer 
For 500ml mix 
lOml 0.5M Hepes (pH 7.9) 
0.75m1 MgCl 2 
SOml KC1 
50m1 Glycerol 
Water to 500 ml 
2.13.3 Co-immunoprecipitation of proteins from yeast protein extracts. 
IgG agarose beads (35il) were washed three times with NTN. Commercially 
available conjugated beads were prepared as IgG agarose, but usually 15d of the 
beads were taken. Beads were mixed with 30-50tl of 2xIPP buffer and 
corresponding volume of the splicing extracts and incubated on rotating wheel for 1 
hour at 4°C. After the precipitation beads were washed 3 times with NTN, and 
resuspended in SDS loading buffer. Loaded on a NuPAGE 4-12% gel, and then 
transferred to PVDF membrane for 2 hours at 32V, blocked in 5% milk in PBST for 
1 hour and incubated with appropriate antibodies in PBSTI5% milk. 
2xSDS loading buffer 





0.025% Bromophenol blue 
2.13.4 Preparation of total protein extracts for western immunoblotts. 
An overnight culture was (5m!) was inoculated. Next morning OD of the culture 
was measured and the volume equivalent of 3 013 6 of the cells was spun down. The 
pellet was resuspended in 0.5m1 of freshly prepared 0.2M NaOH and leaved on ice 
for 10 minutes. 50tl of 50% TCA was added to the sample, mixed, and leaved on ice 
for additional 10 minutes. Sample was spun down at 14000rpm for 5 mm, and the 
pellet was resuspended in 35d of Dissociation buffer (100mM Tris pH6.8, 4mM 
EDTA, 4% SDS, 20% Glycerol, 2% 13-Mercaptoethanol, and a little bit of 
Bromphenol Blue), and 15.d of TrisBase. The samples were heated for 5 minutes at 
95°C and loaded on NuPAGE gel, blotted and probed with antibodies as described 
above. 
2.13.5 Glycerol gradient analysis. 
Linear glycerol gradients (10-30% v/v) were made using Glycerol Gradient Master 
(Biocomp). As splicing extract contains 20% Glycerol, splicing extracts were diluted 
with AGK buffer without Glycerol to reduce final Glycerol concentration. Normally, 
120..t1 of AGK buffer without Glycerol was mixed with 80i..tl of splicing extract, and 
layered onto the gradient. Samples were spun for 15 hours at 35000rpm in a SW40 
Ti rotor (Beckman). Fractions (400tl) were collected and stored at -80 till further 
analysis. 
2.14 Splicing analysis by Real-Time Quantative RT-PCR. 
This protocol was designed to quantify pre-mRNA, mRNA and lariat RNA species 
of ACT] and ASCJ genes, which allows investigate defects in pre-mRNA splicing. 
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In order to detect pre-mRNA splicing products and intermediates cDNA of RNA 
species has to be obtained. First, RNA samples were treated with DNase to prevent 
contamination with genomic DNA, and used for cDNA synthesis. cDNA from pre-
mRNA, mRNA and lariat species was specifically made. qPCRs with these cDNAs 
using specific sets of primers allowed detect variety of RNA intermediates. During 




For each sample the following components were mixed 
12.5tg of RNA 
water — to 8tl 
1.d of DNaseI buffer 
0.2tl of RNAsein 
0.8i.il of DNAseI 
Samples were carefully mixed and incubated at 37°C for 1 hour, 
subsequently DNAseI was heat-inactivated at 75°C for 10 mm. 
First strand synthesis 
To each sample 2tl of RT primer mix and 2.5itl of water was added, mixed, and 
6.25tl of the mixture was transferred to a new tube (for negative no-RT control). 
Tubes were incubated at 70°C for 5min and then placed on ice to denature RNA. 
For cDNA synthesis reaction following components were mixed (for each sample) 
2tl of 2xcDNA synthesis buffer 
0.251.Ll 0.1M DTT 
0.75tl 10mM dNTP mix 
0.25ltl RNAsein (Promega) 
0.5tl of Thermoscript (Invitrogen) or water for no-RT control 
3.75tl of the cDNA mix was added to the denatured RNA, mixed, and incubate for 
1-2 hours at 55°C. After that RNAaseA (90tl of 0.1mg/ml stock solution) was added 
to the reactions and reactions were placed for 1 hour at 37°C. 
59 
3. qPCR reactions 
Reactions were performed at least in duplicate with no-RT controls. 
1.cDNA was diluted a further 1/10 with water (cDNA was diluted in a total of 
1/100). 
2. For each reaction 5tl of SyBR Green qPCR mix and 11d of each primer pair 
(3.tM) were mixed (total 6tl). This mixture was pipetted onto 96 microwell plate, 
then 4tl of cDNA was added to each reaction. The plate was mixed by tapping, spun 
down and placed into qPCR machine. 
Lariat 
Pre-mRNA 
3SS 	 I 
mRNA 	 I 
snoRNA L- • 	 . 
Figure 2.14 Diagram representing RNA species recognized by specific primer sets in 
qPCR. 
PCR program for the ACTI/ASCI reporters: 




repeat cycles 2-4 for 50 times 
95°C 	lOsec 
60°C 	lOsec 
Plate is read at regular intervals to produce the melt curve. 
4. Quantification 
Relative abundance of RNA species with respect to a control (RNA from a 
wild type strain) was calculated using the formula below. 
Relative abundance =2A-AC  , where 
ffoll 
2.15 Immuno fluorescent staining. 
For immuno-staining, exponentially growing cells (lOml) were fixed with 1/10 
volume of 37% formaldehyde. Tubes were incubated for 40 minutes at RT with 
constant rotation. Then cells were gently spun down at 3500rpm, RT, for 5 minutes, 
and washed three times with 1 ml of Buffer B (1.2M sorbitol, 100mM Potassium 
Phosphate buffer, pH 7). Washed cells were permeabilised in 500d of spheroplast 
buffer (Buffer B containing 100mM DTT and 20tl of lyticase (20mg/mi)) on a 
rotating wheel for 30-45 minutes at 30°C. After that cells were harvested and washed 
twice with lml of Buffer B. Cell pellets were resuspended in lOOptI of buffer B and 
placed on a poly-L-lysine coated slide and left for about 30 minutes for cells to sit. 
Excess solution was aspirated, and seated cells were blocked with 5% milk in PBST 
for 20 minutes at RT. Primary antibody was added to the blocking solution, the slide 
was left overnight in a humid chamber at 4°C. Next morning the slides were washed 
twice with PBST for 20 mm, and covered with PBST with milk and secondary 
antibody of an appropriate dilution. The slide was placed in a humid chamber for 1 
hour at RI, and then washed with PBST as described above. Cells were mounted in 
DAPI containing vectashield, covered with cover slip, and sealed with nail polish. 
Slides were examined under the Leica DMR fluorescence microscope; captured 
images were assembled using image J software. 
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Chapter 3 
Analysis of NTR complex function in splicing 
3.1 Introduction 
Spp382p is an essential protein and conserved throughout eukaryotic kingdoms. 
Large-scale purifications identified Spp382p and its human orthologue, TFIP1 1 
protein, with components of the spliceosomal machinery, suggesting that Spp382p is 
a spliceosomal factor (Boon et al., 2006b; Gavin et al., 2002). Spp382p (also known 
as Ntrl for NineTeen Related) was named after its ability to suppress the prp38-1 
mutation (Pandit et al., 2006), which has a defect in spliceosome maturation, but the 
precise mechanism of suppression is not known yet. 
Spp382p contains a putative RNA binding motif called 0-patch in its N-terminus. 0-
patch motif is characterised by the presence of six highly conserved glycine residues, 
which are proposed to mediate RNA binding, however the precise function of the 0-
patch domain is not determined. 
KL Boon confirmed Spp382p association with the spliceosome by showing that 
Spp3 82p precipitated preferentially excised intron from in vitro splicing reactions, 
and associated with U2, U5 and U6 snRNAs in vivo, which indicated that Spp382p is 
associated with the post-splicing complex. It was established that depletion of 
Spp382 protein caused accumulation of the excised intron during splicing in vitro 
and in vivo, suggesting a role for Spp382p in intron metabolism. 
Previously several proteins were shown to participate in intron metabolism in S. 
cerevisiae. First, DEAH box helicase Prp43p was shown to be necessary for the 
release of the excised intron from the post-splicing complex after completion of the 
splicing reaction (Martin et al., 2002). ATPase deficient mutants of Prp43 caused 
accumulation of the excised intron lariat with the post-splicing complex, therefore 
preventing its degradation. After intron release, the 2'-5' phosphodiester bond of the 
lariat undergoes cleavage by de-branching enzyme Dbrlp (Ruskin and Green, 1985), 
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which makes it a suitable substrate for degradation 5'-3' by Rati and Xml, or 3'-5' 
by exonucleolytic activity of the exosome (Coller and Parker, 2004; Mitchell and 
Tollervey, 2001). Mutation of .the non-essential DBRJ caused accumulation of the 
excised introns (Chapman and Boeke, 1991). However in the case of Spp382p it was 
not clear whether inton accumulation was due to the failure of intron degradtion 
process, or a defect of spliceosome disassembly. 
Here I present evidence in support of the latter hypothesis, showing that in Spp382-
depleted extracts spliceosome disassembly is impaired, and excised intron is still 
associated with the post-splicing complex. Additionally I demonstrate requirement of 
Spp382p for stable association of the excised intron release factor Prp43p with the 
post-splicing complex. 
In large-scale characterisation of yeast ORFs with unknown functions Yk022cp 
(later renamed Ntr2p) was co-purified in the complexes containing Spp382p (Gavin 
et al., 2002). Additionally, Ntm2p was shown to interact with Spp382p in yeast two-
hybrid (Gavin et al., 2002). All this taken together strongly suggested that Ntr2p 
might be a newly discovered splicing factor. In this chapter I investigate Ntr2p 
association with the spliceosome and show Ntr2p association with the post-splicing 
complex, confirming that Ntr2p is indeed a new splicing factor. 
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3.2 Depletion of Spp382p affects spliceosome disassembly 
In order to investigate the function of Spp382p, KL Boon constructed a strain with 
gene SPP382 under control of the regulatable GAL] promoter. On switching to 
repressing (glucose containing) medium, rapid depletion of the protein from the cells 
occurs, allowing study of the defect caused by the absence of the protein, and 
therefore identification of the step of the process where the protein of interest might 
be involved. It was established that upon depletion of Spp382p from the cells, there 
is an accumulation of the excised intron in vivo and in vitro, suggesting that intron 
metabolism was affected (Boon et al., 2006a). 
I immunoprecipitated Prp8p from an in vitro splicing reaction and analyzed the 
precipitated products. The in vitro splicing assay is based on cell-free extract, pre-
mRNA substrate radiolabelled by in vitro transcription; using this assay allow 
monitoring of splicing activity and analyse individual components of spliceosomal 
machinery. An important advantage of this assay is its ability to easily distinguish 
between the products and intermediates of the splicing reaction by the speed of their 
migration in the gel. In the following experiments ACT] pre-mRNA was used as a 
substrate for in vitro splicing assay. 
Prp8p is a U5 snRNP component, and core spliceosomal protein and co-precipitates 
all the intermediates and products of in vitro splicing, including the excised intron 
under normal conditions. Therefore, repeating the assay under Spp3 82-depleted 
conditions would allow to distinguish between a general disassembly defect, or a 
defect in de-branching of the excised intron. 
Strain BK4H with SPP382 under control of P0 1 promoter was pre-grown in YPGR 
medim, and than transferred to YPDA medim for 10 hours for the depletion of 
Spp382p. Strain BMA38a (isogenic wild type) was treated as BK4H and used as 
wild-type control. Splicing extracts from the frozen cell pellets were prepared as 
described in 2.13.2, and 50il in vitro splicing reactions were assembled with normal 
and Spp3 82-depleted extracts. Reactions were immunoprecipitated with anti-Prp8 
antibodies as decribed in 2.12.4. After the immunoprecipitation samples were 
washed extensively, subjected to RNA extraction, loaded on PAGE gel and analysed 
by autoradiography. 
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Figure 3.1. Co-immunoprecipitation of Prp8p with the products of in vitro 
splicing reaction. Splicing reactions (50t1) were assembled using normal and 
Spp3 82-depleted extracts with ACT] pre-mRNA as substrate. Reactions were 
mixed equal volume of 2XPPT buffer and beads with pre-bound anti-Prp8 
antibodies or beads incubated with pre-immune serum (P1). Immunoprecipitations 
were carried out for 1 hour at 4°C, subsequently beads were washed extensively 
with NTN buffer, and subjected to RNA extraction. For Unbound fraction RNA 
was extracted from 10% of the supemates after immunoprecipitation. RNA 
species were analysed by PAGE (7%) and autoradiography. 
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As can be seen in figure 3.1, in splicing reaction assembled with Spp382p-
depleted extract there is an accumulation of the excised intron and decrease in 
production of mRNA (lane 3). This implies that Spp382p affects spliceosome 
disassembly and recycling. Under splicing conditions Prp8p is associated with the 
excised intron-lariat, which indicates that excised intron is associated with the 
post-splicing complex and stays inaccessible for the debranching activity of 
Dbrlp. 
3.3 Ntr2 protein is associated with the post-splicing complex. 
In order to investigate the putative function of Ntr2p in pre-mRNA splicing, 
physical association of Ntr2p with the spliceosome was tested. First, the ability of 
TAP-tagged Ntr2p to co-precipitate spliceosomal snRNAs was investigated. 
Splicing extracts from strains containing TAP-tagged Ntr2 (BK2T), TAP-tagged 
Spp382(BK4T) and an untagged strain (BMA38a) were prepared. 5pp382-TAP 
was used as a positive control, as it has been established that it co-precipitates U2, 
U5 and U6 snRNAs (Boon et al., 2006a). snRNAs precipitation was performed as 
described in 2.12.4, and results are presented in figure 3.2. 
As can be seen in figure 3.2, Ntr2p, like Spp382p, co-precipitates U2, U5, and U6 
snRNAs, which indicates that Ntr2p is indeed associated with the spliceosome. 
The level of the precipitation of U 1 snRNA is the same as in non-tagged strain, 
suggesting that Ntr2p does not precipitate Ui snRNA. U4 snRNA is also absent 
from the precipitate indicating that Ntr2p is not associated with complex B. This 
suggests that Ntr2p is associated with the catalytic spliceosome and/or post-
splicing complex as these complexes consist of U2, U5 and U6 snRNAs. 
In order to determine on which stage of splicing Ntr2p is associated with the 
spliceosome precipitation of the products of an in vitro splicing reaction was 
performed. TAP-Prp8 (BK8T) and TAP-Spp382 (BK4T) were employed as 
positive controls, as it is known that Prp8p is associated with all the intermediates 
and products of in vitro splicing reaction and KL Boon reported that Spp382p 
precipitates presumably excised intron from in vitro splicing reactions. Non-
tagged BMA38a strain was used as a negative control for background level. 
Additionally, as Ntr2p was reported to interact with Spp382p in a yeast two-
hybrid screen and not with any other splicing factor (Gavin et al., 2002), it was 
conceivable that Spp382p is required for the association of Ntr2p with the 
spliceosome. To test this, Ntr2-TAP strain with SPP382 under control of glucose-
repressible GAL] promoter was used (BK4H2T). Pre-culture of BK4H2T was 
grown in YPGR media, then transferred to YPDA for depletion for 10 hours. 
Growth of the BK4H2T is severely impaired with doubling time of approximately 
4 hours (KL Boon's thesis). To grow culture for the depletion, appropriate volume 
of pre-culture was spun down, resuspended in YPDA medium and inoculated in 
corresponding volume of pre-warmed YPDA medium. Splicing reactions (5011) 
were assembled and precipitated with rabbit IgG agarose beads, washed 
extensively, and loaded on the gel. Dried gel was subjected to autoradiography. 
As shown in figure 3.2, Ntr2p efficiently precipitates excised intron from in vitro 
splicing reactions, and pre-mRNA and mRNA on a level slightly above 
background (Non-TAP precipitation, lane 6). This result suggests that Ntr2p is 
presumably associated with intron-containing post-splicing complex, and might 
be weakly associated with catalytic spliceosome. Interestingly, Ntr2p also 
precipitates excised intron and pre-mRNA from Spp3 82-depleted extract, 
indicating that Spp382p is not necessary for Ntr2p association with the post-
splicing complex. This finding suggests that Ntr2p has other unidentified 
interactions within the spliceosome. 
In order to investigate the function of Ntr2p, NTR2 was placed under control of 
Poi promoter. The strain was verified by yeast-colony PCR and western blot. 
Depletion of Ntr2p was confirmed by western blot with the sample obtained after 
10 hours after shift to YPDA medium. Despite that NTR2 is an essential gene, 
depletion of the Ntr2p using this system does not affect cell viability and growth, 
probably due to some residual expression of JVTR2. However, the lack of the 
RIM 
phenotype in Ntr2-depleted culture prevented studying of the effect of Ntr2 
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Figure 3.2. Ntr2p is associated with snRNAs. 
Splicing extracts (50 p1) prepared from non-tagged strain (BMA38), or TAP-
tagged Spp382 or Ntr2 were mixed with equal volume of 2xIPP buffer, and 30p1 
of rabbit IgG agarose extensively washed with 1xTPP buffer. Samples were 
incubated for 2 hours at 4°C on rotating wheel. Beads were washed in NTN 
buffer, RNA was extracted from the beads and analysed by nothern blotting using 
specific probes for Ui, U2, U4, U5 and U6 snRNAs. Total RNA (Input) was 
extracted from 12.5p1 of splicing extract. 
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Figure 3.3. Ntr2p is associated with the excised intron, and does not require 
Spp382p for its association with the post-splicing complex. 
Splicing reactions (50 pi) were assembled using Prp8-TAP, Spp382-TAP, Ntr2-TAP. 
Ntr2-TAP Spp382-depleted and non-tagged strain BMA38a as a negative control. 
Reactions were incubated for 30 min at RT, mixed with equal volume of IPP2x 
buffer and 30p.l of pre-washed rabbit lgG agarose beads. Samples were incubated on 
rotating wheel at 4°C for I hour, RNA was extracted, resolved on 7% PAGE gel and 
subjected to autoradiography. 
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3.4 Spp382p and Ntr2p co-sediment in Glycerol Gradients. 
To investigate Ntr2p distribution by glycerol gradient centrifugation strain with TAP-
tagged Ntr2 P GALl :3HA-Spp382 (BK4H2T) was used. In order to test co-distribution of 
Ntr2p and Spp382p, splicing extract was prepared from the strain BK4H2T grown in 
YPGR medium. To test the effect of Spp3 82-depletion on Ntr2p distribution, starin 
BK4H2T was pre-grown in YPGR medium, and then transferred to YPDA medium for 
depletion as described above. For glycerol gradients splicing extracts (80tl) were 
diluted with AGK buffer without glycerol (120tl), and loaded on 10-30% (v/v) 
glycerol gradients. After centrifugation 400i.tl fractions were collected, and alteRNAte 
fractions were immunoprecipitated with IgG agarose as described in 2.13.3, samples 
were resolved on 4-12% gel, blotted and probed with PAP (for TAP-tag detection) and 
anti-HA antibodies. 
Ntr2p and Spp382p co-sediment in glycerol gradient with the peaks at the bottom of 
the gradient (fractions 1-3) and in the fractions 17-23 (figure 3.4A). The peak at the 
bottom of the gradient likely represents large splicing complexes, while the peak in 
the low density fractions 17-23 probably represents Ntr2p/Spp382p complex, which 
is not associated with the spliceosome. Noticeably, only in the top fractions of the 
gradient Spp382p is represented by two bands, a phenomenon initially observed by 
KL Boon. He suggested that as the human orthologue of Spp382 TFIP lip is heavily 
phosphorylated (Well et al., 2005), the lower band might be unmodified form of the 
protein, however the possibility that it is a degradation product cannot be excluded. 
On next stage, distribution of Ntr2p in Spp3 82-depleted extract was tested. 
Presumably, if the depletion of Spp382p protein disrupts Ntr2p association with the 
spliceosome, a shift in Ntr2p distribution could be observed. As shown in figure 3.413 
depletion of Spp382p does not affect distribution of Ntr2p, supporting the in vitro 
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Figure 3.4. Distribution of Ntr2p and Spp382p. 
Extracts prepared from BK43.6 Spp382p is necessary for Prp43p 
association with the spliceosome 
DEAH box helicase Prp43p was shown to be necessary for the release of the excised 
intron from the post-splicing complex (Martin et al., 2002). Additionally, Prp43p 
was shown to interact with Spp382p in a yeast two-hybrid screen (Lebaron et a!, 
2005). Spp382p was the only splicing factor reported to interact with Prp43p, 
therefore possibility that Spp382p is necessary for the Prp43p association with the 
spliceosome was tested. 
As Prp43p was believed to associate with the spliceosome only transiently, it was 
decided to employ an ATPase-deficient dominant negative mutant Prp43T123A in 
order to stall complexes with bound Prp43p. Mutation in Walker motif A drastically 
impairs the ATPase activity of Prp43p, and blocks the release of the excised intron 
from the post-splicing complex (Martin et al., 2002). Plasmid expressing 
His7Prp43Tl23A in pET16b (pETI6-prp43Tl23A) was the gift of Dr B. Schwer. 
BL21-Codon Plus (DE3)RIL strain of E.coli was transformed with the plasmid, and 
recombinant protein was affinity purified as described in 2.13.1. Elution and purity 
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of the sample was confirmed by Coomassie staining. Subsequently recombinant 
protein was added to an in vitro splicing assay as described in (Martin et al., 2002). 
To determine whether the depletion of Spp382p affects Prp43p association with the 
spliceosome, immunoprecipitation of Prp43p from an in vitro splicing reaction was 
performed from normal and Spp3 82-depleted extracts. To stall the spliceosomes in 
post-splicing complex, ltg of recombinant Prp43T123A protein was added to each 
in vitro splicing reaction (50tl). Samples were processed as described in 2.12.4. As 
shown in figure 3.5, lane 5 depletion of Spp382p impairs Prp43p association with the 
post-splicing complex. 
In order to confirm that Prp43p fails to co-precipitate excised intron due to the 
absence of Spp382p, and not due to a secondary effect, a reconstitution experiment 
was performed. As previous attempts to reconstitute Spp3 82-depleted extract using 
recombinant Spp382 protein proved to be unsuccessful probably because of the 
nature of the protein (recombinant preparations of proteins with nucleic acid binding 
domains often contain RNA and RNAases from E. coli which could interfere with the 
assay), Spp382p was affinity purified from yeast splicing extract. Strain BK4H over-
expressing SPP382 from P GALl  promoter was used for affinity purification of 
Spp382p. To prepare reconstituted extract, affinity purified protein was eluted from 
the beads, and mixed with Spp3 82-depleted extract. Reconstituted splicing extract 
was used for in vitro splicing assay as described above. Results of the reconstitution 
are presented in figure 3.5, lane 6. It is clear that addition of affinity purified 
Spp3 82p restored the ability of Prp43p to precipitate excised intron from in vitro 
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Figure 33 Spp382p is necessary for Prp43p association with the post-splicing 
complex. 
50 tl splicing reactions were assembled with normal, Spp3 82—depleted and 
reconstituted extracts. Reactions were supplemented with recombinant 
dnPrp43Tl23A, and processed as usual. Anti-Prp43 antibodies were used for the 
immunoprecipitation. For affinity purified Spp382p, strain BK4H over-expressing 
SPP382 from PGALJ  promoter was used. Extract prepared from the strain grown in 
YPGR media (20tl) was used for immuno-precipitation with 15[d of anti-HA 
agarose beads, on the next step beads were extensively washed with NTN buffer. 
Two last washes were performed in 1 xsplicing buffer. Subsequently beads were 
mixed with 10tl of lxsplicing buffer, and 0.5tg of HA-peptide (Sigma) was added 
to the sample for the competitive elution of Spp382p from the beads. Elution was 
performed for 8 hours at 4°C, after that 5tl of the supeRNAtant was mixed with 
100t1 of Spp382-depleted splicing extract, and incubated for 30 min at 4°C to 
promote incorporation of purified Spp382p into the spliceosomal particles. 
Reconstituted splicing extract was used for in vitro splicing assay together with 
Spp3 82-depleted extract and non-depleted extracts. 
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3.7 Spp382p, Ntr2p and Prp43p are associated with catalytic 
spliceosomes. 
Spp382p, Ntr2p and Prp43p are predominantly associated with the excised intron in 
vitro splicing reaction, but these proteins also precipitated little amounts of pre-
mRNA and mRNA from in vitro splicing, which suggested that Spp382p, Ntr2p and 
Prp43p might be associated with the catalytic spliceosomes. To further investigate 
this issue, aberrant ACT] pre-mRNA truncated just upstream of the 3'SS was used. 
Spliceosomes assembled on this substrate undergo first step, but are unable to 
perform second step of splicing, therefore using this substrate for in vitro splicing 
causes accumulation of catalytic spliceosomes. 
Splicing reactions (50d) with non-tagged extract (BMA38a), Prp8-TAP (BK8T), 
Spp382-TAP (BK4T), Ntr2TAP (BK2T), Spp382-depleted Ntr2TAP (BK4H2T), and 
Prp43TAP (BK43T) with aberrant substrate were assembled, and processed as 












Figure 3.6. Spp382p, Prp43p, and Ntr2p are associated with catalytic 
spliceosomes. Aberrant substrate (i3'SS) was used for in vitro splicing reaction. 
Splicing reactions (50 [tl) were assembled, incubated for 30 min at RT, and 
precipitated with rabbit IgG agarose. RNA extracted from beads and 20% of 
unbound fractions was loaded on 7% PAGE gel, gel was dried and subjected to 
autoradiography. 
Results of this experiment indicate that Spp382p, Ntr2p and Prp43p are likely to be 
associated with catalytic spliceosomes as Spp382p, Ntr2p and Prp43p efficiently 
precipitate aberrant lariat and exonl from in vitro splicing reaction with aberrant 
substrate. Interestingly, while Prp8p precipitates approximately equimolar amounts 
of aberrant lariat and exonl, Spp382p, Prp43p and Ntr2p show preferential 
precipitation of the aberrant lariat. This suggests that under conditions of the 
precipitation these proteins are more stably associated with the lariat species. 
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Strikingly, Ntr2p shows only background precipitation of the aberrant intermediate 
of the splicing reaction in Spp3 82-depleted extract, suggesting that Spp382p is 
required for Ntr2p association with the catalytic spliceosome. As Ntr2p is still 
associated with normal excised intron-lariat in the absence of Spp382p, this finding 
might point to extensive protein-protein re-arrangements within the spliceosome 
between catalytic steps. 
/ 
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3. 8 Discussion 
In this chapter I present evidence that depletion of Spp382p causes a spliceosome 
disassembly defect, as it appears that Prp8 is accumulated in a complex with the 
excised intron. In vivo Prp8p is found to be associated with an increased amount of 
U2, indicating accumulation of Prp8 in aberrant post-splicing complexes (Boon et 
al., 2006a). 
Large-scale yeast two-hybrid screens previously identified interaction between Ntr2p 
and Spp382p (Ito et al., 2001; Uetz et al., 2000). I present data that Ntr2p is a newly 
identified splicing factor as it is physically associated with the post-splicing complex. 
Ntr2p precipitates excised intron from in vitro splicing reaction, and U2, U5 and U6 
snRNAs, which suggests a role for the protein in spliceosome disassembly. 
Additionally, it appears that Spp382p is not required for Ntr2p association with the 
post-splicing complex as in Spp3 82-depleted extract Ntr2p is still associated with the 
excised intron. This finding indicates that Ntr2p has unidentified interactions within 
the spliceosome. Indeed, when the work on this thesis was in progress, a paper on the 
subject was published. It showed that Ntr2p interacts with DExD/H box helicase 
Brr2p in yeast two-hybrid assay, and suggested that Ntr2p acts as a receptor to bring 
Spp382p to the spliceosome (Tsai et al., 2007). 
Analysis of sedimentation profiles of Ntr2p and Spp3 82p established that Ntr2p and 
Spp382p co-distribute in glycerol gradients with distinctive peaks in the top and in 
the bottom of the gradient. This result indicated that Ntr2p and Spp382p likely co-
exist within high and low molecular weight complexes. While bottom fractions are 
likely to represent various high molecular weight spliceosomal complexes, it is not 
entirely clear what the top peak represents. It was suggested that the lower-density 
peak might be a Ntr2-Spp382p dimer, which is not snRNP-associated (Boon et al., 
2006a). Previously it was established that Spp382p co-sediments with Prp43p, which 
suggests that Prp43p, Spp382p and Ntr2p might form, a complex (Boon et al., 
2006a). Moreover, based on yeast two-hybrid and biochemical studies it was 
proposed that Ntr2p, Spp328p and Prp43p form a trimer (Tsai at al., 2005). 
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Interestingly, the only other protein found in this snRNP-free part of the gradient is 
the DExDIH box helicase Brr2p (mature U5 snRNP component). Brr2p is proposed 
to leave U5 snRNP or replaced by Aar2p during spliceosome recycling, and it is not 
clear whether Brr2p stays associated with other proteins after it leaves U5 snRNP 
(Boon et al., 2007). As Ntr2p interacts with Brr2p in a yeast two-hybrid assay (Tsai 
et al., 2007), it is possible that Brr2p, Ntr2p, Spp382p and Prp43p form a sub-
complex following spliceosome disassembly. Further experiments are required to 
support this hypothesis. 
Association of Prp43p with the spliceosome is very weak, and barely detectable in 
vitro splicing reactions assembled with normal substrates and normal splicing 
extracts (Martin et al., 2002; Tsai et al., 2005). Prp43T123A mutant blocks the 
release of the excised intron-lariat from the post-splicing complex (Martin et al., 
2002), and is used to study Prp43p association with the post-splicing complex. In this 
chapter I show that Spp382p is required for the association of the Prp43pTl23Ap 
with the post-splicing complex. In Spp382-depleted extract Prp43Tl23Ap does not 
precipitate excised intron from in vitro splicing reaction, however addition of the 
affinity purified Spp382p restores the association of the Prp43T123A with the 
excised intron. Interestingly, Prp43p also co-precipitates pre-mRNA from in vitro 
splicing reaction on a level above background, which might indicate that Prp43p is 
present in early spliceosomal complexes. Significantly, human Prp43p is a U2 
snRNP-associated protein (Dybkov et al., 2006), which might suggest that Prp43p is 
associated with the spliceosome at all stages of splicing as a part of U2 snRNP, but 
its activity is required for the spliceosome disassembly. Additionally human 
orthologue of Spp382p, TFIP11 protein (for tuftelin-like protein), is found in tn-
snRNPs, suggesting that Spp382p might join the spliceosome as a part of tri-snRNP. 
Indeed, Spp382p, Ntr2p and Prp43p are associated with in vitro assembled catalytic 
spliceosomes stalled after first catalytic step, supporting the idea that these proteins 
might associate with the spliceosomes before disassembly step. 
Chapter 4 
Spp382 is a pre-rRNA processing factor 
4.1 Introduction 
In addition to its association with splicing factors, the helicase Prp43p was co-
isolated with multiple pre-ribosomal particles (Dez et al., 2002, Lebaron et al., 2005, 
Combs et al., 2006, Leeds et al., 2006), including precursors of both small and large 
ribosomal subunits. However, the precise function of Prp43p in pre-rRNA processing 
and the stage where it acts remains to be determined. 
Spp382p and Ntr2p were shown to be accessory factors for DEAH-box helicase 
Prp43p in splicing (Tsai et al., 2005; Boon et al., 2006; this thesis), and co-factors for 
Prp43p in pre-rRNA processing have not been identified. This led to suggestion that 
Spp382p and Ntr2p might assist Prp43p in pre-rRNA processing as well as in 
splicing. In this chapter I present evidence that Spp382p, but not Ntr2p, is indeed 
associated with pre-rRNA particles and plays a role in rRNA biogenesis. 
4.2 Depletion of Spp382p causes a defect in pre-rRNA processing 
It was previously established that depletion of Spp3 82p affects cell growth (Boon et 
al., 2006). However, it was also established that depletion of Spp382p causes only a 
mild splicing defect, and it was proposed that Spp382p might have an essential 
function different from splicing (Boon et al., 2006). Since Prp43p was implicated in 
both splicing and pre-rRNA processing, the effect of Spp3 82-depletion on pre-rRNA 
processing was investigated. 
In order to study the effect of Spp3 82-depletion on pre-rRNA processing, strain 
BK4H was pre-grown in YPGR, transferred to YPDA medium, and aliqouts of the 
culture maintained in early log phase were taken after 0, 2, 4 and 6 hours. Depletion 
of Spp382p was confirmed by western blot (Fig 4.1 C). For positive control culture 
of BMA38a strain was treated in the same way. RNA was extracted from the 
VU 
samples using the GTC/Phenol method, and steady state levels of pre-RNA 
precursors and mature species were analyzed by northern blot (figure 4.1 A and B). 
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Figure 4.1. Depletion of Spp382p has a rapid effect on pre-rRNA processing. 
BMA38a and BK4H strains were grown in YPGR, and transferred to YPDA. At the 
time-points given, samples of the cultures were taken, and total RNA was extracted. 
RNA was resolved on 1.2% agarose gel (large molecular weight species, panel A) 
and 6% (wlv) polyacrylamide gel (small molecular weight species, panel B). RNA 
was transferred to NylonN+ membrane, and was subjected to northern blot analysis 
using various probes. Depletion of Spp382 was confirmed by western blot analysis 
(Panel C). Samples for western were prepared as described in 2.13.4 and loaded on 
4-12% gel, blotted and probed with HRP conjugated anti-HA antibodies (1:3000). 
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Result presented in figure 4.1 indicates that depletion of Spp3 82p affects pre-rRNA 
processing. Thus, after two hours in YPDA there is an accumulation of 35S and 23S 
precursors, and a decrease in a level of 20S, which suggests that cleavages at Ao, A 1 
and A2 are affected (figure 4.1A). Decrease in the level of 20S indicates a defect in 
mature 18S processing. At the same time, levels of 27SB and 7S appear unchanged, 
suggesting that depletion of Spp382p does not affect large subunit processing, and 
has a primary effect on the small subunit biosynthesis. Levels of mature 25S, 18S, 
and 5.8S also remain unchanged, however taking into consideration the short time 
frame of the experiment (6 hours), it is likely that the defect on the level of the 
mature species is not yet apparent, due to the slow turnover of mature rRNAs. 
Additionally, no change in the level of mature U3 snoRNA is observed, indicating 
that at Ao, A 1 , A2 defect can not be explained by U3-depletion. In support that 
Spp3 82-depletion only causes mild splicing defect, there is a very modest 
accumulation of pre-U3 snoRNA after 4 hours of depletion (figure 4.1 B). These data 
suggest that the defect in splicing caused by Spp3 82-depletion, cannot solely account 
for the defect in pre-rRNA processing, and indicate that Spp382p might play a direct 
role in pre-rRNA processing. 
Pulse-chase analysis was performed to investigate the kinetics of pre-rRNA 
processing in the Spp3 82-depleted strain. BMA38a and BK414 strains carrying 
empty pRS3 13 vector (as uracil uptake and its incorporation into pre-rRNA was 
studied) were pre-grown in —ura +gal medium, and transferred to —ura+glucose 
medium for 4 hours to deplete Spp382p. Pulse labelling was performed with 3H-
uracil, and excess of non-labelled uracil was added for the "chase" (described in 
2.12.7). Samples were collected, and processed as described in 2.12. 7. Results are 
presented in figure 4.2. 
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Figure 4.2 Pulse-chase analysis of Spp382-depleted strain shows defects in 
pre-rRNA processing. Pulse labelling was performed with 3H- Uracil for I mm, 
then excess of unlabelled uracil was added to the culture. Samples were collected at 
indicated times after unlabelled uracil addition. RNA was extracted from the 
samples, separated on 1.2% (w/v) agarose gel, blotted and subjected to 
autoradiography. 
Analysis of the labelled RNA from the pulse-chase experiment shows a significant 
delay in maturation of 35S, which accumulates present at later time points in the 
Spp3 82-depleted strain. Additionally, processing of both 27SA/B and 20S is delayed 
as no mature species are produced in the mutant strain. The results suggest that there 
is a severe pre-rRNA processing defect in Spp3 82-depleted strain, which affects 
biosynthesis of small and large subunits. 
As depletion of Ntr2p did not show any effect on cell viability, effect of Ntr2p 
depletion on pre-rRNA processing was not assessed. 
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4.3 Spp382p is associated with pre-rRNA precursors. 
To establish whether Spp382p and Ntr2p take part in pre-rRNA processing, physical 
association of Spp382p and Ntr2p with pre-rRNA particles was investigated. For 
this, affinity purification of these proteins was performed based on the Protein A 
moiety of the TAP tag (first step only), and precipitates were tested for the presence 
of pre-rRNA precursors. 
TAP-tagged Spp382p (KL4T), Ntr2p (KL2T) strains were used, with non-tagged 
strain (BMA38a) as a negative control, and TAP-tagged Prp43p (KL43T) as a 
positive control. Extracts for purification were prepared as described in 2.12.5 from 
21 cultures and mixed with IgG agarose beads. After co-precipitation, RNA was 
extracted, loaded on the gel and analysed by northern blot. 
As shown in figure 4.3, Spp382p, but not Ntr2p precipitates pre-rRNA precursors. 
The level of the precipitation of pre-rRNA precursors by Spp3 82p is similar to that 
of Prp43p, which was previously reported to be weakly associated with pre-rRNA 
precursors. Levels of 35S, 32S, 20S, 27SA/B and 7S were enriched in the Spp382p 
precipitate, suggesting that Spp382p, like Prp43p, is associated with the precursors of 
both small and large ribosomal subunits. Intriguingly, Spp382p, like Prp43p, 
precipitates 20S and mature cytoplasmic 18S on a level above background. As 
conversion of 20S to 18S occurs in the cytoplasm, this result suggests that Spp382p 
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Figure 4.3. Spp382p, but not Ntr2p precipitates pre-rRNA precursors. IgG 
agarose beads (50t1) were washed with lysis buffer and mixed with extracts prepared 
from 21 of exponentially growing culture. Co-immunoprecipitation was performed 
for 1 hour at 4°C on rotating wheel. Beads were washed extensively and subjected to 
RNA extraction. "Total RNA" extracted from the cell lysate corresponded to 1% of 
that used for immuno-precipitation served as Total sample. Half of the samples were 
glyoxal -denatured and resolved on 1.2% agarose gel, while another half was loaded 
on 6% PAGE gel. After the transfer membranes were hybridized with variety of 
probes to multiple RNA species. 
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4.4 Discussion 
In this chapter I show that Spp382p, like Prp43p is associated with the precursors of 
rRNA processing, and depletion of Spp382p affects pre-rRNA processing, which 
suggests that Spp382p might be a new pre-rRNA processing factor. 
Depletion of Spp382p causes substantial accumulation of 35S and 23S after 2 hours 
in YPDA medium, and a decrease in 20S, which suggests that A0, Al or A 2 cleavages 
might be affected, which is also consistent with the results of the pulse-chase 
experiment. 
As Spp382p is also implicated in splicing, there is a likely argument that the 
observed defect in pre-rRNA processing is secondary. U3 snoRNA is implicated in 
A0, A 1 and A2 cleavages, and depletion of U3 due to the splicing defect will have a 
phenotype similar to that of Spp3 82-depletion. Additionally, a large proportion of 
genes coding ribosomal protieins are intron-containing, which suggests that defective 
splicing of ribosomal protein transcripts might cause a secondary effect on pre-rRNA 
processing. However, there are several observations that favour a direct effect of 
Spp382 on pre-rRNA processing. First, depletion of Spp382p has no effect on the 
level of mature U3 snoRNA and causes only mild accumulation of pre-U3 after 4 
hours in YPDA. This eliminates the possibility that drastic effect of Spp382-
depletion on pre-rRNA processing is due to the lack of U3 snoRNA. 
It was suggested that assembly of ribosomal proteins on pre-rRNA probably provides 
a platform for the pre-rRNA processing enzymes, and therefore correct assembly of 
ribosomal proteins on pre-rRNA is necessary for pre-rRNA processing events to take 
place (Ferreira-Cerca et al., 2005), therefore it is conceivable that Spp382-depletion 
affects pre-rRNA processing through deficiency of r-proteins. However, it was 
shown that depletion of Spp382p does not cause significant reduction of any mRNA 
coding ribosomal proteins (Boon et al., 2006), suggesting that it is highly unlikely 
that the defect in pre-rRNA processing is due to the lack of ribosomal proteins. 
Additionally, analysis of the splicing arrays suggests that ribosomal genes form a 
regulon, which might indicate a common regulatory mechanism for genes coding r-
proteins (Pleiss and Guthrie., 2007). It was reported that mRNAs, coding r-proteins 
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have long half-lives, and splicing defects affect the level of r-mRNAs proportionally 
to the level of the splicing defects (Pleiss and Guthrie, 2007), supporting the that a 
defect in Sr-proteins production cannot solely cause the observed defect in pre-rRNA 
processing. All the above supports the idea that Spp382p is directly involved in pre-
rRNA processing. 
The TAP affinity purification experiment reveales that Spp382p, but not Ntr2p, co-
precipitates pre-rRNA precursors, which indicates physical association of Spp382p 
with the pre-rRNA processing machinery (or with pre-ribosomes). Moreover, as 
Spp382p repeats the pattern of precipitation of pre-rRNA precursors by Prp43p, it 
suggests that Prp43p and Spp382p may act together in pre-rRNA processing as well 
as in splicing. 
Spp382p, like Prp43p, is associated with the pre-rRNA precursors rather weakly. It is 
believed that DExD/H-box helicases have very weak and/or very dynamic 
association with the spliceosome and pre-rRNA processing machinery. In a view of 
the chaperone-like function of DExD/H-box helicases, it is conceivable that their 
activity is required for a certain step, after which the enzyme dissociates from the 
substrate(s) and gets recycled. Therefore, at a given moment in time there is only a 
small sub-population Of the spliceosomes or pre-ribosomes that is associated with a 
particular helicase, and also this interaction by definition is very transient. A recent 
paper, in which splicing competent catalytic complexes were isolated, divided 
splicing proteins into "core" and "top" sub-groups (Bessonov et al., 2008). DExD/H-
box helicases, including Prp43p and its accessory factor Spp382p, belong to the 
"top" group, which is easily dissociated from the "core" spliceosome. Applying 
similar logic to pre-rRNA processing machinery, Prp43p and the rest of DExD/H 
box helicases of pre-rRNA processing, the majority of RNA modifying enzymes and 
nucleases would constitute the putative "top" group of the pre-rRNA processing 
machinery, which ab initio has weak/transient association with the "core" machinery. 
Thus, several known pre-rRNA processing factors proved to be elusive to isolate 
with pre-RNA processing machinery. G-patch protein Gnolp interacts with Prp43p 
and is proposed to be an accessory factor for Prp43p in pre-rRNA processing 
(Lebaron et al., 2005). Deletion of Gnolp results in pre-rRNA processing and 
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snoRNA maturation defects (Guglielmi and Werner, 2002). However, Gnolp failed 
to be co-purified with pre-rRNA precursors. Therefore, despite weak association of 
Spp382p and Prp43p with splicing and pre-RNA processing machineries, these 
proteins might play an important function in both processes. The remarkable fact that 
Spp382p and Prp43p are shared subunits between two machineries probably has 
some functional relevance. It is very tempting to propose that Spp382p and Prp43p 
play a role in a concerting mechanism between the two processes, however further 
experiments are needed to prove this. 
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Chapter 5 
Role of Prp43 protein in splicing 
5.1 Introduction 
Multiple reports have placed yeast protein Prp43p within the post-splicing complex, 
which was confirmed by Prp43p association with U2, U5, U6 snRNAs, and excised 
intron (Martinet al., 2003; Lebaron et al, 2005; Leeds at al., 2006; Combs et al., 
2006; Small et al., 2006). Despite that Prp43p is required for spliceosome 
disassembly, the target of Prp43p activity in the process remains unknown. In this 
chapter I show that Prp43p might play a role in U6 snRNA release from the post-
splicing complex. 
In chapter 3 I showed that Prp43p is associated with catalytic spliceosomes stalled 
after the second step of splicing. Interestingly, Prp43p precipitates significant amount 
pre-mRNA from Spp3 82-depleted extract from an in vitro splicing reaction, 
suggesting that Prp43p might be associated with the pre-catalytic complex. In 
support of this hypothesis, the human orthologue hPrp43 was found to be U2 
snRNP-associated (17S), and was also co-purified with complex A (Behzadnia et al., 
2006; Deckert et al., 2006; Dybkov et al., 2006). Additionally, hPrp43p was shown 
to co-precipitate U2 and Ui snRNAs, indicating that hPrp43p may be associated 
with early spliceosomal complexes (Fouraux et al., 2002). In this chapter I present 
evidence that the yPrp43 protein is likely to be associated with the spliceosome as 
early as Complex A. 
All DEAH-box proteins have a conserved helicase core domain and unique N- and 
C-terminal regions. It was shown that the C-terminus of Prp43p is not required for 
the ATPase activity of Prp43p in vitro, but is essential for cell viability (Tanaka et 
al., 2007). Additionally, the C-terminus of Prp43p interacts with 5pp382p (Tsai et 
al., 2005). The role of this interaction is unknown, as Spp382p also interacts with the 
helicase core of Prp43p, and this interaction is enough to activate ATPase activity of 
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Prp43p in vitro (Tanaka et al., 2007). Here, I demonstrate that a mutation in the C-
terminus of Prp43p causes a defect in splicing, but not in pre-rRNA processing. I 
propose that the C-terminus is likely to play a role in regulation of the ATPase 
activity of Prp43p within the post-splicing complex. 
5.2 Prp43 protein is associated with Complex A. 
In order to investigate the possibility that Prp43p is a part of pre-catalytic 
spliceosomal complexes, the association of Prp43p with splicing complexes was 
assayed in Prp8-depleted yeast splicing extract that is unable to form Complex B. It 
was previously reported that depletion of Prp8p destabilizes U5 snRNP, and 
therefore affects tri-snRNP formation and formation of Complex B (Brown and 
Beggs, 1992). Therefore, this splicing extract will form Complexes E and A, and 
potentially aberrant B complex, but not catalytically competent spliceosomes. Strain 
KU (PGALJPRP8) was used for the preparation of Prp8-depleted extract. First, 
growth defect of the culture of KU strain was assessed following shift to YPDA 
media. Depletion of Prp8p severely affects growth of the culture (figure 5.1), 












Figure 5.1. Depletion of Prp8p causes a severe growth defect. Strain KU and the 
isogenic wild type, BM38A, were pre-grown in YPGR, and than transferred to 
YPDA. Optical density of the culture was measured every two hours. 
Splicing extracts were prepared from strains KU and BM38A 6 hours following 
transfer into YPDA, and were checked for their splicing activity in vitro. Reactions 
(1 OOIkl) were assembled using wild-type and Prp8-depleted extracts, incubated for 30 
minutes at RT, and precipitated with anti-Prp8 or anti-Prp43p antibodies. Indeed, 
Prp8-depleted extract does not possess the splicing activity. Additionally, wild-type 
Prp43p is very weakly associated with spliceosomes under normal conditions as the 
observed precipitation of splicing products is very close to background levels. On the 
other hand, Prp43p precipitates an increased amount of pre-mRNA from Prp8-
depleted extract, which might indicate the association of Prp43p with early 
spliceosomal complexes. Precipitation of pre-mRNA with anti-Prp8 antibodies from 








Figure 5.2. Depletion of Prp8p has a splicing defect and causes an increase in 
Prp43p association with pre-mRNA. Splicing reactions (100t1) with normal and 
Prp8-depleted extracts were assembled. Reactions were incubated for 30 min at RT, 
products of in vitro splicing reaction were co-precipitated with either anti-Prp8 or 
anti-Prp43 antibodies (prepared as described). After the precipitation beads were 
washed extensively, retained RNA was extracted, and resolved in a 7%(wlv) 
polyacrylamide gel. The gel was dried at 80°C for 2 hours, and subjected to 
autoradiography. 
In order to confirm this result, biotinylated pre-mRNA was used as a substrate for an 
in vitro splicing assay. Using biotin labelled substrate allows affinity selection of 
complexes formed on the pre-mRNA and monitoring of protein and snRNAs 
associations with pre-mRNA. Biotinylated pre-mRNA (bRNJA) was generated using 
in vitro transcription as described in 2.12.2, except that in the nucleotide mixture, 
modified nucleotide was used in ratio 1 biotin-16-uracil :8 uracil, according to the 
manufacturer's (Fermentas) instructions. 
To assay snRNAs and protein association with bRNA under splicing conditions, 
spicing reactions (200.il) were assembled, with non-labelled substrate used as a 
negative control. After 30 min of incubation at RT, bRNA and associated complexes 
were precipitated using magnetic streptavidin beads. The magnetic beads are 
essential for this experiment, as high background was observed with streptavidin 
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agarose beads. For snRNA analysis, RNA was extracted from the beads, loaded onto 
the PAGE gel, blotted and probed for the presence of various snRNAs. For protein 
analysis, beads were boiled in 2XSDS loading buffer, loaded on 4-12% PAGE gel, 
blotted and probed for the precipitation of Prp43p and Prp8p. Results are presented 
in figure 5. 3 
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Figure 5.3 Prp43p is associated with pre-mRNA in Prp8-depleted extracts. 
Splicing reactions (200 t1) were assembled with unlabeled substrate or biotinylated 
RNA, incubated for 30 min at RT, mixed with streptavidin magnetic beads, 
incubated for 1 hour at 4°C and washed extensively with NTN buffer. For analysis of 
protein association (panel A), beads were resuspended in 2xSDS loading buffer, and 
processed as normal protein samples, loaded on a gel 4-12% page gel, blotted, and 
probed with anti-Prp43 and anti-Prp8 antibodies. For analysis of snRNAs (panel B), 
RNA was extracted from the beads, and subjected to northern blot analysis as 
described in 2.12.6. 
As shown in figure 5.3B, bRNA efficiently precipitates U2, Ui, U5 and U6 snRNAs 
from a normal splicing extract, suggesting that spliceosomal complexes are 
assembled on bRNA substrate under these conditions. In the case of Prp8-depleted 
extract, bRNA precipitates U2 and Ui snRNAs, supporting the fact that depletion of 
Prp8p causes a defect in spliceosome assembly and causes formation of Complex A 
under splicing conditions. Low levels of U4, U5 and U6 snRNAs associated with 
bRNA indicate a residual Complex B complex formation. 
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Analysis of the protein content of the bRNA precipitates (figure 5.3A) revealed the 
presence of a band corresponding to Prp8p only in the case of normal (non-depleted) 
extract, confirming a genuine depletion of Prp8p from the treated extract. At the 
same time, Prp43p was observed in bRNA precipitates with both normal and Prp8-
depleted extracts, but not in the case of unlabelled RNA, indicating that Prp43p 
association with bRNA is specific and eliminating the possibility that Prp43p 
association with RNA is due to non-specific binding often described for proteins 
participating in nucleic acid metabolism. These results taken together suggest that 
Prp43p is likely to be associated with pre-catalytic spliceosomes as early as Complex 
A, possibly as a part of U2 snRNP. However, it remains unclear whether Prp43p has 
a function in early spliceosomes or if it joins the spliceosome as a component of U2 
snRNP, and is activated only in the post-splicing complex. 
94 
5. 3 Role of the C-terminus of Prp43p in splicing and pre-rRNA 
processing 
It was proposed that the flanking regions determine specific protein-protein, or 
protein - RNA interactions and possibly regulate the activity of DExD/H box 
proteins. It was shown that the C-terminus of Prp43p is not required for ATPase 
activity of Prp43p in vitro, but is essential for cell viability (Tanaka et al., 2007), 
therefore it was suggested that the C-terminus of Prp43p is required for the protein-
protein interactions, or binding of Prp43p to the complexes. 
Several temperature-sensitive C-terminus mutants of Prp43p were isolated by our 
collaborator on this project, Dr G. Edwalds-Gilbert. One of these mutant alleles, 
prp43E716A, was chosen to assay effect of the C-terminus mutation in vivo on 
splicing and pre-rRNA processing. 
When the work on this project was in progress, it was established that the E716A 
substitution lies in the region of interaction of Prp43p with Spp382p (Prp43 aa712-
720; Tanaka et al., 2007), and therefore this mutant protein is likely to be defective in 
its interaction with Spp382p. Strikingly, Spp382p also binds ATPase domain of 
Prp43p, and this interaction is enough to stimulate ATPase activity of Prp43p in 
vitro, and therefore the role of interaction between Spp382p and the C-terminus of 
Prp43p in unclear. 
In the first instance, growth of the mutant strain at the restrictive temperature was 
assessed. The mutant strain and isogenic wild type were pre-grown at 30°C, shifted 
to 37°C, and optical density was measured every two hours. Strain E716A shows 
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Figure 5.4. Prp43E716A has a defective growth at 37°C. Strain Prp43E716A 
carrying mutation in the C-terminus and the isogenic wild-type strain were pre-
grown at 30°C, and shifted to 37 0C. Aliquots of the culture were taken each two 
hours and their optical density measured. 
In order to investigate a possible splicing defect in the mutant strain after the 
temperature shift, qPCR analysis of splicing products and intermediates was 
performed. Total RNA was extracted from the Prp43E7 1 6A and isogenic wild-type 
cultures after 4 hours at 37°C, and used for production of cDNA of ACT] RNA. 
Several qPCR reactions were set up using sets of oligos (as presented in figure 2.1 in 
materials and methods, section 2.14) to amplify different RNA species. Relative 
amounts of different ACT] RNA species from the mutant strain were compared to 
those of the wild type (calculated using ACTSOf the PCR reactions performed with 
cDNA as described in materials and methods section 2.14). As can be seen from the 
results shown in figure 5.5A, the E716A mutation causes an increase in the level of 
both lariat and pre-mRNA species, which agrees with the previously described role 
of Prp43p in spliceosome disassembly and recycling. At the same time levels of 
mRNA and the level of total RNA (as indicated by the level of the second exon) are 
not affected, suggesting that E7 1 6A mutation has a mild defect in splicing, which 
cannot account for the slow growth of the mutant strain at this time-point. To 
eliminate the possibility that 4 hours at restrictive temperature was not enough for 
the development of the defect, samples from cultures shifted for 8 hours to non-
permissive temperature were prepared. qPCR analysis of mutant sample shows no 
increase of accumulation of the splicing intermediates in comparison to the earlier 
time-point (figure 5.5B). A decrease in the accumulation of the splicing 
intermediates and amount of total ACT] RNA produced suggests that cell 
metabolism is severely affected at this time-point, and reporter RNA is not made. 
Mild accumulation of splicing precursors in the case of the mutant can be explained 
if this mutant affects late steps of spliceosome disassembly and snRNP dynamics, or 
the alteRNAtive explanation - this mutant is defective in a process different from 
splicing 
To assay pre-rRNA processing, northern blot analysis of steady state levels of pre-
rRNA precursors following 4 hours shift was performed (Figure 5.5C). No defect in 
pre-rRNA processing is observed at this timepoint, suggesting that pre-rRNA 













Figure 5.5 The C-terminus mutant of Prp43p has a mild splicing defect and no 
defect in pre-rRNA processing after temperature shift. Total RNA extracted from 
Prp43E7I6A and BMA38a strains following 4 hours (A and C), and 8 hours (B) 
shifts were subjected to qPCR analysis and nothern blot. 
5.4 Prp43 is necessary for U6 snRNA release from the post-splicing 
complex. 
Up to now, little information about snRNP composition of the post-splicing complex 
is available, and the pathway of spliceosome disassembly is not characterised. As 
Prp43p plays a role in spliceosome disassembly, the question we wanted to address 
was whether Prp43p played an early role in spliceosome disassembly, or had a 
function in partially disassembled spliceosomes. Prp43p was shown to be weakly 
associated with U2, US and U6 snRNAs (Lebaron et al., 2005, Leeds et al., 2006. 
Combs et al., 2006), which are believed to compose the post-splicing complex. As 
the ATPase deficient mutant Prp43T123A was shown to stall spliceosomes in 
excised intron-containing post-splicing complexes (Martin et al. 2002), assaying the 
snRNP composition of this complex in comparison to wild type would allow us to 
distinguish between two distinct possibilities and roles of Prp43p in spliceosome 
disassembly. First, if Prp43T123A is stalled in a genuine post-splicing complex 
which is formed immediately after mRNA release, in this case the increased 
association of Prp43Tl23Ap with U2, US and U6 snRNAs is expected, and would 
suggest that Prp43p acts early in spliceosome disassembly. Another possibility is that 
Prp43p functions later, and using the mutant form of the protein would lead to 
accumulation of aberrant complexes limiting the disassembly process. 
Two Prp43p mutants - ATPase deficient Prp43T123A and C-terminus mutant 
Prp43E716A were assayed on their precipitation of snRNAs. The plasmid p113 
expressing PRP43T123A from PGALI promoter was a gift from Dr. B. Schwer. Strain 
BMA38a was transformed with the plasmid and transformants were selected on —Trp 
media. For the extract preparation the plasmid-containing strain was grown in —Trp 
for pre-culture, and then transferred into —Trp, Gal medium for 8 hours. Prp43T123A 
has a strong dominant negative effect; growth of the culture is severely reduced with 
doubling time of more than 8 hours (doubling time of wild-type culture under these 
conditions is close to 4 hours), which indicates that expression of the dominant 
negative protein causes effect on the growth. 
Splicing extracts were prepared from strains BMA38a and Prp43T123A incubated in 
Gal medium for 8 hours, and from Prp43E7I6A shifted for 4 hours to 37°C, and used 
for immunoprecipitation with anti-Prp43 antibodies. Results are presented in figure 
5.7. 
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Figure 5.7 Prp43 mutant proteins are stalled within spliceosomes. Splicing 
extracts (100tl) were mixed with 100tl of 1xIPP buffer and protein A Sepharose 
beads with pre-bound anti-Prp43p antibodies. After immunoprecipiatation, RNA was 
extracted from the beads, and analysed by northern blot. 
As can be seen in the figure 5.7 wild-type Prp43p precipitated U2, Ui U5 and U6 
snRNAs. Precipitation of U2, US and U6 by Prp43p has been previously reported as 
Prp43p was suggested to function in spliceosome disassembly (Lebaron et al., 2005, 
Leeds et al., 2006. Combs et al., 2006). Precipitation of Ui snRNA is not surprising 
as I showed that Prp43p is likely to be associated with the splicesomes as early as 
Complex A. Previous lack of detected association of Prp43p with Ui can be 








while polyclonal anti-Prp43 antibodies were used for my experiments. It is 
conceivable that in early spliceosomal complexes the TAP-tag on Prp43p is not 
accessible or the TAP-tagged Prp43p actually has a splicing defect, and presumably 
affects spliceosome disassembly. 
Interestingly, there is a difference in snRNAs precipitation in the case of the prp43 
mutants - there is an increased association of Prp43p with U6 and U  snRNAs and 
there is a slight increase in the level of the precipitation of U4 snRNA. This not only 
proves that Prp43p is associated with the spliceosome during all the stages of 
splicing reaction, but also suggests that spliceosome dynamics in mutants are 
impaired. Additionally, increased precipitation of U6 by mutant proteins suggests 
that Prp43p might play a role in U2/U6 duplex unwinding. Moreover, as both 
ATPase deficient and C-terminal mutants of Prp43p have the same phenotype, it 
might indicate that the C-terminus of Prp43p plays a role in regulation of ATPase 
activity of Prp43p in splicing. 
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5.4 Discussion 
In this chapter I show that Prp43p is likely to be associated with the early 
spliceosomal complexes. I show that Prp43p is present in Complex A using extract 
unable to form functional Complex B, supporting that Prp43p is present in pre-
catalytic spliceosomes. This finding is not surprising as the functional mouse 
orthologue of Prp43p co-precipitates U2 and Ui under splicing conditions (Gee et 
al., 1997), suggesting that mPrp43p is associated predominantly with Complex A, 
and human orthologue of Prp43p is U2 snRNA associated protein (Dybkov et al., 
2006). These data indicate that yeast Prp43p is likely to be associated with the 
spliceosomes during all stages of splicing. It remains to be determined, however, 
whether Prp43p performs any function early in the spliceosome, and whether this 
function requires its ATPase activity. To answer these questions additional 
experiments are required. 
Effects of C-terminus mutations in Prp43p on splicing and pre-rRNA processing 
were investigated. qPCR analysis of splicing intermediates following 4 hours shift to 
non-permissive temperature revealed the presence of a mild splicing defect with the 
accumulation of the lariat species and pre-mRNA of the ACT] gene, which might 
indicate the presence of the defect in recycling of spliceosomal components in C-
terminus mutants. The phenomenon, that prp43 mutants do not show significant 
accumulation of splicing precursors has been previously reported by J. Combs and 
colleagues. In their microarray study of ATPase-deficient mutant of Prp43p no 
drastic changes in levels of splicing precursors and intermediates were observed, and 
splicing defect of Prp43p mutant was comparable to the splicing defect caused by 
non-essential splicing factors, which led to proposition that Prp43p participates in 
pre-mRNA splicing, but has an essential function in pre-rRNA processing. 
Remarkably, no effect on pre-rRNA processing was noticed for lethal Prp43E716A 
mutant after the temperature shift. Lack of the effect of the C-terminus mutation on 
pre-rRNA processing suggests that E7 1 6A mutation affects predominantly splicing. 
The absence of a drastic defect in splicing and pre-rRNA processing, which could 
explain the growth defect, indicates that the assays used here are not sensitive 
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enough (or not general enough, e.g. splicing microarray to investigate splicing 
genome-wide) to reveal the presence of the defect. Interestingly, it was reported that 
essential splicing factors involved in early stages of splicing do not cause significant 
accumulation of precursors probably because non-processed precursors are quickly 
degraded (Combs et al., 2006). It is also possible that similar phenotype will be 
observed for factors involved in snRNP recycling, and might explain lethality of 
E7 1 6A mutation in the absence of drastic splicing defect. 
Another possibility is that C-terminus mutant of Prp43 has an essential function in a 
process different from splicing and pre-rRNA processing. Interestingly enough, 
Prp43p was co-isolated with subunits of Poll and Poll! machineries (Lebaron et al., 
2005), however the role of Prp43p in transcription has not been investigated yet. This 
suggests that the C-terminus mutants of Prp43p might have a role in transcription, or 
coordination of spliceosomal and transcriptional events, but this hypothesis requires 
further investigation. 
It was previously suggested that Prp43p association with spliceosomes is mediated 
via its C-terminus (Tanaka et al. 2007). As Prp43E716Ap is stalled with snRNAs, it 
indicates that the C-terminus is not required for Prp43p association with the 
spliceosome, but rather required for the ATPase activity of Prp43p in splicing. 
Indeed, a role of the C-terminus in regulation of activity of several DExD/H box 
helicases was reported (reviewed in Silverman et al., 2003). The way this regulation 
occurs, however, remains unknown. 
Analysis of snRNAs associated with mutants of Prp43p shows an accumulation of 
U2, Ui and most noticeably, U6 snRNAs. Lack of the accumulation of U5 snRNA 
might indicate that U5 snRNA is not tightly associated with U2/U6 duplex, and 
likely to be the first one to leave the post-splicing complex. It is proposed that the 
main role of U5 snRNP in splicing is exon alignment (Newman and Norman, 1992), 
and after release of spliced mRNA, US snRNA has no RNA-RNA interactions within 
the post-splicing complex. Therefore, it is likely that U5 snRNA is probably weakly 
associated with the rest of the components of the post-spliceosome. On the other 
hand, accumulation of U6 snRNA with Prp43p mutants indicates that ATPase 
IDII 
activity of Prp43p might be required for the release of U6 snRNA from the post-
splicing complex. It is not entirely clear whether Prp43 plays a role in unwinding of 
U2/U6 duplex, or it serves as an accessory factor for another helicase. Processive 
DEIH helicase Brr2p was shown to play a role in spliceosome disassembly (Small et 
al., 2006), and was proposed to unwind U2/U6 duplex. Additionally, Brr2p was 
shown to unwind U2/U6 duplex in vitro (Xu et al., 1996). This allows us to propose 
that Prp43p might play a role in activation of Brr2p and thus facilitates U2/1J6 
duplex unwinding, and spliceosome disassembly. Previously role of conformational 
switches between splicing reactions was proposed for DEAR-box proteins Prpl6p 
and Prp22p (Query and Konarska, 2005). It is conceivable that Prp43p plays a role of 
such a switch in the post-splicing complex, which initiates spliceosome disassembly. 
Therefore, the precise nature of RNA-RNA or RNA-proteins rearrangements 
performed by Prp43p during spliceosome disassembly remains to be identified. 
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Chapter 6 
Prp43p requires Spp382p for pre-rRNA processing. 
6.1 Introduction 
Prp43p and Spp382p are implicated in both splicing and pre-rRNA processing. In 
splicing Prp43p and Spp382 play a role is spliceosome disassembly (Martin et al., 
2003; this thesis), while the role of these proteins in pre-rRNA processing remains to 
be identified. In the splicing process multiple reports showed that Spp382p is a likely 
accessory factor for Prp43p. It was established that Spp382p is not only required for 
Prp43p association with the post-splicing complex (Tsai et al., 2005; Boon et al., 
2006; this thesis), but also stimulates ATPase activity of Prp43p in vitro (Tanaka et 
al., 2007). 
In this chapter I present evidence that Spp3 82p is required for the ATPase activity of 
Prp43p in pre-rRNA processing. I also show that the G-patch motif of Spp382p 
rescues a defect caused by Spp382p-depletion at 30T, but has a ts phenotype at 
37°C. Further investigation of the cause of the decreased viability at elevated 
temperature shows that a G-patch reconstituted strain has a defect in splicing, not 
pre-rRNA processing. Additionally, over-expression of Spp382p affects culture 
growth and causes delocalisation of Prp43p from nucleolus to nucleoplasm and 
cytoplasm. 
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6.2 Spp382p is an accessory factor for Prp43p in pre-rRNA processing. 
As it was established that Spp3 82p physically interacts with the intermediates of pre-
rRNA processing, and repeats the pattern of precipitation of Prp43p, it was suggested 
that Spp382p might act as an accessory factor for Prp43p in the pre-rRNA processing 
machinery as well as in splicing. 
In splicing, Spp382p is required for the stable association of Prp43p with the post-
splicing complex, and as Spp382p and Prp43p are likely to act together in pre-rRNA 
processing, it was investigated whether the depletion of Spp382p affects Prp43p 
association with the pre-rRNA particles. For the experiment strain BK4H (with 
SPP382 under control of PGALJ  promoter) and BMA38a (isogenic wild type) were 
used. 
BMA38a and BK4H strains were pre-grown in YPGR, aliquots of the culture were 
inoculated into pre-warmed fresh YPDA medium thus in 4 hours cell cultures will 
have 0D600 0.6-0.8. Extracts from 2 litres of cultures of BMA38a and BK4H were 
prepared and used for co-in -imunoprecipitation with anti-Prp43 antibodies. Results 












Figure 6.1. In the absence of Spp382p, Prp43p is stalled with pre-rRNA 
particles. Extracts were prepared from 21 of exponentially grown cultures of 
BMA38a and BK4H after transfer to YPDA for 4 hours for depletion of Spp382p. 
Extracts were mixed with Protein A Sepharose beads with bound anti-Prp43 
antibodies, and incubated for 1 hour at 4°C. After precipitation, beads were washed 
with lysis buffer and subjected to RNA extraction. For Total RNA samples RNA 
corresponding to 1% of the amount of the extract used for co-immunoprecipitation 
was extracted. RNA samples were separated on agarose and PAGE (6%) gels, 
blotted and probed for the presence of the various pre-rRNA species. 
Despite an obvious pre-rRNA processing defect in Spp382p-depleted extract, the 
increased precipitation of Prp43p with the pre-rRNA precursors cannot be explained 
solely by the increased abundance of the particular intermediate. Thus, depletion of 
Spp382p causes an accumulation of Prp43p with 35S, aberrant 23S, 20S, U3 
snoRNA (levels of precipitation of these species by mutant strain was on average 5 
times more than their level of precipitation in wild-type strain, and close to 1%). No 
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significant changes in precipitation of 27SB and 7S species were observed. Only a 
very small proportion of mature species was precipitated (less than 0.2%), which is 
likely to be insignificant. This result suggests that in the absence of Spp382p, Prp43p 
is stalled with pre-rRNA processing machinery, and this is especially pronounced for 
small subunitpathway. Interestingly, it was reported that ATPase deficient mutants of 
Prp43p accumulate with pre-rRNA processing particles (Lebaron et al., 2005), 
therefore increased association of Prp43p with pre-rRNA species in Spp3 82-depleted 
extract indicates that Spp382p might affect ATPase activity of Prp43p in pre-rRNA 
processing. This finding strongly suggests that Spp382p is an accessory factor for 
Prp43p in pre-rRNA processing as well as in splicing. 
U3 snoRNA is required for the cleavages at A0, A l and A2 sites and directly interacts 
with pre-rRNA. As Spp382-depletion primarily affects A0, A l and A2 cleavages, 
therefore accumulation of Prp43p with U3 snoRNA reflects accumulation of Prp43p 
with 90S particles. Interestingly, Prp43p also precipitates unspliced pre-U3 snoRNA 
from extract depleted of Spp382p supporting the idea that Prp43p is likely to have an 
earlier function in the spliceosome, and that progression of spliceosome assembly is 
impaired in Spp3 82-depleted extract. 
6.3 G-patch of Spp382p rescues growth defect caused by depletion of 
Spp382p. 
A recent report by Tanaka et al., showed that the G-patch of Spp382p alone was able 
to stimulate the ATPase activity of Prp43p in vitro on a level similar to that of the 
full-length protein (Tanaka et al., 2007). We therefore investigated whether G-patch 
alone would be enough to support viability of Spp3 82-depletion in vivo. 
In order to test this, the G-patch of Spp3 82 (an 1-120) was cloned under control of 
the SPP382 promoter in the .ThoI site of the pRS3 16 vector to produce pTAG- 1. 
Yeast strains BMA38a and BK4H were transformed with pTAG-1, and selected on 
Ura medium with a mixture of 2% raffinose and 2% sucrose as carbon source, as no 
transformants were obtained in galactose-containing medium for BK4H strain at 
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30°C. One possible explanation is that over-expression of SPP382 from PGALI and 
the 0-patch from the native promoter is toxic for the cells. Indeed, it was reported 
that over-expression of SPP382 causes decreased viability (Herrmann et al., 2007), 
and therefore control and G-patch reconstituted strains were grown in 0.5% Gal, 2% 
Raf and 2% Suc (GRS) in order to minimize the over-expression of SPP382. 
Viability of the strains was tested on UraGR medium. BMA3 8a, BK4H and G-patch 
reconstitution strains (BK4H+pTAG- 1) were pre-grown in GRS medium, spotted on 
OR agar and YPDA agar, and incubated at 30°C or 37°C for 3 days. As can be seen 
in figure 6.2, panel A, BK4H shows slight delay in growth in comparison with the 
wild type, while the G-patch reconstitution strain grows slower than the BK4H 
strain. This suggests that the Spp382p and G-patch dosage might have an effect on 
growth of yeast cells. Interestingly, the result presented in figure 6.2, panel B 
indicates that G-patch alone was enough to support viability of the BK4H strain at 
30°C in YPDA as 0-patch reconstituted strain grows in YPDA medium with a rate 
similar to the wild-type strain. In contrast, strain BK4H does not grow on YPDA 
medium, showing that depletion of Spp382p severely affects cell growth (several 
colonies were observed for BK4H strain after 7 days of incubation in YPDA, 
therefore the possibility of very slow growth cannot be excluded). As growing G-
patch reconstitution strain at 30°C in GR medium affected cell growth, all 
subsequent experiments with the G-patch reconstitution strain were performed using 
YPDA or Ura medium. In figure 6.2, panel C is shown that growth of the 0-patch 
reconstituted strain is affected by elevated temperature, therefore 0-patch 
reconstitution strain has a ts phenotype. 
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Figure 6.2. G-patch of Spp382p rescues growth the defect caused by depletion of 
Spp382p. Spot assay with wild-type strain with pRS3 16 and BK4H (SPP382 under 
PGAL/ promoter control) with pTAG-1 (containing G-patch of Spp382p expressed 
from native SPP382 promoter in pRS3 16 vector). Cultures were pre-grown in Ura 
medium. 0.3 0D600 of the each culture was spun, washed and resuspended in 50t1 of 
water. Serial 5x dilutions were set up, and spotted on the plates. Plates were 
incubated for 3 days at 30 or 37'C. 
As Spp382p participates in both splicing and pre-rRNA processing, the growth 
defect of G-patch reconstitution at 37°C might be determined by aberrant splicing or 
pre-rRNA processing, or both. To investigate the defect further, total RNA was 
extracted from the cultures of G-patch reconstitution strain and wild-type strain 
shifted to 37°C for 8 hours. No defect in growth-rate was observed at this time, 
however it was noticed that after the temperature shift most of the mutant cells 
increased in size with enlarged vacuoles, which might alter the optical density 
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readings. Splicing specific qPCR analysis of ASCJ transcripts revealed the presence 
of a mild splicing defect with the accumulation of the lariat species and pre-mRNA, 
which indicates a snRNP recycling defect in the G-patch reconstituted strain at 
elevated temperature (figure 6.3, Panel A). Spp382p is an accessory for Prp43p in 
spliceosome disassembly, therefore it is possible that in the G-patch reconstituted 
strain at 37°C the function of Prp43p is impaired. Association of snRNAs with Prp8p 
and Prp43p was investigated in extract prepared from G-patch reconstituted strain 
shifted to 37°C for 8 hours. For control sample, splicing extract was prepared from a 
culture of BMA38a strain treated in the same way. 100t1 of each extract were mixed 
with beads with pre-bound anti-Prp8 and anti-Prp43 antibodies. After 
immunoprecipitation retained RNA was extracted from the beads, resolved in a gel, 
blotted and hybridised with probes to snRNAs. The result is presented in figure 6.3, 
Panel B. 
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Figure 6.3. G-patch reconstitution strain shows a splicing defect at non-
permissive temperature. 
Panel A. ASCJ splicing was assayed by qPCR analysis. Relative abundance of RNA 
species in G-patch reconstituted strain is shown. 
Panel B. Co-precipitation of snRNAs with Prp8p and Prp43p from wild-type and G-
patch reconstituted extracts after 8 hours temperature shift. Splicing extracts (100[d) 
were mixed with an equal volume of 2XIPP buffer containing beads with pre-bound 
anti-Prp8 and anti-Prp43 antibodies. Samples were incubated for 1 hour at 4°C, RNA 
was extracted from the beads and resolved on the 6% PAGE gel, blotted and probed 
with specific snRNA probes. 
Strikingly, at least two times increase in amount of U6 snRNA associated with 
Prp43p in G-patch reconstituted extract was repeatedly observed, which suggests that 
snRNA dynamics in G-patch-reconstituted strain is impaired. Interestingly, increased 
precipitation of U6 was observed for C-terminus and ATPase deficient mutants of 
Prp43p (previous chapter), which suggests, that in the G-patch reconstituted strain 
the function of Prp43p in splicing is impaired. 
In order to investigate whether G-patch reconstitution causes a defect in pre-rRNA 
processing, total RNA extracted from the cultures incubated at 37°C was subjected to 
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northern blot analysis. As Spp382-depletion primarily affects the levels of 35S and 
20S pre-rRNAs, these species were investigated as a hallmark of the Spp382-
depletion defect in pre-rRNA processing. Total RNA samples (2mg each) were 
resolved on denaturing agarose gel, and probed for accumulation of 35S and 23S, 
and decrease of 20S. However no accumulation of pre-rRNA processing 
intermediates was observed in the reconstituted strain (figure. 6.4 A), suggesting that 
G-patch reconstitution rescues the growth defect caused by Spp3 82-depletion in pre-
rRNA processing. There is a possibility that lack of the accumulation of the pre-RNA 
precursors is due to the low expression of pre-rRNA. Therefore in order to fully 
eliminate the presence of the pre-rRNA processing defect, pulse chase analysis of 
rRNA processing was performed. 
For the pulse chase experiment both BMA3 8a (with pRS3 16 plasmid) and yTAG- 1 
strains were pre-grown at 30°C in -Ura, and then transferred to 37°C for 8 hours. 
Pulse (1 mm) was performed using 3 H-Uracil, then excess of non-labelled Uracil was 
added, and aliquots were taken at 0, 2.5, 5, 10 and 20 minutes. Total RNA was 
extracted, resolved on denaturing agarose gel and blotted. Membrane was dried and 
used for autoradiography. 
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Figure 6.4. G-patch reconstituted strain does not have a defect in pre-rRNA 
processing. 
A. Total RNA from wild-type and 0-patch reconstitution strains was extracted 
following 8 hours temperature shift, resolved on the gel, and blotted. 
Panel B. Pulse chase analysis of 0-patch reconstitution after 8 hour shift to 37°C. 
RNA was labelled with 3 H-uracil for I min and chased with an excess of cold uracil. 
Samples were collected at the indicated time-points, Total RNA was extracted and 
resolved on a 1.2% agarose gel, and then transferred to HybondN+ membrane. The 
membrane was subsequently subjected to autoradiography. 
As can be seen in figure 6.4 panel B, the 0-patch reconstitution strain shows the 
same kinetics of pre-rRNA processing as the wild-type strain, which indicates that 
there is no kinetic defect in pre-rRNA processing between 0-patch reconstituted 
strain and wild type after 8 hours of incubation at 37°C. These results indicate that 
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the growth defect of yTAG-1 strain at elevated temperature is caused by aberrant 
splicing, not aberrant pre-rRNA processing. 
6.4 Over-expression of Spp382p causes delocalisation of Prp43p. 
As previously stated, Prp43p and Spp382p are shared between the splicing and pre-
rRNA processing machineries. Pre-rRNA processing largely takes place in the 
nucleolus. Only late stages of 60S maturation occur in the nucleus, and late stages of 
40S maturation occur in the cytoplasm. Prp43p is predominantly nucleolar (Combs et 
al., 2006), consistent with its function in pre-rRNA processing, and it was also found 
to be associated with late 60S and 40S precursors, suggesting that there is a small 
sub-population of Prp43p, which is located in nucleoplasm and cytoplasm. 
Additionally, splicing takes place in the nucleoplasm, and this suggests that there is a 
nuclear sub-population of Prp43p involved in splicing. As Prp43p is connected to the 
complexes found in nucleolus, nucleoplasm and cytoplasm, it is likely that Prp43p 
shuttles between the two processes, however evidence of the shuttling was missing. 
Immuno-fluorescent staining was used to analyse localisation of Prp43p in BMA38a 
and in a strain over-expressing Spp382p. For this, BK4H and BMA38a strains were 
grown in YPGR, and used for immuno-fluorescent staining analysis. In wild-type 
cells Prp43p is localized to the nucleolus (as indicated in figure 6.5, Panel A) 
consistently with the previous report (Combs et al., 2006). Surprisingly, over-
expression of Spp382p causes delocalisation of Prp43p from the nucleolus to nucleus 
and cytoplasm (figure 6.5, Panel B), suggesting that Prp43p shuttles between cellular 
compartments and processes. It was observed that over-expression of the proteins 
might promote accumulation of the proteins in non-functional complexes, or 
aggregate formation. Therefore, it is not clear whether Prp43p forms aggregates with 
Spp382p, or it accumulates in aberrant high-molecular weight complex(es). 
Preliminary data (not shown) indicate that Prp43p is likely to be stalled in aberrant 
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Figure 6.5. Over-expression of Spp382p causes delocalisation of Prp43p. 
Immuno-fluorescent staining of a strain over-expressing SPP382 was performed. 
Affinity purified rabbit anti-Prp43p antibodies and mouse anti-Nopi antibodies were 
used for immunostaining in dilution 1:500. Secondary antibodies goat anti-mouse 
AlexaFluor 488 and goat anti-rabbit AlexaFluor594 were used for the visualisation 
of the proteins. 
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6.4 Discussion 
In this chapter I show a role of Spp382p as an accessory factor for Prp43p in pre-
rRNA processing. I demonstrate that in the absence of Spp382p, Prp43p accumulates 
with pre-rRNA processing particles. There are several plausible explanations for the 
this. First, lack of Spp382p might result in loss of Prp43p's ATP hydrolysis/helicase 
activity and therefore results in stable association of Prp43p with the RNPs. This is 
supported by the observation that ATPase deficient mutants of Prp43p are stalled in 
post-splicing complex and in pre-RNA processing particles (Martin et al., 2003, 
Lebaron et al., 2005). Another possibility is that the presence of Spp382p is required 
for the release of Prp43p from the RNPs after ATP hydrolysis. In this case Spp382p 
may provide a binding site for an unknown release factor for Prp43p, or Spp382p 
might play the role of the release factor itself. However, as Spp3 82p was already 
shown to stimulate helicase activity of Prp43p directly, it is more likely that Spp3 82p 
is required for the helicase activity of Prp43p in pre-rRNA processing than Spp382p 
plays two independent and different roles in regulation of the activity of Prp43p. 
Interestingly, Prp43p does not require Spp382p for association with the pre-rRNA 
particles, while in splicing it is required for the stable association of Prp43p with the 
post-splicing complex. This implies that Prp43p-Spp382p dimer might form a 
complex with dual properties and functions. 
In this chapter I also show that the 0-patch of Spp382p alone is able to reconstitute 
viability of otherwise lethal Spp3 82-depletion at 30°C. It is not entirely surprising as 
G-patch alone stimulates the helicase activity of Prp43p in vitro on a level similar to 
that of full-length Spp382p (Tanaka et al., 2007). Further investigation revealed that 
the 0-patch reconstitution strain has a mild ts phenotype with decreased growth at 
37°C. qPCR analysis of RNA extracted from the 0-patch reconstitution strain 
following a shift to 37°C for 8 hours shows accumulation of pre-mRNA and excised 
intron-lariat, suggesting a recycling defect. This result was confirmed by the report 
from Tanaka et al., that 0-patch alone cannot substitute for full-length Spp382p in 
vitro splicing reaction (Tanaka et al., 2007). Co-immunoprecipitation of Prp8p and 
Prp43p with snRNAs revealed an increased association of U6 snRNA with both 
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proteins, as in case with ATPase deficient and C-terminal mutants of Prp43p, 
suggesting that in the 0-patch reconstitution strain elevated temperature affects 
Prp43p function in spliceosomes. Surprisingly, the reconstitution strain does not 
show any defect in pre-rRNA processing at the time-point tested, which indicates 
that the ts phenotype of 0-patch reconstitution is due to the defect in splicing, not 
pre-rRNA processing. 
Delocalisation of Prp43p in the strain over-expressing Spp382p supports the idea that 
Prp43p shuttles between spliceosomal and pre-rRNA processing machineries. 
Despite it is not entirely clear whether Prp43p forms aggregates with Spp382p, or 
accumulates in large molecular complexes, I favour the latter hypothesis. Over-
expression of Spp382p affects cell viability (this thesis, Herrmann et al., 2007), 
suggesting that a dosage effect of Spp3 82p is important. It is possible that decreased 
cell viability is caused by partial displacement of Prp43p from its functional sites. 
Indeed, a mild defect in pre-rRNA processing was observed (data not shown) in the 
strain over-expressing SPP382, suggesting that 5pp382p titrates away or saturates 
binding sites of the components essential for pre-rRNA processing. As the biological 
significance of sharing components between two processing machineries is not 
known, the existence of the gene-dosage effect indirectly supports the idea of the role 
of Prp43p and Spp382p in a concerting mechanism. 
118 
Chapter 7 
7 Final discussion and future experiments 
7.1 The role of Prp43p in splicing 
DEAH-box helicase Prp43p is implicated in both splicing and pre-rRNA processing. 
ATPase mutants of Prp43p are stalled with the multiple pre-rRNA processing 
particles and post-splicing complex. Remarkably, C-terminus mutant of 
Prp43E716Ap affects splicing, but not pre-rRNA processing. Isolation of the mutant 
of Prp43p with predominant defect in splicing will allow identifying the target of the 
helicase activity of Prp43p in the post-splicing complex. As prp43 mutants affect 
snRNP dynamics, and cause accumulation of U2/1J6 duplexes, it is likely that the 
activity of Prp43p affects U2/U6 dissociation, however, cross-linking of the C-
terminus mutant of Prp43p to RNA is required to support this hypothesis. 
Additionally, as no post-splicing complex was isolated, using this mutant would 
allow investigation of the protein content of the post-splicing complex. 
DEIH helicase Brr2p was suggested to unwind U2/1J6 duplex in post-splicing 
complex, and as prp43 mutants cause an accumulation of aberrant RNP complexes, it 
suggests that Prp43p might govern Brr2p activity. Brr2p is a only ATPase of the 
post-splicing complex, and U21U6 unwinding is believed to be strictly ATP-
dependent, suggesting that Brr2p unwinds U2/U6 in post-splicing complex. Other 
factors implicated in regulating Brr2p activity in spliceo some disassembly are 
Snul 14p and Prp8p. So far no direct interaction of Prp43p with Brr2p, Prp8p or 
Snul 14p has been reported, and it remains to be determined how the Prp43p 
influences Brr2p activity. For better understanding of the regulation events, it is 
important to investigate interactions between these proteins. 
It is shown that decreasing the ATPase activity of Prp43p suppresses the prp38-1 
mutant. The prp38-1 mutant causes retention of U4 in Complex B probably by 
affecting Brr2p activity. As the level of the suppression is inversely proportional to 
the level of residual ATPase activity of Prp43p, it indicates that perhaps decreasing 
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Prp43p activity gives more time for the remodelling step involving Prp38p and Brr2p 
to occur, suggesting that Prp43p is involved in modulation of Brr2p activity in 
spliceosome assembly as well as disassembly. 
7.2 The role of Prp43 in pre-rRNA processing 
Prp43p was co-isolated with multiple pre-rRNA processing particles, however, the 
role of Prp43p in pre-rRNA processing is not clear, which opens a broad range for 
future research. Several potential co-factors of Prp43p in pre-rRNA processing have 
been identified (Lebaron et al., 2005); they are Spp382p, Gnolp and Pfalp. 
Significantly, they all have a G-patch motif - a putative RNA binding domain, 
however, the biological role of this is not known. However it was proposed that G-
patch motif plays an important function in regulation of activity of DEAH-box 
proteins (Silverman et al., 2004). Intriguingly, Spp382p, Gnolp and Pfalp have 
different localization sites in the cell. Thus, Gnolp is nucleolar, Spp382p is nuclear 
and Pfalp is nuclear and cytoplasmic (Herrmann et al., 2007; Huh et al., 2003), 
which allows hypothesize that activity of Prp43p can be regulated in site-specific 
way by these proteins. Additionally, these co-factors might bind same region of 
Prp43p. At the same time, only sites of interaction of Prp43p with Sp382 were 
mapped (Tanaka et al., 2007), and nothingis known about whether the binding sites 
of Pfalp and Gnolp overlap with binding site of Spp382p. Therefore mapping 
binding sites of Pfalp and Gnolp with Prp43p might be important to establish how 
the activation of Prp43p occurs. 
ATPase deficient mutants of Prp43p are stalled with multiple pre-rRNA precursors, 
which implies that the ATPase activity of Prp43 is required for several stages of pre-
rRNA processing (Lebaron et al., 2005). As DExD/H box proteins might function as 
fidelity factors, the possibility that Prp43p is a fidelity factor in pre-rRNA processing 
should be investigated. Identification of potential targets of Prp43p and investigation 
of effects of ATPase deficient yet viable mutants of Prp43p on pre-rRNA processing 
might provide a way to uncover role of Prp43p as a fidelity factor. 
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7.3 Crosstalk 
Several factors were identified as shared subunits between pre-rRNA processing and 
spliceosomes. Those include 5pp382p, Prp43p, Snul3p and potentially Pfalp. The 
significance of this is not known. While sharing of Snul3p can be explained by 
likely common evolutionary origin between RNAs it interacts with (Watkins et al., 
2000), nothing can be stated about Prp43p and Spp382p as their targets have not 
been identified yet. However, it is likely that Prp43p and Spp382p form a complex, 
and putative shared protein Pfalp might be a part of this complex based on reported 
interactions. Thus Pfalp co-purifies with Prp43p (Lebaron et al., 2005), and genetic 
interaction between Spp382 and Pfal was reported (Pandit et al., 2006). The 
interaction between Spp382p and Pfalp is based on a gene-dosage effect as over-
expression of Pfalp antagonizes the suppression of the prp38-1 mutation by spp382 
mutants (Pandit et al., 2006). This suggests that these proteins might compete for the 
same binding partners, or have overlapping binding sites within Prp43p. Despite 
genetic interaction of Pfalp with spliceosomal components was reported, it is not 
known whether Pfalp participates in splicing, and therefore it would be interesting to 
determine this for the further understanding of subunits sharing. 
Normally Prp43p is localised to the nucleolus (Combs et al., 2006). Over-expression 
of Spp382p causes delocalisation of Prp43p from the nucleolus to the nucleus and 
the cytoplasm, which suggests that Prp43p is shuttling between RNA processing 
machineries. It is not clear whether Prp43p is accumulated with Spp382 in a non-
functional dimer or Spp382p saturates binding sites for co-factors of Prp43p causing 
formation of aberrant high molecular weight complexes. These possibilities can be 
easily distinguished by gradient centrifugation analysis of the strain over-producing 
Spp382p. 
It is established that Prp43p accumulates with the catalytic spliceosomes assembled 
on aberrant substrates (these thesis, Pandit et al., 2006). Therefore if Prp43p shuttles 
between processing machineries a defect in splicing might cause depletion of Prp43p 
from pre-rRNA processing machinery and vice versa. For pre-rRNA processing, U3 
snoRNA and many ribosomal protein pre-mRNAs are required to be spliced. 
121 
However, U3 snoRNA has a long half-life and mRNAs encoding ribosomal proteins 
are resistant to splicing defects (Pleiss et al., 2007). This suggests that it is very 
unlikely that defective splicing will have an immediate effect on pre-rRNA 
processing. Hypothetically, pre-rRNA processing is dependent on correct splicing 
and might require a way to identify that splicing is taking place. In this case sharing 
subunits between machineries might provide a way of concerting ribosomal 
biogenesis, and additionally it might provide a quick way of slowing down pre-RNA 
processing machinery before depletion of U3 and r-proteins occurs. Interestingly, 
Prp43p is also found to be associated with the Poll and Poll! subunits (Lebaron et al., 
2005), however a role for Prp43p in transcription has not been identified. Association 
of Prp43p with multiple RNA processing machineries suggests the hypothesis that its 
potential role is as a universal chaperon, connecting transcription, splicing and pre-
rRNA processing in ribosomal biogenesis. 
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The Ntrl and Ntr2 proteins of Sacclw.romyces cerevisiae have been reported to interact with proteins involved in 
pre-mRNA splicing, but their roles in the splicing process are unknown. We show here that they associate with a 
postsplicing complex containing the excised intron and the spliceosomal U2, US, and U6 snRNAs, supporting a link 
with a late stage in the pre-mRNA splicing process. Extract from cells that had been metabolically depleted of Ntrl 
has low splicing activity and accumulates the excised intron. Also, the level of U4/U6 di-snRNP is increased but 
those of the free US and U6 snRNPs are decreased in Ntrl-depleted extract, and increased levels of U2 and 
decreased levels of U4 are found associated with the US snRNP protein Prp& These results suggest a requirement 
for Ntrl for turnover of the excised intron complex and recycling of snRNPs. Ntrl interacts directly or indirectly 
with the intron release factor Prp43 and is required for its association with the excised intron. We propose that Ntrl 
promotes release of excised introns from splicing complexes by acting as a spliceosome receptor or RNA-targeting 
factor for Prp43, possibly assisted by the Ntr2 protein. 
The excision of introns from precursor mRNAs (pre-mRNAs) 
occurs by two consecutive transesterification reactions in the 
spliceosome, a large and highly dynamic ribonucleoprotein 
complex (9). These chemical reactions are likely catalyzed by 
small nuclear RNAs (snRNAs) that exist within small nuclear 
nbonucleoprotein particles (snRNPs), but non-snRNP pro-
teins also play essential roles such as conferring specificity, 
checking the fidelity of the process, and regulating conforma-
tional rearrangements in the spliceosome (8, 34, 42). Five 
snRNPs, called Ui, U2, U4, U5, and U6, assemble on the 
substrate pre-mRNA to form the spliceosome. First, the Ui 
snRNP binds at the 5' splice site, followed by the U2 snRNP at 
the branch point, and then the U4, U5, and U6 snRNPs, in the 
form of a U4/U6.U5 tri-snRNP, join the assembling complex. 
Activation of the assembled spliceosome requires dynamic re-
modeling of an intricate network of RNA-RNA and RNA-
protein interactions within the spliceosome such that the Ui 
and U4 snRNPs are released. Concomitantly, the Prp19-asso-
ciated complex of proteins (nineteen complex or NTC) (27, 28, 
35, 36) associates with the spliceosome, remodeling the U5 
snRNP (24, 25) and stabilizing interactions of the U5 and U6 
snRNAs with the pre-mRNA (10, 11) prior to the first catalytic 
step of splicing. 
Upon completion of the splicing reaction, the spliced exon 
RNA (mRNA) is released and the postsplicing ribonucleopro-
tein complex dissociates in an active process that involves two 
members of the ATP-dependent DExH box RNA helicase 
family, Prp22 and Prp43 (3, 26,32). Prp22 is needed for release 
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of the spliced exons (32, 43), while Prp43 is required for dis-
assembly of the spliceosome and release of the excised intron 
in its branched, lariat form (26). The U4 snRNP reassociates 
with the U6 snRNP (31, 41) to form the U4/U6 di-snRNP that 
will then join the US snRNP to form the U411J6.U5 tri-snRNP 
once more. 
Although many protein components of the splicing machinery 
have been identified through their physical or genetic interactions 
with known splicing factors, the functions of a large number of 
these remain to be determined. For example, the name SPP382 
(S. Pandit and B. C. Rymond, unpublished results; http:lldb 
.yeastgenome.orglcgi-bin/locus.pl?locus=spp382) was given to 
Sacchammyces cereviriae open reading frame YLR424W to indi-
cate its ability to suppress the pp38-I mutation that causes a 
defect in spliceosome maturation (45); however, the function of 
the Spp382 protein is unknown. Spp382 has been reported to 
associate directly or indirectly with many protein components of 
the splicing machinery, including Prp43 and components of the 
US snRNP (1, 7, 13, 16), and recently the name Ntrl (nineteen 
complex related) was proposed because of its interaction with the 
NTC (38). In addition, Spp382/Ntrl interacts with YkrO22c/Ntr2 
(16, 17, 38,39). 
We demonstrate here that Ntrl and Ntr2 are spliceosome 
associated and coprecipitate mainly excised intron from an in 
vitro splicing reaction mixture. Under nonsplicing conditions, 
Ntrl and Ntr2 coprecipitate the U2, US, and U6 snRNAs. 
Northern and microarray analyses show increased levels of 
pre-mRNAs in cells depleted of Ntrl, and in vitro, Ntri-de-
pleted extract has low splicing activity and accumulates excised 
intron in a postsplicing complex that includes Prp8 and Cefi. 
Glycerol gradient analysis of Ntri-depleted extract suggests a 
defect in recycling snRNPs, and the US snRNP protein Prp8 is 
shown by immunoprecipitation to be associated with eightfold 
more U2 snRNA and with U6 snRNA that is not complexed 
with U4 snRNA, supporting its accumulation in the U2/U5/U6 
postsplicing complex. The intron release factor Prp43 cofrac-
tionates with Ntrl and Ntr2, and in the absence of Ntri, Prp43 
6016 
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TABLE 1. Plasmids and yeast strains used in this study 
Plasmid or strain Purpose or genotype Source or] 
Plasmids 
pFA6a-kanMX6-PGALI -3HA PCR template for KanMx6-P0i-3HA insertion 23 
pBS1479 PCR template for TAP tag with TRP1 marker 30 
pBSI539 PCR template for TAP tag with URA3 marker 30 
pETI6-PRP43TI23A pET16b-based plasmid for production of Prp43T123A protein in E. co/i 26 
pGEX4T-2-424 pOEX4T-2-based plasmid for production of Ntrl protein in E. co/i This v 
Strains 
BMA38a MATa his3ta200 /eu2-3,112 ura34 irpiM ade2-1 can 1-100 5 
RO8T PRP8-TAP-TRPI, otherwise same as BMA38a 7 
KL4T NTR1-TAP-TRPI, otherwise same as BMA38a This v 
KL2T NTR2-TAP-URA3, otherwise same as BMA38a This v 
KL4G KanMX6-P GAL1 -3HA-NTR1, otherwise same as BMA38a This v 
KL4G2T KanMX6-P L ,-3HA-NTR1 NTR2-TAP-URA3, otherwise same as BMA38a This v 
is unable to associate with spliceosomes to release the excised 
intron. These results complement and extend the recently re-
ported results of Tsai et al. (38), demonstrating that Ntrl and 
Ntr2 function in the Prp43-mediated release of the excised 
intron. We propose that Ntrl acts as a spliceosome receptor or 
RNA-targeting factor to promote interaction of Prp43 with the 
excised intron, possibly assisted by the Ntr2 protein. 
MATERIALS AND ME1HODS 
Yeast strains and plasmids. The S. cerevisiac strains and plasmids used in this 
work are described in Table 1, and the oligonucleotides used are described in 
Table 2. For metabolic depletion of Ntrl, cultures of KL4G or KL4G2T were 
grown in YPGR (1% yeast extract, 2% Bacto Peptone, 2% galactose, 2% rat- 
finose) medium to an optical density at 600 nm (OD) of 0.5. spi 
washed with YPD (1% yeast extract, 2% Bacto Peptone. 2% gluco 
down, resuspended in the original culture volume of YPD. and grown f 
as indicated (with addition of fresh YPD to keep the cells in log phas 
transformation was performed as described previously (14). Strain 
KL4T. KL4G, and K1_4G2T were generated from BMA38a (1) by one-s 
transformation by using pl&smid DNAs as templates (Table 1). 
Splicing extract preparation and in vitro splicing analysis. Prepa 
whole-cell yeast extracts was performed as described previously (40), 
splicing reaction mixtures were prepared as described previously (22). 
p283, which contains part of the yeast ACT! gene, was transcribed in 
Ti RNA polymerase and [ct- 3 P]ATP to produce a uniformly labelec 
substrate (29). 
Glycerol gradient analysis. For glycerol gradient analysis (essential 
scribed in reference 4), 80 liJ  of splicing extract (without added AT] 
TABLE 2. Deoxyoligonucleotides used in this study 




















Oligonucleotides for PCR amplification of NTRJ from genomic 
DNA (BMA38a) and cloning into pGEX4T-2 via Sal! and 
Noll restriction sites 
F-YLR424W-aa2................................................................................................................... AAAAG TCOACCGAGGATFCGGACTCCAAC 
R-YLR424W-aa709 .............................................................................................................. AAAAGCGGCCGCACFAGAGGTCAAGOGCC 
Oligonucleotides used for C-terminal NTRI TAP tagging 
F-YLR424W-TAP ................................................................................................................. TCCAGTGGGACc2TVrAAGCCAATITA1TTA 
CCCTTGACCrCTCCATGOAAAAGAGAAG 
R-YLR424W-TAP ................................................................................................................ ATATATAAATCGTGCCFATCrCACCTUIIEI 
GTACTTT'CTATACGACTCACTATAGGG 
Oligonucleotides for N-terminal N7RI P 411 promoter and 
triple HA tagging 
Fl -YLR424W........................................................................................................................CAACCGAGAGAGGTCGAAGAACTTAAGCC 
GTACGCCAAAACGAATI'CGAOCFCGTrL 
R2-YLR424W .......................................................................................................................1TTGAAAAAGAAU 1IETJATCTGTGTTGGA 
GAATCCTCCATGCACTGAGCAGCGTAATI 
B) 
ZO-, Unt,o,jnd 	 tP 
A) 
25% input 	tP 
- 
- 
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mRNA) was diluted to 200 jiJ with 120 p.l of GG buffer (20mM HEPES [pH 7.01. 
100 mM KCI. 0.2 mM EDTA) and layered onto an I 1-ml 10 to 30% glycerol 
gradient containing GG buffer. After centrifugation at 37.000 rpm for 17 h in an 
SW40 Ti rotor (Beckman) at 4°C, 400-pi fractions were collected and stored 
at - ACC. Alternate fractions were analyzed by Western or Northern blotting. 
Immunoprecipisation. Immunoprecipi tat ions were performed as described 
previously (37). with IPPI50 buffer (6 mM HEPES [pH 7.91. 150 mM NaCI, 5 
ntM MgCl2. 0.1% [voL'voll Nonidet P40) and with immunoglobulin 0 (IgO) 
agarose (Sigma)-, antihemagglutinin (anti-HA) agarose (mouse anti-HA [F-7] 
Santa Cruz Biotechnology), anti-His agarose (rabbit anti-His [H-IS]; Santa Cruz 
Biotechnology)-, or protein A-Sepharose-bound antibodies, i.e., anti-PipS rabbit 
polyclonal antibodies (raised against a peptide corresponding to amino acids 2 to 
34 of Prp8; this lab), anti-HA antibodies (Santa Cruz Biotechnology), affinity-
purified anti-Prp43 antibodies raised against a peptide corresponding to amino 
acids 714 to 727 or obtained as a gift from Y. Henry (20). For immunoprecipi-
tation of spliceosomes, splicing reaction mixtures (10 pA for splicing activity or 50 
At for immunoprecipitation) were incubated at 23°C for 25 min and the reaction 
products were fractionated on a 7% (wt/vol) polyacrylamide-8 M urea gel and 
visualized by aucoradiography of the dried gel. For immunoprecipitation of 
snRNPs (tee Fig. 1A and 3C). splicing extracts were used but without addition of 
ATP or pre-mRNA. 
Western blotting, Proteins were resolved in Novex NuPAGE 4 to 12% bis-Tris 
gels (Invitrogen), electroblotteel to a polyvinylidene dilluoride membrane 
(Hyhond-P; Amersham Bioscience), probed with primary antibodies, and de-
tected with horseradish peroxidase-conjugated goat anti-rabbit antibodies and 
ECL reagents (Amersham Bioscience). 
Northern analysis of RNAS. RNAs were deproteinized by sodium dodecyl 
sulfate-proteina.se K treatment, followed by phenol-chloroform-isoamyl alcohol 
extraction and fractionated in a 6% (wt/sol) polyacrylamide-8 M urea gel. The 
sn(o)RNAS were detected by Northern analysis with end-labeled deoxyoligo-
nucleotides complementary to UI. U2, U4, US, and U6 or U3 , (Table 2). The 
amounts of radioactivity in RNA bands were quantified with a Storm 860 
Phosphorimager and ImageQuant software (Molecular Dynamics). The 
amounts in precipitates were normalized against the input amounts. 
RESULTS 
Ntrl and Ntr2 proteins associate with a postsplicing intron-
containing complex. To investigate whether the Ntrl or Ntr2 
protein associates with spliceosomal snRNPs. we tested the 
ability of C-terminally tandem affinity procedure (TAP)-tagged 
Ntrl (Ntrl-TAP) or Ntr2 (Ntr2.TAP) protein to coprecipitate 
the Ui, U2, U4. U5. or U6 snRNA. As shown in Fig. IA, both 
Ntr2-TAP and Ntrl-TAP, when immunoprecipitated in the 
presence of 150 mM salt, coprecipitated the U2, U5 (Land S), 
and U6 snRNAs but no Ui or U4 snRNA above the back- 
ground (compare lanes 5 and 6 with lane 4). This indicates that 
each of these proteins associates with a significant amount of 
the U2. U5, and U6 snRNPs (approximately 200/c of the U2 
and U5 snRNPs were precipitated; note that U6 snRNP is 
normally present in excess over the other spliceosomal 
snRNPs). To determine directly whether the NO or Ntr2 
protein interacts with spliceosomes, the association of the 
TAP-tagged proteins with ACT! substrate RNA or the inter-
mediates or products of its splicing in vitro was tested by 
immunoprecipitation. As previously reported (37), the US 
snRNP protein Prp8 coprecipitated unspliced RNA, as well as 
intermediates and products of the splicing reaction (Fig. lB. 
lane 7). In contrast, Ntrl-TAP and Ntr2-TAP coprecipitated 
the excised intron preferentially over the other RNA species 
(Fig. lB, lanes 8 and 9). The U2, US, and U6 snRNPs have 
been found in a postspliceosome complex that contains the 
excised intron, following release of the spliced exons in a HeLa 
cell splicing reaction mixture (19). Thus, the association of the 
Ntrl and Ntr2 proteins with U2, US, and U6 snRNPs and with 
excised intron RNA most likely indicates their association with 
FIG. 1. Ntrl and Ntr2 associate with snRNPs and excised intron 
RNA. (A) Coprecipitation of snRNAs with Ntt -1 and Ntr2. Splicing 
extracts (50 pA) with nontagged proteins (BMA38a; lane 4). Ntr2-TAP 
(KL2T; lane 5), or NIrI -TAP (KL4T; lane 6) were mixed with an equal 
volume of precipitation buffer containing IgG-agarose beads and in-
cubated at 4°C for 2 h. The beads were washed in buffer containing 150 
mM NaCI and deproteinized, and the RNAs were precipitated, frac-
tionated in an 8% polyacrylamide-8 M urea gel, blotted, and probed 
for UI, U2, U4, U5, and Ub snRNAs. Total RNA extracted from 12.5 
pA of each extract is shown in lanes I to 3. (B) coprecipitatton of 
splicing complexes by Nirl and Ntr2. Splicing extracts derived from 
cultures with nontagged proteins (BMA38a; lanes I and 6). Prp8-TAP 
(RGST; lanes 2 and 7), Ntr I-TAP (KL4T: lanes 3 and 8). Ntr2-TAP 
(KL2T; lanes 4 and 9), and Ntr2-TAP with HA-Ntrl depleted 
(KL4G2T cells grown in glucose for 10 h; lanes 5 and 10) were incu-
bated under splicing conditions in vitro (60-(Ll total volume) with 
32P-labeled ACT! RNA as the substrate. The reactions were stopped 
after 25 mm. and 10-ILA volumes were removed as splicing controls (not 
shown). The remaining 50-pi volumes were mixed with lgG-agarose 
beads and incubated at 4°C for 2 h. Beads were washed in buffer 
containing IPPI50 and deproteinized, and the RNAs were precipi-
tated. The unbound samples were also deprotemnized. and 20% ali-
quots were analyzed (lanes 1 to 5) alongside the precipitates (lanes 6 
to 10) by fractionation in a 7% polyacrylamide-8 M urea gel and 
autoradiography. The various RNA species are indicated diagrammat-
ically to the right of panel B. with rectangles representing exons, a thin 
line representing the intron, and a lariat loop representing the 
branched form of the intron following the first catalytic step of splicing. 
I P. immunoprecipitation. 
a postsplicing intron-containing complex and suggests either 
that they may be absent at earlier stages of the splicing process 
or that the TAP tag was masked within earlier spliceosome 
complexes. 
Depletion of Ntrl. The NTRI gene is essential for cell via- 
bility. Therefore, to investigate the requirement for Ntrl pro-
tein for splicing, yeast strain KL4G, in which chromosomal 
NTRI is transcribed under the control of the glucose-repress-
ible QALl  promoter, was grown in galactose medium and then 
shifted to glucose medium. As a control, a second culture was 
treated identically but was transferred back to galactose me-
dium. Approximately 2 h after the metabolic shift, the growth 
of the culture slowed considerably and then the cells continued 
to grow slowly (approximately 4-h doubling time; data not 
shown). Northern analysis of extracted RNA showed a barely 
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FIG. 2. Effects of NtrI depletion on splicing in vitro. (A) Northern 
analysis of 113 snoRNA. BMA38 (lanes I to 5) or KL4G 
(P(;41 1'3HANTRI; lanes 6 to 10) cells were grown in YPGR (galac-
tose medium) to an OD,-,,, of 0.5 and then transferred to YPD (glucose 
medium: repressing conditions). RNA was extracted after 0, 2, 4, 6, or 
10 h following the shift, subjected to denaturing polyaciylamide gel 
electrophoresis. blotted, and probed for U3A snoRNA. (B and C) 
KL4G cells were grown in YPOR to an OD 1 of 0.5 and then trans-
ferred to YPD and grown for 10 h before harvesting to produce a 
splicing extract. A nondepleted control culture of KL4G was produced 
by similar treatment but with a return to YPGR instead of YPD. 
(B) Western blot assay showing the relative amounts of HA-tagged 
NtrI in KL4G cells at 0 h (lane I) and at 10 h (lane 2) after the shift 
to YPD. NopI was probed as a loading control. (C) In vitro splicing 
assays with extracts derived from Ntrl-depleted (lanes 4 to 6) and 
nondepleted (lanes I to 3) cells. Aliquots (5 iJ) were withdrawn and 
halted after incubation for 0, 10, and 25 min at 23'C. The RNAs were 
analyzed by fractionation in a 7% polyacrylamide-8 M urea gel and 
autoradiography. Splicing reaction mixtures with Ntrl -depleted (lanes 
9 and II) and nondepleted (lanes 7. 8. and 10) extracts were incubated 
with preimmune (P1) serum (lane 7), anti-PrpS antibodies (lane 8 and 
9), or anti-efl antibodies (lanes 10 and II). and precipitated RNAs 
were extracted and analyzed as described above. The various RNA 
species are indicated diagrammatically on the right as described in the 
legend to Fig. I. IP. immunoprecipitation. 
detectable amount of unspliced pre-U3 RNA 2 h after the 
shift, with the amount increasing for 6 to 10 h po.stshift (Fig. 
2A, lanes 6 to 10). Microarray analysis showed a mild splicing 
defect for some transcripts of intron-containing genes 2 h after 
the shift and a substantial genomewide accumulation of un-
spliced pre-mRNAs by 10 h postshift (data not shown). Extract 
from KL4G cells grown for 10 h in glucose contained a barely 
detectable amount of Ntrl (Fig. 2B, lane 2) and, when incu-
bated under in vitro splicing conditions with an ACT! substrate 
RNA. produced only a small amount of spliced e 
accumulated a substantial amount of excised intron 
lane 6) compared to nondepleted extract (Fig. 2C, 
Incubation of the reaction mixtures with anti-Prp8 (Ian 
9) or anti-Cefi (lanes 10 and 11) antibodies showed 
Ntrl -depleted extract the excised intron is associated v 
Prp8 and Cefi, supporting its accumulation in a pos 
complex. When KL4G2T (same as KL4G but with TA! 
Ntr2) cells were treated similarly by growth in glucose 
to deplete Ntrl, TAP-Ntr2 coprecipitated a substantial 
of excised intron from a splicing reaction mixture (Fig. 
10). Therefore, Ntr2 is able to associate with the excise 
complex despite the substantial depletion of Ntrl. Th 
ence in the amounts of the spliced exon and excises 
species in the Ntrl -depleted reaction mixture is most lii 
to inhibition of splicing as a consequence of the retei 
essential splicing factors within a postsplicing comple, 
dition to which the excised intron RNA in the con 
protected against degradation (26). This indicates that 
required for efficient pre-mRNA splicing and for met 
of excised intron and suggests that Ntrl might play a 
recycling the postspliceosome components for new to 
splicing. 
The distribution of snRNPs in extracts from Ntrl-d 
and nondepleted cells was analyzed by fractionation in 
gradients, followed by Northern blotting. The densest ft 
contained U41U6.U5 tri-snRNPs and possibly some 
nous spliceosomes and/or postsplicing complexes (Fig. 
B, fractions I to 7) and then free US snRNPs (fractions 
U4/U6 di-snRNPs (fractions 9 to 13), and free U6 
(fractions 15 to 19). Quantification of these results 
that, compared with nondepleted extract, in Ntrl-deph 
tract there was a 50% reduction in the amount of U4: 
in the high-density fractions (fractions 1 to 3) and a 
sponding increase in the amount of U4 snRNA presen 
form of U4/U6 di-snRNP (Fig. 313, fractions 9 to 13), v 
the free U5 snRNP (fractions 5 to 9) was essentially at 
Ntrl-depleted extract. There was also a small but repro 
decrease in the level of free U6 snRNP (fractions 15 
although this is less obvious, as free U6 snRNP is usi 
excess. The dramatic shift of U4 snRNA from high-
fractions to the U4/U6 di-snRNP region of the gradien 
bined with the reduction of free U5 and U6 snRN} 
presumably of free U2 snRNP, although this cannot 
sessed with these gradients), suggests a detect in recyc 
snRNPs as a consequence of the defective disassembly 
postsplicing U21U5/U6 snRNP complex. Thus, free US 
became the limiting factor for the conversion of U4i 
snRNP to U4/U6.U5 tn-snRNP (since U6 snRNP is in 
and presumably tri-snRNP and/or free U2 snRNP 
limiting for spliceosome assembly. 
Next, the association of snRNAs with Prp8 in Ntr1-d 
and nondepleted extracts was examined by immunoprc 
tion. As expected, anti-Prp8 antibodies efficiently pullet 
U5, U4, and U6 snRNAs from nondepleted extract (F 
lane 3) because of its presence in US snRNP and U41 
tri-snRNP (15). With Ntrl-depleted extract, immunoprc 
tion of Prp8 pulled down an eightfold increased amouni 
(compared to nondepleted extract and normalized agai 
total amounts in each extract) but only half the amount 
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FIG. S. Depletion of Ntrl leads to a redistribution of snRNP com-
plexes. To examine the profile of snRNP distribution. non-Ntrl-de-
pleted (A) and Ntrl-depleted (B) cell extracts (no added ATP or 
pre-mRNA) were centrifuged through 10 to 30% glycerol gradients 
and RNAs were extracted from alternate fractions and analyzed by 
Northern blotting with hybridization with probes for U!. U2, U4, U5, 
and U6 snRNAs. The sedimentation of snRN P complexes is indicated. 
In addition to U4/U6.U5 tri-snRNPs and US snRNPs, fractions I to 7 
may contain some endogenous spliceosome and postsplicing com-
plexes. (C) Coprecipitation of snRNAs by anti-PrpS antibodies in 
extracts from Ntr I-depleted (lanes 4 to 6) or nondepleted (lanes Ito 
3) cells. RNAS were analyzed by fractionation in a 6% polyaciyl-
amide-8 M urea gel and Northern blotting. Preimmune (Pt) serum was 
used as a background control. (D) Same as panel C, but the precipi-
tated snRNAs were analyzed by nondenaturing gel electrophoresis as 
described previously (41). IP. imniunoprecipi tat ion. 
(Fig. 3C. lane 6) and an equivalent amount of U6. The in-
creased association of Prp8 with a U2 snRNA-containing com-
plex and decreased association with U4 snRNP in Ntrl-de-
pleted extract supports the accumulation of PrpS in the U2/ 
U5/U6 excised intron-containing complex. These precipitates 
were also analyzed by nondenaturing gel electrophoresis to 
distinguish free U6 snRNA from a U4/U6 heterodimer that is 
derived from U4/U6.U5 tri-snRNPs following phenol extrac-
tion (nota bene, Prp8 is not a component of U4/U6 di-snRNPs 
or free U6 snRNPs). As shown in Fig. 31), the Prp8 precipitate 
from Ntrl-depleted extract contained less U4/U6 heterodimer 
and more free U6 snRNA (presumably derived from the U2/ 
U571J6 complex) than the Prp8 precipitate from nondepleted 
extract. This supports the conclusion from the glycerol gradi-
ents that Ntrl depletion results in a defect in recycling of 
snRNPs and indicates that Prp8 accumulates in a U2/U5/U6 
snRNP complex. 
Ntrl, Ntr2, and Prp43 cofractionate in at least two distinct 
complexes. Ntr2, Prp8. and the excised iritron release factor 
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FIG. 4. Associations among Ntrl. Ntr2. l'rp43, and Prp8. (A and B) 
Glycerol gradient fractionation (without added ATP or pre-mRNA). 
(A) Extract from galactose-grown KL4G2T cells containing HA-NtrI 
and Ntr2-TAP was fractionated in a 10 to 30% glycerol gradient. 
Alternate gradient fractions were immunoprecipitated with lgG-aga-
rose, and the precipitated proteins were analyzed by Western blotting 
with anti-HA and anti-Prp8 (8.6) antibodies. (B) KL4G cell extract 
containing HA-NtrI was fractionated in a 10 to 30% glycerol gradient. 
Alternate gradient fractions were imniunoprecipitated with anti-HA 
agarose, and the precipitated proteins were analyzed by Western blot-
ting with affinity-purified anti-Prp43 antibodies and with anti-Prp8 
antibodies. (C) Extracts (without added ATP or pre-mRNA) from 
galactose-grown (lanes 2 and 5) or glucose-grown (lanes 3 and 6) 
KL4G2T cells or from BMA-18a (untagged control) cells (lanes I and 
4) were incubated with lgG-agarose to precipitate Ntr2-TAP, and the 
precipitated proteins were analyzed by Western blotting with anti-HA 
and anti-Prp8 antibodies. Note that the Ntr2-TAP protein in whole 
extract is very poorly recognized by lgG on the blot. IP. immunopre-
cipitation. 
Prp43 are among many proteins that have been found in 
affinity-selected complexes along with Ntrl (13, 16). To inves-
tigate this further, extract from KL4G2T cells containing HA-
Ntrl and Ntr2-TAP was fractionated in a glycerol gradient and 
alternate fractions were analyzed by precipitation of Ntr2-TAP 
with IgG-agarose and detection of precipitated proteins by 
Western blotting. Interestingly. HA-Ntrl was associated with 
Ntr2-TAP in most of the gradient fractions (Fig. 4A, fractions 
1 to 23), whereas Prp8 was associated with Ntr2-TAP only in 
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FIG. 5. Immunoprecipitarion (IF) of splicing reaction mixtures 
shows that Ntrl is required for association of Prp43 with the excised 
intron. Ntrl -depleted (lanes 2, 3, 5, and 6) and nondepleted (lanes I 
and 4) extracts were prepared from KL4G cells grown as described in 
the legend to Fig. 2. Splicing reaction mixtures (50 d) were assembled 
with - P-labeled ACT! substrate RNA and 0.9 p.g of purified recom-
binant Prp43 T1 . A . For reconstitution of the NtrI-depieied extract 
(lanes 3 and 6), the splicing reaction mixture was mixed with 31-IA-NiH 
affinity selected from galactose-grown KL4G cell extract (overproduc-
ing 3HA-Ntrt). Following incubation for 25 min at room temperature. 
90% of each splicing reaction mixture was mixed with 20 p.1 of affinity-
purified anti-Prp43 antibodies immobilized on Sepharose CL45 beads 
in IPPI50. After mixing at 4C for I h, the beads were washed and the 
RNA was extracted. Precipitated RNA (lanes 4 to 6) and RNA ex-
ti-acted from 10% aliquots of the total reaction mixtures (lanes Ito 3) 
were separated on a 7% polyacrylamide-8 M urea gel. For each re-
constitution reaction mixture. 10 0 of extract from YPGR-grown 
KL4G cells was incubated with anti-HA.-agarose beads for I h at 4C 
and the beads were washed five times with IPP15O butter and once in 
0.6 M potassium phosphate buffer (pH 7) and then incubated with 0.5 
g of HA peptide (Sigma) for 8 hat 4C to elute the HA-NtrI from the 
beads. Recombinant His,()-tagged PrP43TI23A  protein was produced in 
Escherichia coli BL2 I -CodonPlus(DE3)RIL (Stratagene) and purified 
essentially as described by Martin et al. (26). The various RNA species 
are indicated diagrammatically on the right as described in the legend 
to Fig. I. 
the higher-density fractions (fractions 3 to 7) that contain high-
molecular-weight complexes. Similarly, glycerol gradient frac-
tionation of extract from KL4G cells (HA-tagged Ntrl and 
nontagged Ntr2). followed by precipitation with anti-HA anti-
bodies, showed coprecipitation of Prp8 and of Prp43 with HA-
NtrI in the same high-density fractions (3 to 7) (Fig. 413). 
Therefore, as Ntr2 pulls down Ntrl and PrpS and NtrI pulls 
down Prp8 and Prp43 in the same high-density fractions, it is 
most likely that these four proteins are present in the same 
high-molecular-weight complex. In addition, it is notat 
the bulk of Ntrl-associated Ntr2 and Prp43 occurs in 
density fractions (Fig. 4A and B. fractions 13 to 21). Thi 
represents an Ntrl/Ntr2/Prp43 complex that is not snR 
sociated. Also, Ntr2-TAP coprecipitated both HA-Nt 
Prp8 in extract from galactose-grown (nondepleted) K 
(PGAL-HA-Ntrl and Ntr2-TAP) cells and coprecipitate 
in extract from glucose-grown KL4G2T cells, despite 1 
pletion of Ntrl (Fig. 4C. lanes 5 and 6). Thus, aithoc 
level of Prp8 that coprecipitated with Ntr2 was lower it 
depleted extract, the association of Ntr2 and Prp8, 
direct or indirect, is not absolutely Ntrl dependent, a 
case for its association with excised intron (Fig. 113). 
Ntrl is required for the association of Prp43 with 
cised intron complex. The interaction of Prp43 with the 
intron is only weakly detectable in an in vitro splicing ri 
mixture, presumably because it is highly transient ( 
unpublished data). Martin et al. (26) have produced an A 
defective mutation (T123A) in conserved motif I of the 
RNA helicase that confers a dominant negative phe 
such that the Prp43TI211  protein interferes in trans witl' 
vitro splicing function of the wild-type Prp43 protein, hi 
release of the excised intron from the spliceosome (26) 
the accumulation of postsplicing intron-retaining corn 
the presence of the Prp43T23 A protein provides a se 
assay for the interaction of the Prp43T I 23A protein wi 
complex. We therefore tested whether the purified, re 
nant PrP43TI3A protein is able to associate with the po 
ing complex produced in reaction mixtures with Ntrl-d 
and nondepleted extracts. As shown in Fig. 5. the Prp4 
protein coprecipitated excised intron RNA only from 
action mixture with nondepleted extract (Fig. 5, lanes 4 
As a control, HA-tagged Ntrl was affinity selected from 
tose-grown KL4G cell extract that contained a very hi 
centration of HA-Ntrl. The affinity-selected material v 
able, by itself, to support pre-rnRNA splicing (data not s 
however, this protein partially restored the splicing act 
Ntrl-depleted extract (Fig. 5, lane 3) and allow 
PrP431 , 123A protein to coprecipitate the excised intron I 
lane 6). These results show that the presence of Ntrl 
quired for the interaction of Prp43 with the postsplicl 
cised intron complex and explains the observed accumi 
of the excised intron complex in reaction mixtures w 
Ntrl-depleted extract. 
DISCUSSION 
Evidence that the Ntrl and Ntr2 proteins are compon 
the postsplicing excised intron complex includes the coç 
tation by Ntrl and Ntr2 of the U2, US. and U6 snRNF 
IA); the coprecipitation of more excised intron than 
intermediates or products of the pre-rnRNA splicing 
(Fig. IB): and the association of Ntr2 with Ntrl and Pr 
of Ntrl with Prp8 and with the intron release factor Prp 
high-molecular-weight complex (Fig. 4). Evidence tha 
affects the release of excised intron RNA and dissocia 
the postsplicing complex includes the reduced splicing 
and accumulation of excised intron in an in vitro .splic 
action mixture with Ntrl-depleted extract (Fig. 2C); the 
cipitation of the accumulated excised intron with Pq 
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Cefi (Fig. 2C); the reorganization of snRNPs, including a 
reduction in U41U6.U5 tri-snRNPs, and free U5 and U6 
snRNPs, and accumulation of U41U6 di-snRNPs. suggesting 
that snRNP regeneration after splicing is defective in an Ntrl-
depleted splicing reaction mixture (Fig. 313): the association of 
the U5 snRNP protein Prp8 with a U2/U5/U6 complex in an 
Ntrl-depleted splicing reaction mixture (Fig. 3C and D); and 
the failure of the Prp43II., A protein to associate with the 
excised intron in the absence of Ntrl (Fig. 5). Furthermore, 
Northern and microarray analyses of pre-mRNA splicing dem-
onstrate that NtrI is required for efficient splicing in vivo, as 
well as in vitro (Fig. 2A and data not shown). 
Taken together, these data provide compelling evidence that 
Ntrl and Ntr2 are present in the late-stage excised intron-
containing spliceosome complex and that Ntrl is required for 
the interaction of Prp43 with the excised intron prior to its 
release and recycling of the splicing factors. While the manu-
script was under review, Tsai et al. (38) published data showing 
that metabolic depletion of Ntr2 resulted in accumulation of 
pre-mRNA and excised lariat-intron in vivo and that a dimeric 
complex of Ntrl and Ntr2 is required for dissociation of spli-
ceosomes and release of lariat-intron in vitro. The data pre-
sented here complement and extend that stud y, showing that 
Ntrl is required both in vivo and in vitro for efficient splicing 
and for Prp43 to function in release of the excised intron and 
recycling of snRNPs. Tsai et at. (38) found that immunodeple-
tion of NErl quantitatively removed Ntr2 from cell extract and 
vice versa, indicating that these two proteins form a stable 
complex. We have shown that, following metabolic depletion 
of Ntrl, Ntr2 is still present in a complex with Prp8 (Fig. 4C) 
and with excised intron (Fig. 113). indicating that Ntr2 can 
associate with late splicing complexes independently of Ntrl 
but is not by itself sufficient to activate the intron release 
function of Prp43. 
Ntrl was originally named Spp382 after the role of this 
protein in suppression of the prp38-1 temperature-sensitive 
growth defect. Prp38 is a tri-snRNP-specific protein that was 
shown to be dispensable for spliceosome assembly but required 
for spliceosome maturation (6, 45). The depletion of Prp38 
caused a spliceosome maturation defect with accumulation of 
U4/U6, and the temperature-sensitive prp38-1 mutant strain 
accumulated unspliced pre-mRNA at the nonpermissive tem-
perature (45). The suppression of prp38-1 by Spp382/Ntrl may 
suggest an additional role for this protein at an earlier stage. 
during spliceosome maturation. Alternatively, ntrl mutations 
may alleviate the prp38-1 defect indirectly, for example, by 
moderating the interaction of NtrI with a common interacting 
factor or altering the rate of spliceosome assembly by affecting 
the availability of splicing factors. 
Near its N terminus, Ntrl contains a G-patch region (gly-
cine-rich sequence found in nucleic binding proteins [21, amino 
acids 61 to 106) that is the most highly conserved region of this 
protein. The mammalian 0-patch protein called TFIP11 
(tuftelin-interacting protein) is a possible ortholog of Ntrl. 
Human TFIP1I has been found in affinity-purified spliceo-
somes (18, 46), and mouse TFIP11 was reported to affect the 
alternative splicing of an adenovirus E1A reporter transcript in 
a transfection assay (44). 
Interestingly, yeast Spp2, another 0-patch protein and spli-
eosome component, interacts with the ATP-dependent 
DExI-1-box splicing factor Prp2 (33). As this interaction in-
volves the 0-patch sequence in Spp2 and is required for the 
recruitment of Prp2 to the spliceosome prior to the first cata-
lytic step of splicing, it was proposed that Spp2 may be an 
accessory factor that confers spliceosome specificity on Prp2 
(33). Thus, Ntrl appears to be an analogous accessory factor 
for Prp43, targeting it to the excised intron complex, in addi-
tion to which it might conceivably he a cofactor for Prp43 
helicase activity. Tsai et al. (38) showed that the G-patch re-
gion of Ntrl interacted with Prp43 in a two-hybrid assay. Thus. 
Ntrl might promote the interaction of Prp43 with the excised 
intron through an RNA binding activity of the 0-patch region. 
The role of Ntr2 in these proposed functions remains to be 
determined. 
Intriguingly, Prp43 was recently shown to function also in 
ribosome synthesis and to associate both with ribosome pre-
cursor complexes and with mature ribosomes (12, 20, 21). It is 
not known how Prp43 is targeted to these distinct cellular 
processes or whether this dual function allows Prp43 to coor-
dinate the regulation of ribosome biogenesis with pre-mRNA 
splicing, a process that is vital for ribosomal protein synthesis 
in budding yeast as many ribosomal protein genes contain an 
intron. It will be interesting to determine whether Ntrl acts as 
an accessory factor for both of these processes or interacts with 
only a fraction of Prp43, conferring splicing specificity and 
possibly regulating this in response to different metabolic re-
quirements of the cell. 
ACKNOWLEDGMENTS 
We are extremely grateful to Y. Henry for the generous gift of 
affinity-purified anti-Prp43 antibodies, to K. Gould for Cefl antibod-
ies, to J. Aris for and-Nopi antibodies, and to B. Schwer for the 
His-PRP43Tj ,?3A  expression plasmid. Thanks to Martin Reijns for help-
ful comments on the manuscript. 
This work was funded by studentships from The Darwin Trust of 
Edinburgh to K.LB. and T.A. and by Wellcome Trust grant 067311 to 
J.D.B. G.E.-G. is supported by NIH grant R15 GM072622. C.D. was 
supported by an EMBO fellowship. J.D.B. is a Royal Society Darwin 
Trust Professor. 
REFERENCES  
I. Albers, M., A. Diment, M. Muraru, C. S. Russell, and J. D. Beggs, 2003. 
Identification and characterization of Prp45p and Prp46p, essential pre-
mRNA splicing factors. RNA 9138-150. 
Aravind, L., and E. V. Koonin. 1999. G-patch: a new conserved domain in 
eukaryotic RNA-processing proteins and type D retroviral polyproteins. Trends Biochem, Sci. 24:342-344. 
Arenas, J. F., and J. N. Abelson. 1997. Prp43: an RNA helicase.like factor 
involved in spliceosome disassembly. Proc. Natl. Acad. Sci. USA 94:11798- 11802. 
Bartels, C., H. Urlaub, R. Luhrmann, and P. Fabrizin. 2003, Mutagenesj suggests several roles of SnuiI4p in pre-mRNA splicing. J. Blot. ('hem. 278:25324-28334 
Baudin.Baillieu, A., E. Guillemet, C. Collin, and F. Laeroute. 1997. Con-struction of a yeast strain deleted for the 7RP! promoter and coding region 
that enhances the efficiency of the polymerase chain reaction-disruption method. Yeast 13:353-356 
Blanton, S., A. Srinivasan. and B. C. Ryniond. 1992. PRP38 encodes a yeast 
protein required for pre-messenger RNA splicing and maintenance of stable 
Uh small nuclear RNA levels, Mol. Cell. Biol. 12:3939-3947 Boon, K.-L, C. Norman, P_ J. Grainger. A. Newman, and J. D. Beggs. 2006. 
Prpsp dissection reveals domain structure and protein interaction sites. 
RNA 12(2):195-205. 
S. Brow. B. A. 2002. Allosterjc cascade of spliceosome activation. Annu. Rev. 
Genet. 36333-360, 
9. Burge, C. B., T. Tuschl, and P. A. Sharp. 1999, Splicing of precursors to mRNAs by the spliceosome, p. 525-560, in R. F. Gesteland, T. R. Cech, and J. F. Atkins (ed.), The RNA world, edition 2. Cold Spring Harbor Labora-
tory Press, Cold Spring Harbor, N.Y. 
VOL. 26, 2006 
	
Ntrl MEDIATES Prp43 FUNCTION 
Chan, S. P., D. I. K,o, W. V. TaiL and S. C. Cheng. 2003. The Prpl9p-
associated complex in spliceonosne activation. Science 302279-282. 
Chan. S. P.. and S. C. Cheng. 2005. The Prp19-a.csociated complex is re-
quired for specifying interactions of US and U6 with Pre-mRNA during 
spliceosome activation. J. Biol. ('hem. 280:31190-31199. 
Combs, D. J_ R. J. Nagel, M. Ares, Jr., and S. W. Stevens. 2006. Pr$3p is 
a DEAl-I-box spliceosome disassembly factor essential for ribostome biogen-
esis. Mol. Cell. Biol. 2&623-534. 
GavIn, A. C.. M. Bosehe, R. Krause, P. Grandl, M. Marzloch. A. Bauer. J. 
Schultz, J. M. Rick, A. M. Michon, C. M. Cruclat, et al. 2002. Functional 
organization of the yeast proteome by systematic analysis of protein com-
plexes. Nature 415:141-147. 
Gietz, B., A. St. Jean, R. Woods, and R. Schiesil. 1992. Improved method for 
high efficiency transformation of yeast cells. Nucleic Acids Res. 20.142-5. 
Grainger, R. J., and J. D. Be. 2(E5. Prp8 protein: at the heart of the 
spliceosome. RNA 11:533-557. 
Hazbun,T. R., 1. Maimstrfim, S. Anderson. B. Graczyk, B. Fox., M. Riffle, B. 
Sundili, J. Arands, W. McDonald, and C. ChIu. 2003. Assigning function to 
yeast proteins by integration of technologies. Mol. Cell 12:053-1365. 
Ito, T., T. Chiba, R. Ozawa. M. Yoshida, M. Hattori, and Y. Sakakl. 2001. A 
comprehensive two-hybrid analysis to explore the yeast protein interactome. 
Proc. Nail. Acad. Sci. USA 98:45694574. 
Juries, M. S., and M. J. Moore. 2003. Pre-mRNA splicing: awash in a sea of 
proteins. Mol. Cell 12:5-14. 
Il. Konaraka, M. M., and P. A. Sharp. 1987. Interactions between small nuclear 
ribonucleoprotein particles in formation of spliceonomes. Cell 49763-774. 
Lebaron. S., C. Froment, M. Fromont.Racine, J. C. Rain, B. Monsarrat, M. 
Calzergues.Ferrer, and Y. Henry. 2005. The splicing ATPase Prp43p is a 
component of multiple preribosomal particles. Mol. Cell. Biol. 25:9269-
9282. 
Leeds, N. B., F. C. Small, S. L. Hiley, T. R. Hughes, and J. P. Staley. 2006. 
The splicing factor Prp43p. a DEAH box ATPase. functions in ribosome 
biogenesis. Mol. Cell. Biol. 26:513-522. 
Lin. R.-J., A. J. Newman, S.-C. Cheng, and J. Abelson. 1985. Yeast mRNA 
splicing in vitro. J. Biol. ('hem. 260:14780-14791 
Longtlne, M. S., A. McKenzie, D. J. DeMarini. N. C. Shah, A. Wach, A. 
Brachat, P. Philippsen, and J. Pringle. 1998. Additional modules for versa-
tile and economical PCR-based gene deletion and modification in Saccha-
romyces cerm'isiae. Yeast 14:953-961. 
Mtikarov, E. M.. 0. V. Makarova. H. Urlaub, M. Gentzel. C. L Will, M. 
Wilm. and R. L.uhrmann. 2002. Small nuclear ribonucleoprotein remodeling 
during catalytic activation of the spliceosome. Science 298:2205-2208. 
Makaros'a, 0. V., F. M. Makarov. H. Urlaub. C. L Will. M. Gentzel, M. Wilm, 
and R. Luhrmann. 2004. A subset of human 35S US proteins, including Prpl9, 
function prior to catalytic step I of splicing. EMBO J. 23:2331-2391. 
Martin, A., S. Schneider, and B. Schwer. 2002. Prp43 is an essential RNA-
dependent ATPase required for release of lariat-intron from the spliceo-
some. J. Biol. ('hem. 277:17743-17750. 
Obi, M. 0., and K. L Gould. 2002. Characterization of interactions among 
the Ceflp-PrpI9p-as.sociated splicing complex. RNA 8:798-815. 
Obi, M. D., A. J. Link. J. I. Jennings, W. H. McDonald, L. Ren, and K. L. 
Gould. 2002. Proteomirs analysis reveals stable multi-protein complexes in 
both fission and budding yeasts containing Myb-related Cdcsp/Ceflp, novel 
pre-mRNA splicing factors, and snRNAs. Mol. Cell. Biol. 22:2011-2024. 
O'Keefe, R. T., C. Norman, and A. J. Newman. 1996. The invariant US  
snRNA loop I sequence is dispensable for the first catalytic stel 
mRNA splicing in yeast. Cell 86:679-689. 
PuIg, 0., A. Gottachalk, P. Fabr*zio, and B. Seraphln. 1999. Inter 
the U  snRNP with nonconserved intronic sequences affects 5' s 
selection. Genes Dev. 13:569-580. 
Raghunathan, P. L, and C. Guthrie. 1998. A spliceosomal recycli 
that reanneals U4 and U6 small nuclear nbonucleoprotein particles 
279:857-860. 
Schwer, B., and C. H. Gross. 1998. Prp22, a DExH box RNA helict 
two distinct roles in yeast pre-niRNA splicing. EMBO J. 17:2085- 
Silverman, F. J., A. Maeda, J. Wel, P. SmIth, J. D. Beggs, and R. J. I 
Interaction between a G-patch protein and a spliceosomal DEX 
ATPase that is critical for splicing. Mol. Cell. Biol. 24:10101-1011 
Staley, J. P., and C. Guthrie. 1998. Mechanical devices of the split 
motors, clocks, springs, and things. Cell 92:315-326. 
Tarn, W. V., C. H. Hsu, K. T. Huang, H. R. Chen, H. Y. Kao, K. R. 
S. C. Cheng. 1994. Functional association of essential splicing factc 
PRP19 in a protein complex. EMBO J. 13:2421-2431. 
Tarn, W. Y., K. H. Lee. and S. C. Cheng. 1993. Yeast precursor m 
RNA processing protein PRPI9 associates with the spliceosome con 
with or just after dissociation of U4 small nuclear RNA. Proc. Na 
Sci. USA 90:10821-10825. 
Teigelkamp, S., A. J. Newman, and J. D. Beggs. 1995. Extensive int' 
of PRP8 protein with the 5' and 3' splice sites during splicing suggi 
in stabilization of exon alignment by US snRNA. EMBO J. 14:261J 
Tsai. R. T., R. H. Fu, F. L Yeh, C. K. Tseng, V. C. Lin, V. h. Huang, 
Cheng. 2005. Spliceosome disassembly catalyzed by Prp43 and its a: 
components Ntrl and Ntr2. Genes Dev. 19:2991-3003. 
Uetz, P., L Clot, G. Cagney, T. A. Mansfield, R. S. Judson, J. It K 
Lockshon, V. Narsyan, M. Srinivasan, P. Pochart, A. Qureshl.Em 
B. Godwin, D. Conover, T. Kalbfieisch, G. Vayadamodar. M. 
Johnston, S. Fields, and J. M. Rothberg. 2000. A contprehensie at 
protein-protein interactions in Saccharomyces cerevisiae. Nature 
627. 
Umen, J. G., and C. Guthrie. 1995. A novel role for a US snRNP p 
3' splice site selection. Genes Dcv. 9:855-868. 
Verdone, L S. Galardi, D. Page, and J. D. Beggs. 2004. Lcm 
promote regeneration of pre-rnRNA splicing activity. Curr. Biol. 
1491. 
Villa. T., and C. Guthrie. 2005. The lsylp component of the P' 
complex interacts with the ATPase PrpIfip to regulate the Iideliv 
mRNA splicing. Genes Dcv. 19:1894-.1904. 
Wagner, J. B., E. Jankowsky. M. Company, A. M. Pyle, and J. N. 
1998. The DEAH-box protein PRP22 is an ATPase that mediat 
dependent mRNA release from the spliceosomes and unwinds l 
plexes. EMBO J. 17:2926-2937. 
Wen, X., V. P. Lei, Y. L Zhou, C. T. Okamoto, M. L Snead, and M. 
2005. Structural organization and cellular localization of tuftelin-in 
protein 11 (TFIPII). Cell. Mol. Life Sci. 62:1038-1046. 
Me, J., K. Beickman, F. Otte, and B. C. Rymond. 1998. Progression 
the spliceosome cycle requires Prp38p function for U4/U6 snRNA 
anon. EMBO J. 17:2938-2946. 
Zhou, Z., L J. Lickiider, S. P. Gygi, and H. Reed. 2002. Compr 





rp8 mutations that cause human retinitis pigmentosa 
ad to a U5 snRNP maturation defect in yeast 
im-Loong Boon "3, Richard J Grainger', Parastoo Ehsani', J David Barrass', Tatsiana Auchynnikava', 
iris F Inglehearn 2 & Jean D Beggs' 
8 protein (Prp8p) is a highly conserved pre-mRNA splicing factor and a component of spliceosomal 1)5 small nuclear 
onucleoproteins (snRNPs). Although it is ubiquitously expressed, mutations in the C terminus of human Prp8p cause the 
ma-specific disease retinitis pigmentosa (RP). The biogenesis of 1)5 snRNPs is poorly characterized. We present evidence 
a cytoplasmic precursor U5 snRNP in yeast that lacks the mature 1)5 snRNP component Brr2p and depends on a nuclear 
:alization signal in Prp8p for its efficient nuclear import. The association of Brr2p with the 1)5 snRNP occurs within the 
cleus. RP mutations in Prp8p in yeast result in nuclear accumulation of the precursor 1)5 snRNP, apparently as a consequence 
disrupting the interaction of Prp8p with Brr2p. We therefore propose a novel assembly pathway for 1)5 snRNP complexes that 
disrupted by mutations that cause human RP. 
clear pre-mRNA splicing is an essential housekeeping process in all 
Karyotic cells. It is catalyzed by a large ribonucleoprotein complex 
led the spliceosome, which contains the snRNPs UI, U2, U4, U5 
1 U6, as well as many non-snRNP proteins" 2 . Each snRNP consists 
an snRNA, a set of specific proteins, and seven common 
proteins (or, in the case of U6 snRNP, seven Lsm proteins). 
Unexpectedly, mutations in four human snRNP-associated 
)teins—PRPF8 (ref. 3), PRPF31 (ref. 4), PRPF3 (ref. 5) and 
P-i (also called RP9) (refs. 6,7)—were found in people with a 
minantly inherited form of retinal degeneration: RP. Here, we 
'estigate the role of Prp8p (the yeast ortholog of PRPF8) in U5 
NP biogenesis in Saccharomyces cerevisiae, and the effect of RP 
itations on this process. 
Biogenesis of the U snRNPs has been studied extensively in 
tazoans 1 & The UI, U2, U4 and US snRNAs are produced as 
cursors in the nucleus by RNA polymerase II and then exported to 
cytoplasm, which is facilitated by nuclear cap-binding proteins and 
export factors CRMI and PHAX (ref. 8). In the cytoplasm, the 
ding of the Sm proteins, which is facilitated by the SMN corn-
x90, and hypermethylation of the m 7G cap to form a 
,7-trimethylguanosine (m 3G) cap' generates a bipartite nuclear 
alization signal (NLS). Import of this core snRNP to the nucleus 
mediated by the SMN complex, importin-P and snurportin-1 
f. II). Association of snRNP-specific proteins with the core particles 
required to produce mature snRNPs. Several UI- and 1)2-specific 
)teins are imported to the nucleus independently of their cognate 
.NAs, and they associate with core snRNPs in nuclear Cajal 
bodies' 2 ' 5 . It is not known at what stage the US-specific proteins 
associate with the core snRNP. The biogenesis of U snRNPs in yeast is 
less well characterized. No orthologs of PHAX or Snurportin-1 have 
been identified in S. cerevisiae116 which indicates that the nuclear 
export and re-import pathways may not exist in yeast. 
Prp8p is a large (274 kDa in humans) U5 snRNP-specific protein 
that is highly conserved in both sequence and size (reviewed in 
ref. 17). It is essential for pre-mRNA splicing' 8 and is produced in 
all mammalian tissues 19. The human PRPF8 gene consists of 
42 exons that encode a 2,335-residue protein. Mutations in 
PRPF8 cause a severe form of dominant RP (ref. 3). At least 
16 different mutations have been identified so far, including 
missense changes, premature stops and deletions 3 ' 2024 . These 
mutations are clustered at the C terminus of the protein in a 
conserved region within the last exon. 
In budding yeast, Prp8p associates with US snRNA in two com-
plexes. The simpler Aar2–U5 snRNP (ref. 25) consists of Prp8p, 
Snul 14p, Aar2p, Sm proteins and U5 snRNA. The larger U5 snRNP 
(ref. 26) lacks Aar2p but instead contains Brr2p, Prp28p, Snu40p 
and Diblp. it has been suggested that the Aar2–U5 snRNP might 
represent an intermediate particle in US snRNP biogenesis 25. Here, we 
identify a functional NLS in Prp8p and show that in its absence the 
Aar2–U5 snRNP seems to accumulate in the cytoplasm. In contrast, 
the nuclear accumulation of Brr2p, a specific component of the larger 
U5 snRNP, is unaffected. A similar analysis in yeast carrying prp8 
mutations that cause RP in humans also shows an increase in the 
Aar2–U5 5nRNP; however, RP Prp8p proteins accumulate in the 
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nucleus. We therefore propose a model for US snRNP biogenesis and a 	 Prp8o I 	.\NLS 
molecular basis for a splicing defect caused by mutations that lead to 
RP in humans. 
RESULTS 
Evidence for a cytoplasmic U5 snRNP 
A putative NLS was identified at amino acids 90---117 of Prp8p of 
S. cerevisiae within a region rich in basic amino adds that is conserved 
in most eukaryotes' 7. Codons 96-117 of PRP8 were deleted from 
plasmid pJU204 (ref. 27) to produce pKLNLS (prp8JNLS-3HA), 
and these plasmids were introduced into yeast strains KL1 and K1.$ 
(Supplementary Table I online), in which the chromosomal 
PGMI-PRP8 is strongly repressed in glucose medium. pKLNI.S 
supported only slow growth of these cells on glucose (4.5 h doubling 
time; data not shown). Immunofluorescent staining of cells showed 
that full-length Prp8p localizes to the nucleus, whereas iNLS-Prp8p is 
present in both nucleus and cytoplasm (Fig. la). When Prp8p 96_ j17  
was fused to the N terminus of green fluorescent protein (GFP), this 
caused the GFP-NLS fusion protein to accumulate in nuclei (Fig. lb), 
which confirms that this region of yeast Prp8p contains a functional 
NLS. As there was sufficient nuclear iNLS-Prp8p protein to support 
cell viability, albeit with very slow growth, there may be another N1.S 
that allows inefficient nuclear uptake of this very large protein. 
Candidates include another cluster of basic residues in the N-terminal 
portion of Prp8p (ref. 17) or, by analogy with metazoan systems, the 
m3G cap of US snRNA and/or the Sm proteins SmB and SmD1, which 
also have NLSs28 . 
Next, pJU204 or pKIANLS was introduced into yeast strains 
KLI-Aar2, KL1-Brr2p and KL1-Snull4 (in which the indicated 
protein is tandem affinity purification (TAP)-tagged), and the tagged 
proteins were observed microscopically. In strains with full-length 
Prp8p, the localization of Snull4p and Brr2p was nuclear, whereas 
Aar2p was present in both nucleus and cytoplasm (Fig. Ic-e). In 
strains with iNLS-Prp8p, SnuI14p was delocalized, with a substantial 
amount present in the cytoplasm (Fig. Ic), whereas Brr2p was 
consistently nuclear (Fig. ld). The cytoplasmic staining of Aar2p 
was also slightly increased with iNLS-Prp8p (Fig. le), but this 
effect was difficult to assess. However, when Prp8p was overexpressed, 
Aar2p became concentrated in the nucleus, whereas upon Prp8p 
depletion Aar2p was observed throughout the cells (Fig. if). This 
suggests that the nuclear accumulations of Prp8p and Aar2p 
are linked; Prp8p might mediate the nuclear accumulation of Aar2p, 
or vice versa. 
Prp8p is a component of U41U6-U5 tri-snRNPs and of free US 
snRNPs. Importantly, NLS-Prp8p coprecipitated the U5 snRNAs 
almost as efficiently as did full-length Prp8p, but it coprecipitated less 
U4 and U6 snRNAs (50%-60% relative to full-length Prp8p; Supple-
mentary Fig. la online), which suggests a defect in the incorporation 
of \NLS-Prp8p into tri-snRNPs. Such a defect may occur as a 
consequence of defective U5 snRNPs or fewer U5 snRNPs in the 
nucleus. Extract prepared from glucose-grown KLI cells that depend 
on iNLS-Prp8p for viability also showed a lower splicing activity 
(Supplementary Fig. lb), which may be caused by the reduced level 
of tri-snRNPs. 
As the U5 snRNAs seemed to be associated as efficiently with 
iNLS-Prp8p as with full-length Prp8p, despite ANLS-Prp8p being 
distributed throughout the cells, we investigated the localization of U5 
snRNA. RNA fluorescent in situ hybridization (FISH) showed that US 
snRNA was predominantly nuclear in the presence of full-length 
Prp8p but gave a substantial cytoplasmic signal in the ANLS-Prp8p 
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Figure 1 Functional analysis of a nuclear localization signal in Prp 
(a) Immunofluorescent localization of full-length Prp8-3HAp (Prp8 
iNLS-Prp8-3HAp (NLS) in KL1 cells. (b) Localization of GFP and 
fused to amino acids 96-117 of Prp8p (GFP-NLS). (c-f) lmmunofli 
localization of Snu 114-TAP (C), Brr2p-TAP (d) and Aar2p-TAP in KI 
producing either Prp8p or ANLS-Prp8p (e), or of Aar2-TAP in KL1 
grown in YPGR to overexpress Prp8p (1) or shifted into YPDA for 1; 
deplete Prp8p (j) (f). (g,h) RNA FISH for U5 snRNA (g) or 1J2 snR 
IN localization was performed on KL1 cells producing either Prp8p 
NLS-Prp8p. In each panel the protein or RNA being detected is ir 
at the top and the status of Prp8p is shown at the bottom. These ar 
merged images; immunofluorescence is shown as red, DAPI is shoi 
blue and GFP is green. Scale bar, 10 tim. 
with U5 snRNA in the cytoplasm and in the nucleus. In con 
snRNA was nuclear in both strains (Fig. lh), as was U6 snR 
not shown). 
Distinct Aar2- and 6rr2p-U5 snRNPs 
In biochemical studies, human Brr2p was found stably associa 
human Prp8p in the absence of RNA 29. However, a U5 RNP 
has been identified25 that contains Prp8p and Aar2p but fl( 
Indeed, we found that TAP-tagged Prp8p pulls down Aar2p 
but that TAP-tagged Brr2p does not coprecipitate Aar2p frori 
containing either wild-type (WT) Prp8p or ANLS-Prp8p (Fl 
We analyzed the distribution of Aar2p, Brr2p and Snu 
Prp8p-associated complexes using a combination of glycerol 
centrifugation and anti-HA (hemagglutinin) immunoprecipil 
extracts from KL3-Brr2p cells expressing either frail-length PIT 
or LNLS-Prp8-3HAp. Gradient fractions were incubated w 
HA agarose, and the precipitates were analyzed by western blo 
presence of Brr2p- I 3Myc, Snu I 14 and Aar2p. The results sI 
NLS-Prp8p coprecipitated more Aar2p and less Brr2p than 
Prp8p (Fig. 2). With WT Prp8p, Snuli4p was more conceni 
the bottom fractions (Fig. 2b), which contained the Prp8-a 
Brr2p but little or no Aar2p. In contrast, with NLS-Prp8p, 
was more evenly distributed between the fractions containir 
and Aar2p (Fig. 2c). Thus, the NLS-Prp8p extract contain 
Prp8p-Snui 14p-Aar2p complex and less Prp8p-SnuI 14 
complex than the WT. 
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igure 2 More Prp8p-Aar2p-U5 snRNP complex a 	Pull-down with b xms with ANLS-Prp8p. (a) Aar2p is 19G-agarose Botkxn 	tO%-O% glycerol gradient 	Top Size 
Dimmunoprecipitated with Prp8p but not with - Prp8Bn2Br72 FradICIt 1 	3 	5 	7 9 	11 1315 17 19 21 23 25 27 market 
rr2p. Cell extracts from nontagged strain Prp8p-TAP- 	- 	- Prp8-3HAp Bi2) 	- 
(kOa) 
MA38a (lane 1), Prp8p-TAP strain RG8T 191 - BnTAP WT -191 
ane 2) and Brr2p-TAP strain KL1-Brr2 carrying  
JU204 (Prp8-3HAp; lane 3) or pKLNLS 
_ - - Size 97- 	 Saul 14p 
ma 
_______ 
Snu ll4p 	 - 
-97 
NLS-Prp8-3HAp; lane 4) were incubated with Da) 	_ 
G-agarose, and precipitates were analyzed by -M 
estern blotting with anti-HA, anti-Aar2p and 51 - 
riti-Snull4 antibodies (note that Prp8p-TAP in -A.arp -51 
ne 3 and Brr2p-TAP in lanes 3 and 4 are 39- -Aar Aar2p 39 
etected by any lgG). A longer exposure of the Lana I 	2 	3 	4 
ar2p region of the blot is shown below. d C 	Fraction 1 	3 	5 	7 	9 	1113151719 21232527 
Size 
mark 
,c) Glycerol gradient fractionation of Prp8p- ' Bn2p 	- 	- SNLS (kDa) 
Ap-associated complexes from KL3-Brr2p cells 
roducing WT Prp8-3HAp (b) or 	NLS-Prp8- vs, Snull4p 40 110404111MM'm 
HAp (c). Glycerol gradient fractions were 
recipitated with anti-HA agarose, and the ' 	'' 	% F' 
recipitates were western blotted and probed with TotalP 	Total P NLS/WT -64  
rtti-Aar2p, anti-Myc and anti-Snull4p 0% -- U5L- 	- 200   
ritibodies. (d) Immunoprecipitation of Aar2p uss - 0 	- eoo't Aar2p 	- - 	- - 
om splicing extracts derived from KL1-Aar2p Lane 	1 	2 3 4 -39 
roducing WT Prp8p (lane 2) or 	NLS-Prp8p 
ane 4). Extracts were incubated with lgG-agarose and precipitated RNA5 were analyzed by northern blotting, probing for U5 snRNAs. Lanes 1 and 3 show 
5% of the amount of extract used for each immunoprecipitation (lP). 
The association of U5 snRNA with the Aar2p complex was 
lvestigated in cell extracts from KLI-Aar2 containing either Prp8p 
r ANLS-Prp8p. An increased amount of U5 snRNA coprecipitated 
rith Aar2p from extract containing L\N1-S-Prp8p compared with full-
ngth Prp8p (Fig. 2d). This supports the conclusion from the 
radient fractionation experiment that the level of Aar2p-U5 snRNP 
Dmplex increased when nuclear accumulation of Prp8p was hindered. 
Thus, the existence of two distinct Prp8p complexes256 is sup-
orted by our finding that Prp8p was associated independently with 
rr2p or with Aar2p in different glycerol gradient fractions, and that 
rr2p did not pull down Aar2p. Furthermore, the glycerol gradient 
sults showing that the prp8ANLS mutation increased the amount of 
ar2p-Prp8p complex and decreased the amount of Brr2p-Prp8p 
omplex suggest that these complexes may be in equilibrium. The 
resence of U5 snRNA in a cytoplasmic Aar2-Prp8p complex is 
.iggested by the delocalization of U5 snRNA and the association of 
lore Aar2p with US snRNA and with Prp8p in prp84NLS cells. Also, 
[though iNLS-Prp8p is substantially delocalized to the cytoplasm, it 
nevertheless associated with a similar amount of U5 snRNA 
3mpared to full-length Prp8p. We therefore propose that there is a 
ytoplasmic Aar2-Prp8p-Snull4-U5 snRNP complex that, once 
nported to the nucleus, is in equilibrium with the Brr2p-Prp8p-
nul14-U5 mature snRNP complex. 
The existence of a U5 precursor that lacks Brr2p raises the 
uestion as to whether there is a separate pool of Brr2p that is not 
rp8p-associated, or whether Brr2p may be limiting in yeast cells. To 
igure 3 Analysis of Brr2p interactions. (a) Splicing extract from glucose-
own KL1-Brr2p cells carrying pJU204-noHA (Brr2p-TAP, untagged Prp8p) 
as glycerol gradient fractionated and precipitated with lgG-agarose, and the 
ecipitates were analyzed by western blotting, probing with anti-Snul 14p 
itibodies. (b) RG-B64-8T cells (Prp8p-TAP) and RG-MetB2-8T cells 
kp8p-TAP and PMD--BRR2) were grown under inducing conditions (no 
ethionine), and then methionine was added to 10 mM to repress BRR2 
(pression. Cell extracts were prepared at 0, 6.5 and 10 h after addition of 
ethionine (vertical arrows). (C) Extracts prepared as in b were incubated 
ith lgG-sepharose beads, and the pellets were analyzed by western blot 
lalysis, probing with anti-Brr2p, anti-Snu 1 14p and anti-Aar2p antibodies. 
investigate this, cell extract containing Brr2p-TAP and untagged Prp8p 
was analyzed by glycerol gradient fractionation, precipitation with 
IgG-agarose and western blot with anti-Snul 14p antibodies. Notably, 
two peaks of Brr2p were found, one at the bottom of the gradient 
(Fig. 3a) that coprecipitates Snul 14p, and another in lighter fractions 
(Fig. 3a) that does not coprecipitate Snul 14p. Stripping the blot and 
reprobing with anti-Prp8p antibodies showed that Prp8p is associated 
with Brr2p only in the heavier fractions (I to 11, not shown), which is 
in agreement with the Prp8p pull-down of Brr2p (Fig. 2b). Thus, in 
addition to the Brr2p that is complexed with Prp8p and Snul l4p in 
mature U5 snRNPs, there is a pool of Brr2p that is not associated with 
either Snul 14p or Prp8p. Future studies should determine whether 
the latter form of Brr2p is complexed with other proteins, such as the 
U5 snRNP proteins Snu40p, Prp28p and Diblp. 
The proposal that the Aar2p-Prp8p complex is in equilibrium 
with the Brr2p-Prp8p complex also predicts that this equilibrium 
might be disturbed by altering the availability of Brr2p. To test 
this, we constructed strain RG-MetB24T, in which expression 
of BRR2 is repressed by methionine and Prp8p is TAP-tagged. 
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Addition of methionine to the growth medium causes cell growth 
to slow substantially after about 10 h (Fig. 3b) as a consequence of 
Brr2p depletion. Prp8p-TAP precipitation followed by western blot 
showed that at 6.5 and 10 h following addition of methionine, as 
Brr2p became depleted, less Brr2p and more Aar2p was coprecipi-
tated with Prp8p-TAP, whereas the amount of Snul l4p associated 
with Prp8p-TAP was similar (Fig. 3c). This strongly supports an 
equilibrium between the Aar2p-Prp8p and Brr2p-Prp8p complexes. 
Aft 
U5 snRNP maturation and RP 
As all of the RP-causing mutations affect amino acids in the extreme 
C terminus of human Prp8p, a region that is highly conserved from 
yeast to human, we investigated the effects of some of these mutations 
in the budding yeast Prp8p. Seven missense mutations were tested, 
each changing an amino acid that is identical in human and budding 
yeast Prp8p. We previously demonstrated a two-hybrid interaction 
between Brr2p and the C terminus of Prp8p (ref. 30). This interaction 
was disrupted by the yeast prp8-1 mutation, which affects the same 
region of Prp8p as the RP mutations 30. We therefore used an in vitro 
binding assay to investigate the effects of seven missense RP muta-
tions' (referred to hereafter as rpl-rp7; Fig. 4a) on the association 
of a C-terminal Prp8p peptide with Brr2p. Yeast Prp8p 2 ,21 .2413 
was identified as the minimum region for the interaction with 
Brr2p, although the interaction was strengthened with a longer 
peptide (Supplementary Fig. 2 online). The 35S-methionine-labeled 
204 amino acid peptides were produced by in vitro translation and 
incubated with yeast cell extract containing full-length Myc-tagged 
Brr2p and anti-Myc antibodies. Relative to the WI' Prp8p peptide, all 
seven ptp8-rp mutations that were tested reduced or eliminated the 
association with Brr2p (Fig. 4b). Similarly, researchers recently used a 
two-hybrid assay in yeast to show that some of the same RP mutations 
when present in the C terminus of human Prp8p disrupt i 
action with human Brr2p and/or with human Snu 114 (ref. 31 
the molecular defects caused by the RP mutations may be cc 
from yeast to humans. 
We then created yeast strains that express these seven prp8-, 
by introducing the mutations either into the chromosomal P11 
or into PRP8 on a plasmid in a strain in which the chromosor 
is fully repressed in glucose medium. The rp strains made by 
approaches gave similar results. The rpl (P2379T), rp2 (F238: 
(H2387R) and rp4 (H2387P) mutant strains behaved in an I 
manner, showing variable colony sizes, and the rp3 and rp4 I 
failed to grow at 37 °C. The rp5 (R2388K) and rp6 (R2388G 
supported good growth at 23 °C but poor or no growth at hi 
lower temperatures, whereas rp7 (F2392L) caused a mild 
defect at 14 C to 18 °C. As the rp5, rp6 and rp7 mutants 
more stable phenotypes, they were selected for further analy 
presence of the 31-IA tag at the C terminus of Prp8p exacerb; 
growth defects of the rp mutants relative to untagged rp allel 
not shown; also, A. Kutach and C. Guthrie, University of Ca 
San Francisco, personal communication). This is notable in 
the fact that one of the reported RP mutations alters the stop c 
human PRPF8, thereby extending the open reading frame by 4 
acids20. Although the addition of a C-terminal 3HA tag does n 
an obvious growth or splicing defect with WT yeast Prp8p, 
enhance the 1W phenotype of prp8-rp mutants by effectively c 
ing two rp alleles. The extended sequence might further wea 
interaction of the C terminus of Prp8p with Brr2p, when it is 
weakened by the rpl-rp7 point mutations. In all experimc 
tagged mutants were compared with tagged WT. Howei 
C-terminal peptide used in the in vitro pull-down exp 
(Fig. 4b) was not tagged. 
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When extracts from prp8-rp5 cells were tested for the ability to 
lice in vitro, the rate of ACT] pre-mRNA splicing was slower than in 
IT extracts (Fig. 4c). In addition, there was a severe splicing defect 
hen reactions were incubated at both lower and higher temperatures 
upplementary Fig. 3 online). Thus the in vitro splicing activity 
towed the same heat and cold sensitivity as growth of the prp8-rp5 
iutant cells. RT-PCR analysis showed a defect in the splicing of ACTI 
anscripts in vivo in rp5 and rp6 cells grown at 30 °C that increased 
ibstantially at 37 °C (Supplementary Fig. 4 online). In addition, 
licroarray analysis showed a genome-wide splicing defect for rp5 
lutant cells incubated at 14 C or 37 °C and for rp6 mutant cells 
cubated at 37 °C, which confirms a general splicing defect in vivo 
upplementary Fig. 5 online). 
To investigate the effect of the rp5 mutation on the association of 
rp8p and Brr2p with snRNPs, extracts from WT and rp5 mutant cells 
ere incubated with anti-Prp8p or anti-Brr2p antibodies, and the 
)precipitated snRNAs were detected by northern analysis. Mutant 
td WT Prp8ps were associated with similar levels of U5 snRNAs, but 
tutant Prp8p brought down less U4 and U6 snRNAs, which indicates 
defect in the incorporation of mutant Prp8p into U4/U6-U5 
i-snRNPs (Fig. 4d). In contrast, Brr2p was associated with less U4, 
15 and U6 snRNAs in the mutant compared with the WT, but the 
ifference was more pronounced for the U5 snRNAs (Fig. 4d). This 
sult is supported by the amounts of snRNAs that were unbound 
Fig. 4d) and suggests a defect in the association of Brr2p with U5 
iRNA in the mutant strain, with most or all of the mutant U5 
RNPs that do contain Brr2p being incorporated into tri-snRNPs. 
hese results strongly suggest that although the rpS mutation does not 
revent the association of mutant Prp8p with U5 snRNA, it causes a 
efect in the formation of Brr2p-containing U5 snRNPs, which results 
reduced amounts of U4/U6-U5 tri-snRNP complexes, which would 
plain the reduced splicing efficiency. 
Extracts from the prp8-rp mutation strains were fractionated 
glycerol gradients followed by immunoprecipitation of Prp8p 
rid western blot analysis. Compared with WT Prp8p (Fig. 4e), the 
rp8p-rp mutant proteins were associated with less Brr2p (Fig. 4f—h) 
rid more Aar2p (Fig. 4f—h). Also, in the mutant extracts the 
istribution of Prp8p-associated Snu114p was different, with less 
resent in the high-density fractions compared with WT. The effect 
f the prp8-rp5 mutation on Brr2p associations was then investigated 
a similar way. Notably, extract from the mutant strain showed more 
rr2p in the lighter gradient fractions and less Snul 14p coprecipitat- 
g with Brr2p from the denser fractions (Supplementary Fig. 6 
nline). As expected, no Aar2p was detected in any of the Brr2p 
recipitates. This supports the conclusion that the prp8-rp5 mutation 
suses reduced incorporation of Brr2p into U5 snRNPs and larger 
iRNP complexes. 
The effects of the prp8-rp mutations on snRNP formation and 
,licing resemble those of the prp8zlNLS mutation. We therefore used 
nmunofluorescence microscopy to investigate the localization of the 
east Prp8p-rp mutant proteins. However, unlike the ANLS-Prp8p, 
e Prp8p-rp mutant proteins showed no sign of delocalization from 
e nucleus (data not shown). Thus, unlike the situation with ANLS-
rp8p, the Prp8p—Aar2p complex that accumulates in the prp8-rp 
iutants is nuclear and therefore has the possibility to interact with 
rr2p but does so with reduced efficiency as a consequence of the poor 
;sodation of Brr2p with Prp8p-rp mutant proteins. 
ISCUSSION 
)ur data confirm the existence of two distinct US snRNP complexes 
rid suggest that U5 snRNP biogenesis has a cytoplasmic phase in 
Nuchm 40  
SNLS-Prp8p 
\4 16 
r NPC 	 Prp8p 	\ € 
(WIE 
	
A 	Retinitis pigmentosa U5 snRNA 	 (pipe mutations) 
Sm 
US snRNP 
precursor toimaflon 	 U5 &IRNP maturation 
Figure 5 Cartoon showing the proposed pathway for U5 snRNP biogenesis in 
budding yeast. Note that the U5 snRNP proteins Prp28p, Snu40p and 
Dibip are not shown. Their interactions were not investigated in this work, 
but based on the reported compositions of the Aar2p- and Brr2p-containing 
particles25 ' 26 , they are assumed to join the U5 5nRNP in the nucleus at the 
same stage as Brr2p. NPC, nuclear pore complex; Sm, a complex of seven 
core snRNP proteins. 
yeast similar to that found in metazoan cells. Although the association 
of Prp8p with cytoplasmic US snRNP precursor particles has not been 
noted in metazoan cells, considering the high conservation of the US 
snRNP components (especially of Prp8p), it seems likely that the 
pathway of US snRNP biogenesis is also conserved. Indeed, a role for 
Prp8p in the nuclear uptake of U5 snRNP precursor particles could 
explain why this process is m 3G cap—independent in Xenopus sp. 
oocytes32. Within the nucleus, the conversion of US precursor to 
mature U5 snRNP involves substitution of Aar2p at the C terminus 
of Prp8p by Brr2p, and presumably the acquisition of the other three 
US-specific proteins (Prp28p, Snu40 and Diblp). The rp mutations 
residing in the C terminus of Prp8p interfere with US snRNP 
maturation in a different manner than the N-terminal ANLS muta-
tion, causing a defect in the interaction of Prp8p with Brr2p and 
thereby reducing functional U5 snRNP and U4/U6-1J5 tri-snRNP 
formation in the nucleus (Fig. 5). Although a precursor-product 
relationship between the Aar2—U5 complex and the Brr2p—U5 
snRNP has not been formally demonstrated, such a relationship is 
strongly suggested by the finding that (i) the amount of Aar2p—Prp8p 
complex is increased, and the amounts of Brr2p—Prp8p complex and 
U4/U6-U5 tri-snRNP complex are decreased as a consequence of the 
prp8zlNIS or the prp8-rp mutation, (ii) the amount of a new form of 
Brr2p that is not Prp8p-associated is increased by the prp8-rp5 
mutation and (iii) the metabolic depletion of Brr2p also causes an 
accumulation of Aar2p—Prp8p complex. 
We showed previously33 that Prp8p771_4413 associates with Aar2p 
and that dissection of Prp8p at residue 2,173 by expressing it as two 
separate polypeptides disrupts its association with Aar2p. Therefore, 
Aar2p may interact with the C terminus of Prp8p in close proximity to 
the region of Brr2p interaction. This suggests a potential model for a 
competitive interaction of Aar2p and Brr2p with Prp8p. Presumably, 
Aar2p has an as-yet-unknown but important role in the biogenesis of 
US snRNPs, possibly as a chaperone to control the assembly of 
the mature particle. Therefore the cytoplasmic location for the 
formation of the precursor US pat -tide may be a critical feature of 
US snRNP biogenesis, ensuring that Aar2p associates with Prp8p 
before it is exposed to Brr2p in the nucleus. Indeed, there is evidence 
that the prior binding of Aar2p to a C-terminal fragment of Prp8p 
inhibits the subsequent association of Prp8p with Brr2p in vitro 






(A. Kutach and C. Guthrie, University of California, San Francisco, 
personal communication). 
These observations support the hypothesis that the rp defect is a 
consequence of decreased affinity of Brr2p for a mutated C terminus 
of Prp8p; this decreased affinity results in a defect in the production 
of mature U5 snRNPs in the nucleus. This further suggests that 
the normal equilibrium between the Aar2p-U5 complex and the 
Brr2p-U5 snRNP complex depends, at least in part, on this Prp8p-
Brr2p interaction. 
The reduced splicing activity in yeast carrying the rp mutations 
(Fig. 4c) is likely to be a direct consequence of the reduction in the 
concentration of mature U5 snRNPs. This is presumably the earliest 
defect in the splicing pathway that is caused by the rp mutations. 
However, the incorporation of mutant Prp8p into spliceosomes may 
also affect spliceosome activation by Brr2p and might explain the 
observed temperature sensitivity of growth and of splicing caused by 
some of the rp alleles. 
Could this reduced splicing activity explain the clinical conse-
quences of RP in humans? The first symptoms of RP are night 
blindness and loss of peripheral vision, generally beginning in child-
hood. RP is therefore a late-onset, progressive, degenerative disease 
rather than a developmental defect. The retina is a complex, specia-
lized, nondividing tissue with high oxygen consumption and an 
unusually large number of mitochondria, which implies a high 
metabolic rate (reviewed in ref. 34). Rod and cone photoreceptors 
turn over their outer segments daily, which is likely to require a high 
level of expression of both retina-specific and housekeeping genes 
during a particular period early each day. Therefore, a reduced level of 
splicing activity may have a cumulative effect that has much more 
serious consequences in these cells than in other tissues. 
However, mutations causing human inherited disease have been 
identified in other components of the splicing machinery35 , each of 
which may also cause mild splicing defects, and it is unclear what 
makes the effect of the rp mutations retina-specific. The fact that these 
cause a dominant genetic defect in humans may offer a clue. The rp5 
and rp6 mutations did not cause a dominant growth defect in 
heterozygous diploid yeast (data not shown). Therefore, the dominant 
aspect of the disease may be specific to retinal cells. How could our 
model explain dominance? The accumulation of the Aar2p-U5 snRNP 
in the nucleus might cause a dominant defect if it became inappro-
priately incorporated into tri-snRNPs or spliceosomes. Alternatively, 
accumulation of defective Aar2p-U5 snRNP might sequester a specific 
factor required for its conversion to the mature U5 snRNP. Also, this 
factor may be limiting in retinal cells, or the splicing of certain retinal-
specific transcripts may involve a retinal-specific factor (in particular a 
US snRNP or U4/U6-U5 tri-snRNP component) that is more sensitive 
to this defect. It will be important to further characterize the process of 
U5 snRNP maturation and the specific function of the Aar2p protein. 
In the meantime, the results presented here explain how RP mutations 
can cause a splicing defect and suggest testable hypotheses for the 
molecular basis of splicing factor RP in human cells. 
METHODS 
Yeast strains and plasmids. Yeast strains and plasmids used in this work 
are listed in Supplementary Table 1. Oligonudeotides are in Supplementary 
Table 2 online. p LNI.S was constructed by deleting codons 96-117 via site-
directed mutagenesis of PRP8 in pJU204 (ref. 27) using oligos F-NLS-P8-352 
and R-NLS-P8-285. Strain KLI has a chromosomal P(M,.GST-prp8Eiaa1-78 
allele that encodes Prp8p with the nonessential N-terminal proline-rich region 
(amino acids 1-78) missing, thereby allowing use of anti-8.6 antibodies 33 to 
detect only plasmid-encoded Prp8p. KLI and KU cannot grow in glucose 
medium in the absence of plasmid-encoded PRP8, as the chromosomal PRP8 is 
strongly repressed. KU and KL3 were generated from BMA38a b 
PCR gene replacement using pFA6a-kanMX6-pGALI -GST or pFA6a 
pGALI-GST as template. Strains KL1-Snuil4, KLI-Brr2p and J 
were derived from KL1, and KL3-Brr2p was derived from KU b) 
PCR31. The C terminus of PRP8 (encoding amino acids 2,173-2,413 
tag) from pJU204 was cloned next to a hygromycin B marker 
pC8HH. By site-directed mutagenesis, two series of rp mutant plasi 
produced in pC8HH (pC8HH-rpl-pC8HH-rp7) and in pJU204 
pKL-rp7). The RP mutations were introduced into the genomic PRF 
YCL46 (ref. 38) by one-step PCR from pC8HH plasmids using Hphr 
Microscopy. GFP fluorescence was detected in BMA38a cells carry 
pGFP-N.FUS (ref 39) or pGFP-N-NLS and grown in SD-Ura-
immunofluorescence microscopy, cells grown to 0.3-0.5 optical 
600 nm (OD) were fixed with 1/10 volume 37% (v/v) formald 
30 mm, washed 3 times with buffer B (0.1 M potassium phosphat 
1.2 M sorbitol) and resuspended in 0.5 ml buffer B with lyticase for 
30 °C. Cells were collected and washed once with buffer B. Fixed 
immobilized on poly-L-lysine-coated microscope slides, blocked with 
milk in PBST (phosphate-buffered saline with 0.1% (v/v) Tween 
incubated overnight at 4 °C with antibodies (anti-HA 1:1,000, Rochi 
protein A 1:10,000, Sigma) in a humid chamber. After washing s 
6 times for anti-protein A antibodies or 3 times for anti-HA antibo 
were incubated with Alexa Fluor 594 secondary antibodies (Molecula 
for I h at 23 °C in the dark, washed with PBST as before, then mou 
DAPI (4',6-diamidino-2-phenylindole). Images were obtained usin 
DMRA2 microscope with CoolSnap HQ-cooled CCD camera (Rot 
tiflc) and LeicaFW400 software (Leica) 40'41 . 
RNA fluorescent in situ hybridization. The method was adapted 
Singer lab protocol (http://www.singerlab.org/protocoiaIinsitu_yi  
Yeast cells were grown in 36-ml cultures to early log phase (OD( 
0.2 and 0.4) and then fixed for 10 min at room temperature (21-
directly adding to the medium 8 ml of 20% (v/v) formaldehyde, 5 
acetic acid. The fixative was removed by three rounds of washing w 
ice-cold (0-4 C) buffer B and centrifugation (5 min at 1,100g, 4 'C). 
spheroplasted as described above in the Microscopy section, centri 
2 min at I,lOOg and 4 'C, and washed once with ice-cold buffer B. 
resuspended in 500 0 of buffer B, and 100 .d was added to a poly 
coated slide and left to adhere by incubating for 30 min at 4 
were washed once with ice-cold buffer B and stored in 70% (v/v) t 
-20 °C. Hybridization: cells were rehydrated for 5 min in 2x SSC 
NaCl, 30 mM sodium citrate, pH 7.0) and 50% (vfv) formam 
hybridized overnight at 37 'C in 40 ai of a mixture containing It 
dextran sulfate, 0.02% (w/v) RNase-free bovine serum albumin (BS 
Escherichia coli tRNA, 2x SSC, 50% (v/v) fbrrnamide, 1 p1 RNasin 
probe (10 ng). Cells were washed twice for 30 min in 2x SSC, 5 
formamide at 37 'C (U2 probe) or 45 'C (US and U6 probes) 
mounted with Vectashield containing DAPI. The U2 FISH prob 
previously described 42. U2, U5, and U6 FISH probes were 5' Cy3-
oligos as listed in Supplementary Table 2. 
Immunoprecipitation, northern analysis and glycerol gradient fract 
Yeast cell extracts were prepared 17  and splicing reactions were per 
using as substrate 32P-labeled p283 (ACT1) transcript produced b 
transcription. Immunopredpitation of snRNPs and spliceosos 
performed using rabbit anti-Prp8p polyclonal antibodies (anti-8.6 
and washes containing 150 mM NaCl. The immunoprecipitates we] 
teinized by SDS/proteinase K treatment and phenol/chioroform/isoan 
extraction, and the RNA was fractionated on a 6% polyacrylamide gel. 
labeled oligonucleotides used to detect snRNAs in northern blotting 
in Supplementary Table 2. Levels of snRNAs were quantified using 
Phosphorimager (GE Healthcare). 
Glycerol gradients were made and run essentially as described 
splicing extracts (80 0) were diluted with 120 0 GG buffer (20 mM I 
pH 7.0, 100 mM KCI, 0.2 mM EDTA; final glycerol concentration 8 
sedimented through a 10%-30% (vlv) linear glycerol gradient at 243 
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or 17 h in a SW40 Ti rotor (Beckman) at 4 C, and 400-0 fractions were 
llected53. Alternate fractions were incubated with 25 d of anti-HA agarose 
ernight, with mixing at 4°C. The precipitates were fractionated in a 4%-12% 
dyacrylamide gel, blotted and probed with anti-Aar2p (ref. 25), anti-SnuIl4 
if 45), anti-Brr2p (against an N-terminal peptide) and/or anti-Myc anti-
dies (Santa Cruz Biotech). 
p8p peptide counmunoprecipitation. Sequences that encode amino acids 
110-2,413 from the C terminus of Prp8p, with and without the rp mutations, 
crc amplified by PCR from plasmids pC8HH-rpl-pC8HH-rp7. The 
S-methionine--labeled Prp8p peptides were produced using the TnT T7 quick 
PCR DNA kit (Promega). The protein interaction assay contained 25 iI of 
ast extract from strain BCQ1 (overproducing Myc-Brr2p), S 0  of 35S-labeled 
iT reaction, 8 lul of mouse monoclonal 9ElO anti- Myc antibody (Roche) and 
mg of protein A-sepharose, in a total volume of 300 lul of buffer (12 mM 
EPES pH 7.9, 150 mM NaCl, 5 mM MgCl2, 0.1% (v/v) NP-40), incubated 
th mixing for 1 h at 4 °C. The pellets were washed with 50 mM Tris pH 7.5, 
0 mM NaCl and 0.1% (vlv) NP-40, then resuspended in SDS loading buffer 
Ld separated by electrophoresis in an 8% SDS polyacrylamide gel, and the gels 
crc dried and exposed for autoradiography. 
ue: Supplementary information is available on the Nature Structural & Molecular 
slogy website. 
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